Unveiling the mechanisms of evolution towards fluconazole resistance of a Candida glabrata clinical isolate: a
transcriptomics approach
Mafalda Banazol de Santa Rita Cavalheiro
Thesis to obtain the Master of Science Degree in
Biotechnology
Supervisors: Prof. Dr. Miguel Nobre Parreira Cacho Teixeira
Dr. Isabel Alexandra Marcos Miranda
Examination Committee
Chairperson: Prof. Dr. Isabel Maria de Sá-Correia Leite Almeida
Supervisor: Prof. Dr. Miguel Nobre Parreira Cacho Teixeira
Members of the Committee: Dr. Ana Isabel Silva Dias
October 2015
ii
iii
“The only source of knowledge is experience”
Albert Einstein
iv
v
Acknowledgments
First of all, I would like to thank my supervisor Professor Miguel Nobre Parreira Cacho Teixeira
for the opportunity given by accepting me in his team and in this project. His inexhaustible support,
guidance and motivation, as well as the patience showed, were crucial for the success of the work
developed in this master thesis.
Also, I thank my co-supervisor, Dr. Isabel Miranda who, although at some distance, was
always supportive and available regarding the work developed herein.
I would like to thank Professor Isabel Sá-Correia for allowing me to develop my work in the
Biological Sciences Research Group, with an incredible team, always supportive.
For all the help and friendship, a big thanks to Dr. Catarina Costa, a Post-Doc member of our
team. All the work beside you has contributed for my growth as an investigator.
The achievement of this thesis required an indispensable help from several parts, which
deserve my recognition. To Professor Acácio Rodrigues, Dr. Isabel Miranda, Dr. Ana Silva Dias and
all the team, I would like to thank the collaboration in the work performed at Centro Hospitalar of
S. João, Porto. Equally, for the collaboration in the transcriptomic analysis herein accomplished, I
thank Professor Geraldine Butler and her team, from University College of Dublin. For the supply of
Candida glabrata mutants used in this work, I have to thank Professor Hiroji Chibana, from University
of Chiba, Japan. For the study developed in HPLC analysis of ergosterol levels, I thank also Professor
Nuno Mira for his availability and assistance.
My gratitude must also be express towards my colleagues Rui Santos e Pedro Pais, who
helped in several steps of my work.
For all the support and friendship, I leave a big thanks to my friends Alexandra Salvado,
Ângela Neves, Sara Gomes and Ana Luísa Miranda, who never stop believing me.
Without enough words, I thank my better half, Pierre, for his infinite love, patience and support,
for always having faith in me and for being my safe harbour.
Lastly, I thank my family, specially my parents, for the love and support throughout the course
of my life.
This work was financially supported by Fundação para a Ciência e Tecnologia (FCT), contract
PTDC/EBB-BIO/119356/2010 and UID/BIO/04565/2013.
vi
vii
Abstract
Candida glabrata clinical isolates are often found to exhibit azole antifungal drug resistance,
hampering the success of therapeutic procedures. Further insights into the molecular mechanisms
underlying the development of resistance towards individual azole drugs, as thus required.
In this work, a transcriptomics analysis of the evolution of a C. glabrata clinical isolate from
azole susceptibility to posaconazole resistance (21st day), clotrimazole resistance (31st day) and
fluconazole and voriconazole resistance (45th day), induced by longstanding incubation with
fluconazole, was carried out. The acquisition of posaconazole resistance involved increased levels of
expression of genes associated to transcription, translation and cell cycle, while the
posazonazole/clotrimazole resistance development was triggered by an up regulation of CgERG11
gene and of adhesin encoding genes. Finally, the posaconazole/clotrimazole/fluconazole/voriconazole
resistant strain, found to exhibit a GOF mutation in the CgPDR1 gene, displayed an up regulation of
genes encoding multidrug resistance transporters and the eisosome component CgPil1. Along this
evolution, C. glabrata cells displayed the ability to accumulate progressively lower levels of azole
drugs, while their ergosterol concentration was found to change only to lower levels in the final strain.
Based on the obtained global results, a deeper analysis of the role of adhesins and eisosomes in
azole drug resistance was undertaken, leading to the characterization of the adhesin CgEpa3 and the
eisosome component CgPil1 as new determinants of azole drug resistance.
Altogether, this study highlights the multifactorial nature of azole drug resistance acquisition
and that new players have to be considered in this context.
Keywords: Candida glabrata, azole resistance, CgEpa3, CgPil1.
viii
ix
Resumo
Isolados clínicos de Candida glabrata exibem frequentemente resistência a azóis,
comprometendo o sucesso de procedimentos terapêuticos. São assim necessários novos
conhecimentos sobre os mecanismos moleculares subjacentes ao desenvolvimento de resistência a
cada azole.
Neste trabalho, foi realizada uma análise transcriptómica da evolução de um isolado clínico
de C. glabrata susceptivel aos azóis até à aquisição de resistência ao posaconazole (21º dia), ao
clotrimazole (31º dia) e ao fluconazole e voriconazole (45º dia), induzida pela incubação prolongada
com fluconazole. A estirpe resistente ao posaconazole exibe um aumento dos níveis de expressão de
genes associados a transcrição, tradução e ciclo celular, enquanto a estirpe resistente aos
posaconazole/clotrimazole apresenta um aumento da expressão do gene CgERG11 e de genes que
codificam adesinas. A estirpe resistente aos posaconazole/clotrimazole/fluconazole/voriconazole
exibe uma mutação GOF no gene CgPDR1 e um aumento da expressão de genes que codificam
transportadores de resistência a múltiplas drogas e do componente de eisossomas CgPil1. Ao longo
da evolução, as células de C. glabrata foram aumentando a sua capacidade de acumular
progressivamente menores concentrações de azóis, enquanto a concentração de ergosterol
membranar decresceu para níveis mínimos. Baseado nos resultados globais obtidos, foi realizada
uma análise mais profunda do papel das adesinas e eisossomas na resistência aos azóis, levando à
caracterização da adesina CgEpa3 e do componente CgPil1 dos eisossomas como novos
determinantes de resistência aos azóis.
No geral, este estudo realça a natureza multifactorial da aquisição de resistência a azóis e
que novos intervenientes têm que ser considerados neste contexto.
Palavras-chave: Candida glabrata, resistência aos azóis, CgEpa3, CgPil1.
x
xi
Table of Contents
Acknowledgments ....................................................................................................................................v
Abstract................................................................................................................................................... vii
Resumo ................................................................................................................................................... ix
List of Figures .................................................................................................................................... xiii
List of Tables ..................................................................................................................................... xvii
Abbreviations ......................................................................................................................................... xix
1. Introduction .................................................................................................................................... 1
1.1. Candidiasis............................................................................................................................. 1
1.2. Candida glabrata ................................................................................................................... 2
1.3. Antifungal agents utilized for the treatment of Candida infections: focus on azoles .... 2
1.4. Molecular mechanisms of azole resistance in Candida glabrata: specifying the
differences observed for clotrimazole, fluconazole, voriconazole and posaconazole .............. 5
1.4.1. Changes in the expression or sequence of the drug target Erg11 .................................. 5
1.4.2. Sterols incorporation and differences on membrane composition .................................. 7
1.4.3. Mitochondrial DNA deficiency .......................................................................................... 8
1.4.4. Drug efflux pumps – ABC and MFS transporter superfamilies ..................................... 11
1.4.5. Are there azole specific drug resistance mechanisms? ................................................ 13
1.5. Possible new mechanisms of azole drug resistance explored in this study ................ 15
1.5.1. Role of Candida glabrata adhesins as virulence and antifungal drug resistance
determinants ................................................................................................................................... 16
1.5.2. Eisosomes as determinants of resistance to antifungal drugs ...................................... 20
1.6. Motivation and thesis outline ............................................................................................. 25
2. Experimental Procedures ............................................................................................................ 27
2.1. Cell cultures ......................................................................................................................... 27
2.1.1. Candida glabrata strains ................................................................................................ 27
2.1.2. Growth media ................................................................................................................ 27
2.1.3. Antifungal drugs ............................................................................................................. 28
2.2. Transcriptomic analysis ..................................................................................................... 28
2.2.1. RNA extraction ............................................................................................................... 28
2.2.2. Microarray data analysis ................................................................................................ 28
2.2.2.1. GOToolBox analysis ...................................................................................................... 29
2.2.2.2. KEGG Mapper analysis ................................................................................................. 29
2.2.2.3. Expression profiles analysis .......................................................................................... 29
2.3. Gene expression analysis .................................................................................................. 30
2.3.1. Total RNA extraction and quantification ........................................................................ 30
2.3.2. Real Time RT-PCR ........................................................................................................ 31
2.4. 3H-clotrimazole accumulation assays ............................................................................... 33
2.5. Quantification of Biofilm Formation .................................................................................. 33
xii
2.6. Quantification of total cellular ergosterol ......................................................................... 34
2.7. Susceptibility Assays .......................................................................................................... 34
3. Results and Discussion ............................................................................................................... 37
3.1. Stepwise evolution of the 044 clinical isolate to fluconazole resistance ...................... 37
3.2. Identification of transcriptome-wide changes occurring in a clinical isolate of Candida
glabrata, subject to fluconazole stress: general features ........................................................... 39
3.2.1. Analysis of posaconazole resistance acquisition .......................................................... 40
3.2.2. Analysis of posaconazole/clotrimazole resistance acquisition ...................................... 43
3.2.3. Analysis of posaconazole/clotrimazole/fluconazole/voriconazole resistance
acquisition… ................................................................................................................................... 44
3.3. Decreased accumulation of azole drugs and ergosterol content during the evolution
of the Candida glabrata 044 clinical isolate towards fluconazole resistance ........................... 45
3.4. Screening for the possible role of eisosomes in the acquisition of azole resistance in
the Candida glabrata 044 clinical isolate....................................................................................... 52
3.5. Screening for the possible role of adhesins in the acquisition of azole resistance in
the Candida glabrata 044 clinical isolate....................................................................................... 55
3.5.1. Screening the role of Epa1, Epa3 and Epa10 adhesins in azole resistance in Candida
glabrata 56
4. Final Discussion ........................................................................................................................... 65
5. References .................................................................................................................................... 71
xiii
List of Figures
Figure 1. Ergosterol biosynthesis pathway (Adapted from M. Bard et al. 2005 [22]). ........................... 3
Figure 2. Structure of fluconazole, voriconazole, clotrimazole and posaconazole (Adapted from C.
Calderone et al. 2012 [1]). ....................................................................................................................... 4
Figure 3. Representation of several amino acid substitutions within Erg11 related to susceptible and
resistant isolates (Adapted from Marichal et al. 1999 [32]). .................................................................... 6
Figure 4. Multiple subfamilies of adhesin-like proteins in C. glabrata represented in a neighbour-
joining phylogenetic tree, with bootstrap values added (1,000 bootstraps performed), based on the
putative functional domains (the 300 N-terminal amino acids or fewer in cases where the N-terminal
ORF fragment is shorter) of the ORFs is shown (Adapted from Groot et al., 2008 [62]) ...................... 17
Figure 5. Schematic representation of the MCC, MCP and eisosomes (Adapted from Mollinedo, 2012
[108]). ..................................................................................................................................................... 21
Figure 6. MCC/eisosome representation in S. cerevisiae (adapted from Douglas and Konopka,
2014 [82])............................................................................................................................................... 23
Figure 7. Fluconazole in vitro induction of a C. glabrata 044 clinical isolate. Minimal inhibitory
concentrations were measure for fluconazole (◊), voriconazole (□), posaconazole (Δ) and clotrimazole
(×) along the total time of induction (days). ........................................................................................... 25
Figure 8. Spot assays comparing the antifungal resistance profile of the 044 clinical isolate and the
strains evolved from it, through prolonged exposure to fluconazole: A) Comparison of the susceptibility
to imidazole drugs, at the indicated concentrations, of C. glabrata 044 clinical isolate and evolved
strains 044Fluco21 (posaconazole resistant), 044Fluco31 (posaconazole/clotrimazole resistant),
044Fluco45 (posaconazole/clotrimazole/fluconazole/voriconazole resistant); B) Comparison of the
susceptibility to fluconazole, at the indicated concentrations, of C. glabrata 044 clinical isolate and
evolved strains 044Fluco21 (posaconazole resistant), 044Fluco31 (posaconazole/clotrimazole
resistant), 044Fluco45 (posaconazole/clotrimazole/fluconazole/voriconazole resistant); C) Comparison
of the susceptibility to 5-flucytosine and amphotericin B, at the indicated concentrations, of C. glabrata
044 clinical isolate and evolved strains 044Fluco21 (posaconazole resistant), 044Fluco31
(posaconazole/clotrimazole resistant), 044Fluco45
(posaconazole/clotrimazole/fluconazole/voriconazole resistant). All assays were performed on MMG
agar plates. Images are representative of those obtained in at least 3 independent experiments. ...... 38
Figure 9. Frequency of genes of C. glabrata 044 clinical isolate and evolved strains associated to the
displayed GO terms (determined by GOToolbox). RF – Reference Frequency; DF – Dataset
Frequency. A) Frequency of up regulated genes of C. glabrata posaconazole resistant strain; B)
Frequency of up regulated genes of C. glabrata posaconazole/clotrimazole resistant strain; C)
Frequency of up regulated genes of C. glabrata posaconazole/clotrimazole/fluconazole/voriconazole
resistant strain; D) Frequency of down regulated genes of C. glabrata posaconazole resistant strain;
E) Frequency of down regulated genes of C. glabrata posaconazole/clotrimazole resistant strain; F)
Frequency of down regulated genes of C. glabrata
posaconazole/clotrimazole/fluconazole/voriconazole resistant strain. 1 Nucleobase, nucleoside,
nucleotide and nucleic acid metabolic process; 2 Mitochondrial ATP synthesis coupled electron
transport; 3 Mitochondrial electron transport, cytochrome c to oxygen; 4 Generation of precursor
metabolites and energy; 5 Flocculation via cell wall protein-carbohydrate interaction; 6 Purine
ribonucleoside triphosphate biosynthetic process; 7 Cellular amino acid and derivative metabolic
process; 8 Energy derivation by oxidation of organic compounds; 9 Cell wall mannoprotein biosynthetic
process. ................................................................................................................................................. 41
xiv
Figure 10. Number of down regulated genes of C. glabrata clinical isolate resistant to posaconazole
present in each indicated pathway, resulting from the analysis using the bioinformatic tool KEGG
Mapper................................................................................................................................................... 43
Figure 11. Multiple drug resistance genes expression profile of C. glabrata 044 clinical isolate with the
respective fold change for each fluconazole induction time correspondent to the acquisition of
posaconazole, clotrimazole and fluconazole and voriconazole resistance. .......................................... 46
Figure 12. Time-course accumulation of 3H-clotrimazole in C. glabrata 044 clinical isolate (●) and
evolved strains 044Fluco21 (■), 044Fluco31 (▲) and 044Fluco45 (▼). The indicated values are
averages of at least three independent experiments. Error bars represent the corresponding standard
deviations. *p<0.05; **p<0.01. ............................................................................................................... 47
Figure 13. Ergosterol biosynthesis genes expression profile of C. glabrata 044 clinical isolate with the
respective fold change for each fluconazole induction time correspondent to the acquisition of
posaconazole, clotrimazole and fluconazole and voriconazole resistance. .......................................... 48
Figure 14. Temporal evolution of ergosterol content in the C. glabrata 044 clinical isolate during azole
resistance in vitro induction assay. The cells of the 044 clinical isolate and the evolved strains were
harvested after 15h of growth in YPED medium, following the extraction and quantification through
HPLC of total ergosterol. Relative ergosterol content was calculated using ergosterol content of the
initial 044 clinical isolate as a reference. In the scatter dot plot represented each dot corresponds to
ergosterol content (µg) per mg of cells harvested in each sample. The average of ergosterol content
per cells is indicated by a black line (-) corresponds to at least 3 independent experiments. *p<0.05 . 49
Figure 15. Time-course accumulation of 3H-clotrimazole in C. glabrata KUE100 wild-type strain (●)
and ΔCAGL0G05093g (■).The indicated values are averages of at least three independent
experiments. Error bars represent the corresponding standard deviations. ......................................... 50
Figure 16. Spot assays for the evaluation of the importance of CAGL0G05093g gene in the resistance
to antifungal drugs in C. glabrata. Comparison of the susceptibility to: A) imidazole drugs; B) triazole
drugs; C) 5-flucytosine and amphotericin B, at the indicated concentrations, of C. glabrata KUE100
wild-type strain with the deletion mutant ΔCAGL0G05093g. All the assays were performed in MMG
agar plates. Images are representative of those obtained in at least 3 independent experiments. ...... 51
Figure 17. Eisosome’s components genes expression profile of C. glabrata 044 clinical isolate with
the respective fold change for each fluconazole induction time correspondent to the acquisition of
posaconazole, clotrimazole and fluconazole and voriconazole resistance. .......................................... 52
Figure 18. Spot assays for the evaluation of the importance of CgPIL1, CgLSP1 and CgSEG1 genes
in the resistance to antifungal drugs. Comparison of the susceptibility to A) imidazole drugs; B) triazole
drugs; C) 5-flucytosine, at the indicated concentrations, of C. glabrata KUE100 wild-type strain with
the deletion mutants Δpil1, Δlsp1, Δseg1. All the assays were performed in MMG agar plates. Images
are representative of those obtained in at least 3 independent experiments. ....................................... 53
Figure 19. Time-course accumulation of 3H-clotrimazole in C. glabrata KUE100 wild-type strain (●)
and Δpil1 (■). The indicated values are averages of at least three independent experiments. Error bars
represent the corresponding standard deviations. *p<0.05; **p<0.01. ................................................. 54
Figure 20. Ergosterol content in the C. glabrata KUE100 wild-type strain and the deletion mutant
Δpil1. The cells were harvested after 15h of growth in YPED medium, following the extraction and
quantification through HPLC of total ergosterol. Relative ergosterol content was calculated using
ergosterol content of KUE100 wild-type strain as a reference. In the scatter dot plot represented each
dot corresponds to ergosterol content (µg) per mg of cells harvested in each sample. The average of
ergosterol content per cells is indicated by a black line (-) corresponds to at least 3 independent
experiments. *p<0.05 ............................................................................................................................ 55
xv
Figure 21. Adhesins expression profile of C. glabrata 044 clinical isolate with the respective fold
change for each fluconazole induction time correspondent to the acquisition of posaconazole,
clotrimazole and fluconazole and voriconazole resistance. .................................................................. 56
Figure 22. Comparison of the transcript levels of CgEPA1 gene in the 044 clinical isolate and the
evolved strains 044Fluco21, 044Fluco31 and 044Fluco45. The indicated values correspond to the
averages obtained by two independent experiments of quantitative real-time PCR. The error bars
correspond to the standard deviations. *p<0.05. ................................................................................... 57
Figure 23. Biofilm formation, followed by crystal violet staining and measurements of absorbance at
590 nm, for the 044 clinical isolate and the evolved strains 044Fluco21, 044Fluco31 and 044Fluco45.
Cells were grown for 15 h. The experiment was performed in SDB medium pH 5.6. In the scatter dot
plot represented each dot corresponds to the level of biofilm formed in each sample. The average
level of formed biofilm indicated by a black line (-) corresponds to at least 4 independent experiments.
............................................................................................................................................................... 58
Figure 24. Temporal evolution of the C. glabrata 044 clinical isolate and evolved strains obtained after
fluconazole induction at day 0 (044 clinical isolate), day 21 (044Fluco21 - posaconazole resistant), day
31 (044Fluco31 – posaconazole/clotrimazole resistant), day 45 (044Fluco45 –
posaconazole/clotrimazole/fluconazole/voriconazole): A) microscopic visualization of the aggregation
process in each strain; B) scatter dot plot of percentage of aggregates; C) scatter dot plot of number of
cells per aggregate. For this evaluation it was considered that an aggregate was equal to the
aggregation of 10 cells. Standard deviations are represented by **p<0.01; ****p<0.0001. .................. 59
Figure 25. Spot assays for the evaluation of the importance of CgEPA1, CgEPA3 and CgEPA10
genes in the resistance to antifungal drugs in C. glabrata. Comparison of the susceptibility to A)
imidazole drugs; B) triazole drugs; C) 5-flucytosine and amphotericin B, at the indicated
concentrations, of C. glabrata KUE100 wild-type strain with the deletion mutants Δepa1, Δepa3 and
Δepa10. All the assays were performed in MMG agar plates. Images are representative of those
obtained in at least 3 independent experiments. ................................................................................... 61
Figure 26. Biofilm formation followed by crystal violet staining and measurements of absorbance at
590 nm for the KUE100 wild-type strain and deletion mutants Δepa1, Δepa3, and Δepa10. Cells were
grown for 15 h and the experiment was performed in SDB medium pH 5.6. In the scatter dot plot
represented each dot corresponds to the level of biofilm formed in each sample. The average level of
formed biofilm indicated by a black line (-) corresponds to at least 4 independent experiments.
Standard deviations are represented by *p<0.05. ................................................................................. 62
Figure 27. Time-course accumulation of 3H-clotrimazole in C. glabrata KUE100 wild-type strain (●)
and the deletion mutant Δepa3 (■).The indicated values are averages of at least three independent
experiments. Error bars represent the corresponding standard deviations. *p<0.05. ........................... 63
Figure 28. Model of the temporal evolution of the C. glabrata 044 clinical isolate and evolved strains
obtained after fluconazole induction and the principal molecular mechanisms involved in the
acquisition of azole resistance, according to the microarray data and the experimentally demonstrated
features. ................................................................................................................................................. 68
xvi
xvii
List of Tables
Table 1. ECVs, percentage of resistant isolates, total number of isolates in study regarding
fluconazole, voriconazole and posaconazole resistance in C. glabrata. Information obtained in [27]–
[30]. .......................................................................................................................................................... 5
Table 2. Genes up and down regulated in BYP41 mutant resistant to fluconazole and voriconazole
compared to a related C. glabrata azole susceptible isolate (Adapted from Ferrari et al. 2011 [10]). .. 10
Table 3. Molecular mechanisms present in the development of resistant to azoles, for Candida
species [26], [31], [46], [49]–[51], [57], [61]. .......................................................................................... 15
Table 4. MCC/eisosome proteins in S. cerevisiae (adapted from Douglas and Konopka, 2014 [82]).. 22
Table 5. C. glabrata strains used in this study. ..................................................................................... 27
Table 6. RNA samples and respective controls of C. glabrata 044 clinical isolate considered in the
microarrays analysis relative to each resistance acquisition of the clinical isolate. Respective
fluconazole induction time (days). ......................................................................................................... 29
Table 7. Reaction mixture for the first step of real time RT-PCR (Applied Biosystems). ..................... 32
Table 8. Thermal cycling parameters for the first step of the real time RT-PCR (Applied Biosystems).
............................................................................................................................................................... 32
Table 9. Reaction mixture for the second step of real time RT-PCR (Applied Biosystems). ................ 32
Table 10. Thermal cycling parameters for the second step of the real time RT-PCR (Applied
Biosystems). .......................................................................................................................................... 32
Table 11. Primers for CgACT1 and CgEPA1 genes. ............................................................................ 33
Table 12. Range of drug concentrations used in the spot assays. ....................................................... 35
Table 13. Total number of up or down regulated genes in the resistant C. glabrata evolved strains,
when compared to the azole susceptible one. ...................................................................................... 39
xviii
xix
Abbreviations
ABC – ATP-Binding Cassette
AIDS – Acquired Immunodeficiency Syndrome
BAR – Bin/amphiphysin/Rvs
C. albicans – Candida albicans
C. glabrata – Candida glabrata
DEPC - Diethylpyrocarbonate
DHA – Drug:H+ Antiporter
DMSO – Dimethyl Sulfoxide
ECM – Extracellular Matrix
ECV – Epidemiological Cutoff Value
EDTA - Ethylenediaminetetraacetic Acid
EGTA – Ethylene Glycol Tetraacetic Acid
EPA – Epithelial adhesin
GFP – Green Fluorescence Protein
GO – Gene Ontology
GOF – Gain-of-function
GPI – Glycosylphosphatidylinositol
GPI-CWP – Glycosylphosphatidylinositol-dependent Cell Wall Proteins
Hep2 – Human Laryngeal Carcinoma
HIV – Human Immunodeficiency Virus
IAA – Isoamilic Acid
MAP – Mitogen-activated protein
MCC – Membrance Compartment of Can1
MCP – Membrane Compartment of Pma1
MCT – Membrane Compartment of TORC2
MDR – Multiple Drug Resistance
MFS – Major Facilitator Superfamily
MIC – Minimal Inhibitory Concentration
MMG – Minimal Growth Medium
NA – Nicotinic Acid
OD – Optical Density
OPC – Oralpharyngeal Candidiasis
xx
PCR – Polymerase Chain Reaction
PDK1 – Phosphoinositide-dependent Kinase 1
PDRE – Pleiotropic Drug Response Element
PI(4,5)P2 – Phosphatidylinositol 4,5 biphosphate
RFLP - Restriction Fragment Length Polymorphism
RT-PCR – Quantitative Real Time Polymerase Chain Reaction
S. cerevisiae – Saccharomyces cerevisiae
SDB – Sabouraud’s Dextrose Broth
SDS – Sodium Dodecyl Sulfate
TOR – Target of Rapamycin
YEPD - Yeast Extract Peptone Dextrose
YPS – Yapsins
1
1. Introduction
1.1. Candidiasis
The infection caused by Candida species is known as candidiasis, and may be mucosal or
systemic. Mucosal candidiasis is very frequent and occurs chiefly in oral, gastrointestinal and vaginal
mucosae. Systemic candidiasis is not so common, but it is associated to a high mortality rate [1], [2].
Candida albicans is the most frequent organism associated to candidiasis (up to 50-60% of the
cases), while C. glabrata has been found, in the last 3 decades, and with increasing frequency, to be
the second most common cause of such infections [3].
The cause of infection relies in several aspects. However, the health of the patient is often an
important issue to take into account. Epidemiology data show that C. glabrata infections are more
frequent in immunocompromised individuals [2], [4].
Oralpharyngeal candidiasis (OPC) is very common and found within patients with human
immunodeficiency virus (HIV) infection, hematologic malignancies, not controlled diabetes and
xerostomia. The risk factors leading also to OPC are the consumption of sterols and antibiotics, head
and neck radiation therapy, chemotherapy-induced neutropenia and dentures. This infection is
characterized by a burning pain and odynophagia within the patients [1]. 80 to 90% of patients with
Immunodeficiency Syndrome (AIDS) develop OPC [2].
In immunocompromised patients, the esophageal candidiasis is more common than OPC. The
esophageal candidiasis has as symptoms dysphagia, odynophagia and retrosternal chest pain within
the patients. It is identified by the existence of typical white to cream-colored plaques that might lead
to ulceration [1].
On the other hand, vulvovaginal candidiasis is another type of mucosal candidiasis which
corresponds to the second most frequent vaginal infection. 75% of women experience this infection
within childbearing years and 8% of women have multiple episodes that correspond to recurrent
vulvovaginal candidiasis. Besides pregnancy, oral contraceptives with high estrogen content and
uncontrolled diabetes mellitus are also associated with this infection [1].
Another niche of infection is the urinary tract. Interestingly, 20% of Candida urinary tract
infections were caused by C. glabrata, according to a large multicentre study [2].
The chronic infections of candidiasis frequently result from the overuse of antifungal agents
and repeated antifungal therapies that result in the gain of resistance of the strains responsible for the
infection [5].
The systemic infections can arise in any organ system, leading to diverse clinical
manifestations, from low-grade fever to fulminant septic shock. As a result, candidemia translates into
high mortality rates [2]. The mortality in systemic infections is chiefly due to a lack of fast and precise
diagnostic tools or inefficient antifungal therapies [6]. The development of systemic infection is usually
due to the presence of medical devices. C. glabrata systemic infections arise mostly from implantable
cardioverter defibrillators, vascular catheters, cardiac devices, prosthetic valves and urinary
2
catheters [7]. This type of devices enhance biofilm formation, allowing Candida spp. to resist
therapeutic treatments, since antifungal agents have a restricted diffusion due to the extracellular
matrix (ECM) formed [8], [9].
1.2. Candida glabrata
C. glabrata is a haploid, nondimorphic and nonmating organism which belongs to the class of
the Hemiascomycetes [2], [10]. Although being a Candida spp., C. glabrata is phylogenetically closer
to Saccharomyces cerevisiae than to Candida species of the CTG clade such as C. albicans. C.
glabrata exists in the shape of small blastoconidia, as a pathogen [11], and, although this yeast does
not exhibit a sexual stage, it has several genes associated to mating and meiosis. However,
chromosomal alterations, such as chromosome loss, translocations and aneuploidy, have been
reported in C. glabrata, which suggests that this yeast, although lacking a sexual cycle, can have an
impressive clonal population diversity [1],[6].
Regarding the virulence of this species, C. glabrata is known as an organism with low
virulence when compared to the other Candida species, since it lacks hyphae formation ability, which
is recognized as an important factor in adherence and tissue invasion. Also, its deficiency in secreted
hydrolases and biofilm formation contributes to its lower virulence [2],[12]. Nevertheless, C. glabrata
genome encodes a large group of putative glycosylphosphatidylinositol (GPI)-anchored cell wall
proteins, such as those of the epithelial adhesin (EPA) and yapsins (YPS) families, which play a
crucial role in C. glabrata interactions with host tissues [13], [14].
Two distinct colony morphologies are known for C. glabrata: core and irregular wrinkled.
These two morphologies are possibly due to phenotypic switching mechanisms, which depend on the
sites of host colonization [6], [15].
C. glabrata is adapted to the human host, leading to mucosal and bloodstream infections [16].
This species has been found in patients with diabetes, advanced cancer and HIV-infection [1]. C.
glabrata is responsible for 7 to 20% of all the infections caused by Candida species, depending on the
geographical locations, which makes it the second most prevalent [16]. Indeed, cases of systemic and
superficial candidiasis have been found to increase mostly due to C. glabrata. This increase has been
associated with the resistance of this species to the antifungal agents administered as a treatment for
candidiasis, particularly to azoles [17].
1.3. Antifungal agents utilized for the treatment of Candida
infections: focus on azoles
The treatment of candidiasis involves the use of antifungal agents, including mainly polyenes,
azoles and echinocandins.
Among the polyenes, a single molecule is used in the treatment of candidiasis: amphotericin
B. This molecule binds to ergosterol in the plasma membrane of yeast, disturbing its integrity. As a
result, membrane pores are formed, which have as a consequence the disruption of the membrane,
the formed pores allowing the efflux of intracellular material. This disruption causes cell death [1].
3
Azoles, on the other hand, act by inhibiting competitively the activity of cytochrome P-450-
dependent C14 lanosterol demethylase, encoded by the ERG11 gene, a key enzyme in ergosterol
biosynthesis. The nitrogen atoms in the azole ring bind to the heme group in the active site of the
enzyme, blocking the binding of the normal substrate and making ergosterol formation impossible [18].
Ergosterol is required to provide membrane integrity and functionality, being an important component
of the yeast membrane. Thus, its depletion causes membrane instability, while the inhibition of Erg11
leads to the accumulation of toxic 14-methylated sterols, which leads to fungal membrane disruption
[19], [20], [21] and growth arrest [18].
Figure 1. Ergosterol biosynthesis pathway (Adapted from M. Bard et al. 2005 [22]).
The azole class of drugs includes early azole formulations that are considered to have some
toxicity in the treatment of systemic infections, such as the imidazoles miconazole and ketoconazole.
Still one of the most frequent azole formulations used for treatment of Tinea pedis (athlete’s foot), as
well as vulvovaginal and OPC, is the imidazole clotrimazole [23]. Some newer azole drugs, such as
the triazoles fluconazole, itraconazole, posaconazole and voriconazole, are significantly safer and
more tolerable in systemic therapy [1], [2].
Fluconazole is a water-soluble triazole with 90% of bioavailability after oral administration. It
has been extensively used in prophylaxis and in the therapy of candidiasis in organ and bone marrow
transplant recipients, patients undergoing chemotherapy and AIDS patients. It has been shown that
4
prolonged fluconazole exposure may favour the up rise of C. glabrata infections [3]. Voriconazole was
developed by a systematic chemical manipulation of fluconazole, with the purpose of producing a
compound with enhanced potency and spectrum of activity. As for posaconazole, its structure contains
piperazine-phenyl-triazole side chains and a furan ring with fluorine substituted for chlorine [1], having
a wide spectrum of activity and better clinical efficacy than other antifungal agents [24].
Figure 2. Structure of fluconazole, voriconazole, clotrimazole and posaconazole (Adapted from C. Calderone et al. 2012 [1]).
The most recently approved class of antifungal agents is that of the echinocandins, which are
semisynthetic lipopetides, with a chemical structure containing cyclic hexapeptides N linked to a fatty
acyl side chain. Available drugs within this class for the treatment and prevention of fungal infections
are caspofungin, micafungin and anidulafungin. The echinocandins act by inhibiting the biosynthesis
of an essential polysaccharide in the yeast cell wall, β-1,3-glucan [1]. However, echinocandins are not
advisable for the treatment of urinary tract infections [25].
Although there are several antifungal agents to treat candidiasis, this therapy might fail due to
the condition of the patient’s immune system, the antifungal agent characteristics and the altered
sensitivity of the yeast to the drug [5], [26]. Usually, when azole treatment fails the use of
amphotericin B or caspofungin is recommended [27].
This dissertation focuses mainly in the azole antifungal agents fluconazole, voriconazole,
posaconazole and clotrimazole given the high prevalence of resistance against these drugs in C.
glabrata [27]–[30]. This can be observed in Table 1, according to the epidemiological cutoff values
(ECVs), which allow the identification of resistant isolates based on the distribution of minimal
inhibitory concentrations (MICs) of the antifungal agents, and the percentage of resistant isolates.
5
Table 1. ECVs, percentage of resistant isolates, total number of isolates in study regarding fluconazole, voriconazole and
posaconazole resistance in C. glabrata. Information obtained in [27]–[30].
Fluconazole Voriconazole Posaconazole
Reference
ECVs
% of
resistant
isolates
Total
number
of
isolates
ECVs
% of
resistant
isolates
Total
number
of
isolates
ECVs
% of
resistant
isolates
Total
number
of
isolates
128
mg/L 98.6 212 2 mg/L 98.5 205 4 mg/L 96 173
Cantón et al.,
2013
- 8.8 571 > 0.5
µg/mL 10.5 571
> 2
µg/mL 3.5 571
Pfaller et al.,
2013
32
μg/mL 38.4 598
> 0.5
µg/mL 55 598
> 2
µg/mL 63.2 598
Ben-Ami et al.,
2014
- 15 259 - - - - - - Li et al., 2013
1.4. Molecular mechanisms of azole resistance in Candida glabrata:
specifying the differences observed for clotrimazole,
fluconazole, voriconazole and posaconazole
Antifungal drug resistance can be classified as primary or secondary. Primary resistance, also
named intrinsic or innate resistance, occurs when pathogens are naturally resistant to the antifungal
agent. Secondary resistance corresponds to the acquired resistance by the isolate, during infection,
when exposed to the antifungal agent [2]. Understanding the different molecular mechanisms
responsible for the triggering of intrinsic and acquired resistance, is expected to help the development
of new strategies for more effective treatments.
The following topics review the molecular mechanisms that have been described as
responsible for fluconazole, voriconazole, posaconazole or clotrimazole resistance in C. glabrata or,
when related information is lacking for this organism, in C. albicans or S. cerevisiae.
1.4.1. Changes in the expression or sequence of the drug target Erg11
In many clinical isolates, azole resistance results from point mutations which lead to
conformational changes in Erg11, the primary target of azoles (Figure 1). These mutations affect the
affinity of the drug binding to the target while keeping the enzyme activity in ergosterol biosynthesis
unaltered [19]. Other possibilities for the development of azole resistance due to ERG11, are its
overexpression and, in C. albicans, the formation of an isochromosome harbouring ERG11 and TAC1
genes, the later encoding an ortholog of the S. cerevisiae Pdr1 transcription factor [31].
6
Currently, there are more than 140 different amino acid substitutions in ERG11 reported in
C. albicans, either conferring susceptibility or resistance to fluconazole and voriconazole [19], [31].
From a screening of amino acid substitutions in ERG11 gene, the following substitutions were
selected for having potential use as predictive markers of fluconazole and voriconazole resistance:
Y132F, Y132H, K143R, G307S, S405F, G448E, G448V, and G450E. Nevertheless, a new amino acid
substitution, Y447H, found in a strain with reduced susceptibility to azoles, revealed to confer
resistance only to fluconazole and itraconazole, while the strain remained susceptible to voriconazole
[31]. Indeed, it seems likely that certain mutations only confer resistance to a particular antifungal
agent.
An analysis of ERG11 gene mutations in C. albicans revealed that they are clustered in three
regions: near the N-terminus of the protein between 105-165 amino acids and between 266-287 and
405-488 amino acids close to the C terminus [19] (Figure 3).
Figure 3. Representation of several amino acid substitutions within Erg11 related to susceptible and resistant isolates (Adapted
from Marichal et al. 1999 [32]).
In C. glabrata, a G944A mutation in CgERG11 gene was shown to be associated to
fluconazole, voriconazole and polyene resistance in one specific isolate, CG156. This isolate exhibited
low affinity to azoles, a lack of cellular ergosterol, a major resistance to polyenes and the capacity to
survive without sterol auxotrophy by growing in lanosterol-type sterols [33]. Interestingly, though, in
other studies focused on C. glabrata azole resistant clinical isolates, no mutation or up regulation of
CgERG11 gene was observed [34],[35].
Focusing on fluconazole resistance, Ribeiro et al. (2007) investigated the induced expression
of genes in isogenic pairs of C. albicans strains, following exposure to fluconazole in vitro. The authors
observed an up regulation of ERG11 gene expression upon fluconazole exposure, but found that
ERG11 expression quickly decreased to basal values upon the removal of the antifungal agent [21].
Similar up regulation of the ERG11 gene was also seen in C. glabrata, C. tropicalis and C. krusei [36].
Furthermore, a fluconazole resistant isolate of C. glabrata was found to have greater augmentation of
7
CgERG11 gene expression due to the duplication of the entire chromosome containing this gene [37].
Moreover, a single point mutation was identified in ERG11 gene by sequence analysis in a C. albicans
clinical isolate exposed to fluconazole, which resulted in a single amino acid substitution (R467K) near
two residues involved in the active-site of the enzyme [38]. Another interesting mutation, T315A, was
found within this gene, reducing its enzyme activity in C. albicans [39]. These observations give
evidence of the several alterations that can occur within ERG11 gene, which are involved in the
acquisition of fluconazole resistance.
Interestingly, a E139A change in CgERG3 gene, also involved in the ergosterol biosynthesis,
was found to lead to increased resistance to fluconazole in C. glabrata strains [40]. ERG3 gene
encodes a Δ5,6 sterol desaturase. Upon mutation, ERG3 gene leads to the formation of ergosta-7,22-
dien-3β-ol as the major sterol produced, instead of ergosta-5,7,24(28)-trienol [41]. This alteration
prevents azole action since the toxic sterols that accumulate upon the inhibition of Erg11 can no
longer be synthesized by this pathway.
Regarding the study of posaconazole resistance due to alterations in ERG11 gene, seven
isolates from C. albicans were recovered from AIDS patient treated with this antifungal agent. All
isolates showed progressive decrease in susceptibility to posaconazole and had multiple mutations in
the ERG11 gene, but no differences in the expression of ERG11 or CDR1, CDR2 and MDR1 genes,
encoding drug efflux pumps, were observed. This study concluded that, as seen before for
fluconazole, a decrease in susceptibility to posaconazole was achieved by multiple mutations in the
ERG11 gene [42]. Still, the authors could also observe that P230L substitution conferred a higher
posaconazole resistance when the expression of this allele was assessed in S. cerevisiae [42]. This
observation shows that certain mutations may contribute in a more significant way for the gain of
resistance, and may be also related with a specific resistance to a certain antifungal agent.
1.4.2. Sterols incorporation and differences on membrane composition
Aerobic uptake of exogenous sterol has been recently proposed to contribute to azole and
polyene resistance in vivo. Indeed, some isolates of C. glabrata are able to uptake sterol in order to
overcome the blockage of ergosterol biosynthesis.
Effectively, the gain of fluconazole and voriconazole resistance reported for the isolate CG156,
with a mutation (G944A) in CgERG11 gene, was found to be associated to the ability of this strain to
carry out flocculent growth, low efflux and facultative sterol uptake, having the capacity to sequester
and metabolize lathosterol, cholestanol and demosterol, which are precursors of cholesterol. These
alterations lead to changes in membrane composition, which apparently underlie its ability to surpass
the perturbation in the sterol composition exerted by azole antifungal agents. As a consequence,
CG156 isolate could further withstand extended periods of starvation, being resistant to fluconazole
and voriconazole [33]. Another reported mutant obtained by exerting a fluconazole resistance
selective pressure, also revealed an increase in ergosterol content, corroborating the notion that sterol
uptake may facilitate the gain of resistance to azoles [3].
8
Another analysis of C. glabrata mutants further unravelled some of the molecular mechanisms
of fluconazole resistance. The mutants studied had a specific phenotype of respiratory deficiency due
to mutations in the mitochondrial DNA. When exposed to the antifungal agent, the mutants exhibited
an ergosterol content of 92% of the total sterol composition, while the parental isolate only exhibit 17%
of ergosterol. The biosynthesis intermediates were almost undetected in the mutants while the
parental isolate had 54% of them. The increase in ergosterol content explains the gain of resistance to
fluconazole by these mutants [34], since once again it compensates the action of fluconazole.
In another case study, C. glabrata isolates were identified, growing on standard media
supplemented with bile (additive used to suppress bacterial growth) and in the presence of
clotrimazole. Cholesterol was one of the bile components that seemed to be required for these
isolates to growth. From the seven isolates studied, two were defective in lanosterol synthase activity,
which is encoded by CgERG7 gene, and three were defective in squalene epoxidase activity, which is
encoded by CgERG1 gene. These two enzymes are involved in the ergosterol biosynthesis, meaning
the mutants were not able to produce ergosterol. Nevertheless, the mutants could grow by sterol
supplementation from a variety of sources, mainly cholesterol, when ergosterol biosynthesis was
blocked. This indicates that the blockage of ergosterol biosynthesis, caused by clotrimazole action,
was overcome by the cholesterol uptake [22]. The ability to use cholesterol may constitute a major
selective advantage in the colonization of the human host.
Interestingly, two C. glabrata strains isolated from the blood of a candidemia patient were
shown to be cholesterol-dependent resistant to fluconazole, voriconazole and posaconazole, as well
as to amphotericin B. This case study reveals that sterol uptake strategy can be used to surpass
several antifungal agents in the same isolates [43].
1.4.3. Mitochondrial DNA deficiency
Mitochondrial dysfunction has been linked to increased resistance to azoles and other
antifungal agents.
In a specific case study, 10 isolates of C. glabrata, exhibiting a petite phenotype, that
corresponds to the absence of growth on non-fermentable carbon sources, deficient growth in media
supplemented with glucose, reduced oxygen consumption and partial or total mtDNA deletion [3], [10],
[34], showed resistance to fluconazole and clotrimazole. A Restriction Fragment Length Polymorphism
(RFLP) analysis revealed a complete loss of mtDNA or partial deletions in the mtDNA in these
isolates, which explained their respiratory deficiency. Defontaine et al., 1999, proposed that this
respiratory deficiency, observed in the petite mutants, could promote the exhibited azole resistance,
since the biosynthesis of P-450-dependent 14α-sterol demethylase is stimulated by anaerobic
conditions [44]. Probably as a consequence, a higher biosynthesis of ergosterol was induced in these
isolates, leading to increased resistance to fluconazole and clotrimazole. According to this study,
another mutant, P40, obtained by exposure to sodium azide, which is an inhibitor of the cytochrome
oxidase, also revealed fluconazole and clotrimazole resistance [3]. Once again, the respiratory
deficiency may induce a higher ergosterol biosynthesis which allows the mutant P40 to better respond
9
to azole action. Meanwhile, higher susceptibility towards amphotericin B was also observed in this
mutant [3]. In this case, higher ergosterol content in the cell augments the number of amphotericin B
target molecules, leading to a higher susceptibility. Indeed, other isolates exhibiting fluconazole
resistance were reported to simultaneously present higher susceptibility to amphotericin B [34].
Another fluconazole resistant C. glabrata isolate, BPY41, showed an overexpression of
CgCDR1, CgCDR2, CgSNQ2 and CgPDR1 genes, together with the petite phenotype, and exhibited
higher virulence and fitness than expected. This data suggests that mitochondrial dysfunction may
lead to a gain of virulence, besides azole resistance, depending on the origin of the isolate and,
possibly, on the nuclear DNA mutations that may arise in it. A microarray analysis revealed that genes
up regulated in this strain, when compared to a related susceptible C. glabrata isolate, were involved
in cell wall integrity, adherence to mammalian cells, survival in macrophages and virulence. Down
regulated genes were related to mitochondrial proteins, such as cytochrome c oxidase and ATP
synthase, and de novo purine nucleotide biosynthesis, which are regulated by Bas1 and Pho2
transcription factors in S. cerevisiae [10] (for more detail see Table 1). The up regulated genes explain
the gain of fluconazole resistance and virulence while the down regulated genes translate a
stimulation of anaerobic conditions that seem to be responsible for an induction of ergosterol
biosynthesis, also contributing to fluconazole resistance.
A functional genomics analysis also allowed the identification of some genes involved in
mitochondrial function, upon altered susceptibility to fluconazole in C. glabrata isolates. The genes
with insertions were orthologues to S. cerevisiae genes involved in mitochondrial functions. The suv3
strains found had a non-revertible phenotype since the Suv3 protein is essential for mitochondrial
function. However, some mrlp4 strains showed a reversible fluconazole resistant phenotype. These
strains prove that the acquired fluconazole resistance may not be necessarily related to the loss of
mitochondrial genome. Other mechanisms may be regulating the loss or gain of mitochondrial
function, such as epigenetic mechanisms and pathways of cross talk between the mitochondria and
the nucleus [18].
From a review of case studies, the loss of mitochondrial function is mostly present in cases of
fluconazole resistance. However, further studies have to be performed in order to determine more
accurately the frequency of acquisition of resistance to other azoles through this molecular
mechanism.
10
Table 2. Genes up and down regulated in BYP41 mutant resistant to fluconazole and voriconazole compared to a related C.
glabrata azole susceptible isolate (Adapted from Ferrari et al. 2011 [10]).
Altered expression of genes in BYP41 isolate with petite phenotype resistant to fluconazole and
voriconazole
Up regulated Down regulated
Gene Function Gene Function
CgCDR1 Multidrug resistance ADE1 de novo purine nucleotide biosynthesis
CgCDR2 Multidrug resistance ADE5,7 de novo purine nucleotide biosynthesis
CgSNQ2 Multidrug resistance ADE6 de novo purine nucleotide biosynthesis
YOR1 Small-molecule transport process ADE12 de novo purine nucleotide biosynthesis
YBT1 Small-molecule transport process ADE13 de novo purine nucleotide biosynthesis
YCF1 Small-molecule transport process MTD1 de novo purine nucleotide biosynthesis
CgYPS3 Yapsin Family HPT1 de novo purine nucleotide biosynthesis
CgYPS8 Yapsin Family HIS4 -
CgYPS9 Yapsin Family SHM2 -
CgYPS10 Yapsin Family GCV1 -
MNT3 Biogenesis/cell wall GCV2 -
AGA1 Cell surface FCY2 Purine permease
MUC1 Cell surface HPT1 Formation of IMP and GMP
RLM1 Cell wall integrity
ROX1 Heme-dependent
HAP1 Heme-dependent
HAC1 TF1 unfolded protein response pathway
RPN4 Proteasome
ATP6 Mitochondrial proteins
OLI1 Mitochondrial proteins
COX1 Mitochondrial proteins
COX2 Mitochondrial proteins
COX6 Mitochondrial proteins
COX5B Cytochrome c oxidase
COX13 Cytochrome c oxidase
YIM1 DNA damage
MEC3 DNA damage
MAG1 DNA damage
MND1 DNA repair
RAD7 DNA repair
HSM3 DNA repair
HSP12 Heat shock
HSP42 Heat shock
TRX2 Thioredoxin
NHT1 Trehalase - Thermotolerance
GSY2 Glycogen metabolism
SGA1 Glycogen metabolism
GDB1 Glycogen metabolism
11
Nevertheless, one particularly study revealed a mutant with decreased susceptibility to
fluconazole, ketoconazole, clotrimazole, voriconazole and posaconazole. This C. glabrata mutant was
deleted for CgPGS1 gene, unveiling the importance of cardiolipin and, its precursor,
phosphatidylglycerol, in the maintenance of mitochondrial functions and the susceptibility to antifungal
agents by C. glabrata isolates. The CgPGS1 gene encodes the phosphatidylglycerolphosphate
synthase, an enzyme which catalysis the formation of phosphatidylglycerolphosphate, in the
biosynthesis of cardiolipin [45]. The developed resistance can be explained by the essential function of
cardiolipin in the mitochondria. This anionic phospholipid, when in deficiency, leads to the decrease of
osmotic stability and membrane potential of mitochondria, and to mitochondrial DNA instability. This
change in the homeostasis of the mitochondria led to the overexpression of CgPDR1, CgCDR1,
CgCDR2 and CgSNQ2 genes, and consequent increase in azole resistance [45]. These results reveal
that the mitochondria conditions are associated with the expression of the chiefly ATP-binding
cassette (ABC) transporters in azole resistance and the expression of CgPdr1, an important
transcription factor in the regulation of this resistance.
1.4.4. Drug efflux pumps – ABC and MFS transporter superfamilies
One of the most important molecular mechanisms of azole resistance in C. glabrata is the
activation of drug efflux pumps from the ABC superfamily and major facilitator superfamily (MFS).
Indeed, one particular ABC transporter, CgCdr1, has been described in many reports as being
involved in the acquisition of fluconazole resistance in C. glabrata isolates, through the increase of its
expression [17], [40], [34], [46], [47]. When CgCDR1 gene was introduced in a S. cerevisiae strain with
PDR5 gene deleted, the strain became resistant to fluconazole [47]. The PDR5 gene encodes an ABC
multidrug transporter in S. cerevisiae, important for the efflux of several drugs, which means that the
introduction of CgCDR1 gene allowed surpassing the deletion of PDR5. These results provide
evidence for the importance of CgCDR1 gene as a molecular mechanism of fluconazole resistance.
Nevertheless, besides CgCDR1 gene, other genes, such as CgCDR2 and CgSNQ2, were also
associated with fluconazole resistance in C. glabrata. The CgCDR2 gene was described in
fluconazole resistant C. glabrata isolates from a patient with AIDS, revealing an oropharyngeal thrush.
These isolates exhibited an increased drug efflux rate simultaneous to the increased transcripts of this
gene, which encodes a protein 72.5% identical to Pdr5 of S. cerevisiae. The CgCDR2 gene is also
known as CgPDH1 [48]. Interestingly, the coordinated up regulation of CgCDR1 and CgCDR2 genes
has also been observed in fluconazole resistant clinical isolates [46]. CgSNQ2 gene has been shown
as necessary for fluconazole resistance in vivo. The deletion of this gene in a fluconazole resistant
isolate, BPY55, revealed an increased susceptibility, that was overcome by the reintroduction of
CgSNQ2 gene [49]. In this case study CgCDR1, CgCDR2 and CgSNQ2 genes were also seen to
exhibit increased expression due to gain-of-function (GOF) mutations in CgPDR1 gene. Furthermore,
the disruption of CgPDR1 gene led to significant decrease in the expression of CgSNQ2, CgCDR1
and CgCDR2 genes and to a higher susceptibility to fluconazole, while the reintroduction of this gene
allowed the restoration of resistance to fluconazole [49]. Indeed, the promoters of CgSNQ2, CgCDR1
12
and CgCDR2 and other genes, up regulated upon CgPdr1 GOF mutations in clinical isolates, were
found to have the putative pleiotropic drug response element (PDRE) of S. cerevisiae. This motif is
found in genes regulated by the Pdr1 and Pdr3 transcription factors, in S. cerevisiae, of which
CgPDR1 gene is a homologue. This suggests that CgCDR1, CgCDR2 and CgSNQ2 genes are
regulated by CgPdr1 transcription factor in C. glabrata [20]. The same conclusion was taken in a study
of interactions between gene copy number and overexpressed genes in clinical isolates with
fluconazole resistance [17]. From these reports, fluconazole resistance in C. glabrata seems to be
mostly controlled by GOF mutations in PDR1 gene, which lead to the increase of the CgCDR1,
CgCDR2 and CgSNQ2 expression.
One interesting C. glabrata clinical isolate, exhibiting fluconazole resistance, revealed an
overexpression of CgCDR1 and CgCDR2 genes and also of CgERG11 gene [50]. The overexpression
of the two ABC transporters and the CgERG11 gene involved in the ergosterol biosynthesis
demonstrates that fluconazole resistance can be achieved from the development of multiple molecular
mechanisms within a single clinical isolate.
Beyond ABC transporters, MFS transporters have also been linked to fluconazole resistance
in a C. albicans clinical isolate. This isolate exhibited a GOF mutation in MRR1, which encodes a
transcription factor that regulates the expression of Mdr1, a drug efflux pump from the MFS. This GOF
mutation led to an increase of resistance to fluconazole, but not to voriconazole, indicating a more
specific mechanism relative to fluconazole resistance [51]. Nevertheless, a study of a C. albicans
petite mutant resistant to fluconazole and voriconazole, revealed an overexpression of MDR1 gene
that seemed to be the main molecular mechanism responsible for this resistance [52].
Besides Mdr1, the FLU1 gene was identified, encoding a new multidrug efflux transporter
similar to MFS transporters in C. albicans. The cloning of FLU1 gene in S. cerevisiae Δpdr5 mutant
resulted in an increase of resistance to fluconazole. Nevertheless, when the disruption of FLU1 gene
was assessed in C. albicans, only a small increase of susceptibility to the antifungal agent was
observed [53]. Indeed, in another study of isolates resistant to fluconazole, the overexpression of
FLU1 gene could not be correlated to the increase of resistance [54].
A study of the acquisition of fluconazole resistance and cross-resistance with voriconazole, in
C. glabrata strains susceptible to azoles, obtained between 1917 and 1975, revealed the
overexpression of CgCDR1 and CgCDR2 genes [55]. These results reveal that C. glabrata strains
never exposed to azoles can also develop fluconazole resistance by the overexpression of these ABC
transporters. This work shows that voriconazole resistance may be develop by the same molecular
mechanism that emerged from fluconazole exposure.
Taking into account voriconazole resistance in more detail, the study of recombinant
S. cerevisiae AD strains (deleted in seven ABC transporters PDR5, PDR10, PDR11, PDR15, SNQ2,
YCF1 and YOR1) expressing one of C. albicans genes, CDR1, CDR2 or MDR1, was carried out.
When exposed to voriconazole, the recombinant strains exhibited lower susceptibility to this antifungal
agent, although the recombinant strains expressing CDR1 or CDR2 genes revealed the higher
resistance indexes (defined by the ratio of MICresistant/MICsensitive cells) [56].
13
In the case of clotrimazole resistance in C. glabrata, a recent study associated this resistance
to a drug:H+ antiporter (DHA) that belongs to MFS, encoded by CgQDR2 gene. In C. glabrata, the
CgQdr2 was found to be localized in the plasma membrane and its deletion resulted in a higher
susceptibility to imidazoles, such as clotrimazole, but no changes in fluconazole resistance. The
reintroduction of the gene restored the imidazole resistance [57], revealing that CgQdr2 is an
important drug efflux pump responsible for the efflux of imidazoles, although not having the same
capacity for triazoles. Still, the same study allowed to conclude that the up regulation of CgQDR2 gene
was regulated by CgPdr1, transcription factor [57]. More recently, clotrimazole resistance in C.
glabrata was further linked to a homologue of the S. cerevisiae TPO3 gene, which is a DHA
transporter, localized in the plasma membrane. CgTPO3 gene was capable of mediate clotrimazole
efflux, revealing its role in clotrimazole resistance. Interestingly, this DHA transporter was also found
to confer resistance to other imidazoles, but also to triazoles, such as fluconazole, in C. glabrata. From
these observations, CgTpo3 is the third member of DHA transporters to be involved in azole
resistance in C. glabrata, which indicates the relevance of this family of transporters [58].
Clotrimazole is known as a poorer substrate for Mdr1 than triazoles [56], its resistance in
several clinical isolates has been reported as a result of the overexpression of CDR1 and CDR2
genes, but not as due to the overexpression of MDR1 gene [54]. These results reveal that Mdr1
probably has not a main role in clotrimazole resistance.
Regarding posaconazole resistance, a study of seven isolates recovered from AIDS patients
treated with posaconazole revealed that the levels of expression of the ABC transporters Cdr1 and
Cdr2, as well as Mdr1 MFS transporter, exhibited no significant changes [42]. However, a wider
investigation with more case studies has to be developed in order to be certain that posaconazole
resistance is not associated with these molecular mechanisms involving antifungal transport.
1.4.5. Are there azole specific drug resistance mechanisms?
At this point, it is clear that azole resistance is achieved in most cases by a few different
molecular mechanisms, alone or in combination. These few mechanisms have been detected for
different C. glabrata isolates and strains and the same mechanisms may be developed for different
azoles. Although more studies in this topic must be performed, it is clear that some isolates react in
very similar ways to different azoles, which reveals that a general response may be developed within
C. glabrata isolates. That is the case of mitochondrial dysfunction. This phenotype has been observed
for different isolates exposed to different azoles [10], [44], [45]. The loss of mitochondrial function
gives an anaerobic environment in C. glabrata cells, which stimulates the ergosterol biosynthesis.
Therefore, the augmentation of ergosterol biosynthesis leads to the resistance towards the azole to
which the isolates have been exposed, in a non-specific way.
Another very important and common molecular mechanism developed in C. glabrata is the
overexpression of ABC and MFS transporters, which can be developed simultaneously to achieve
azole drug resistance [10]. The most frequent ABC transporters involved in fluconazole, voriconazole
and clotrimazole resistance are CgCdr1 and CgCdr2 [46], [49], [50], [54]. These transporters are
14
commonly up regulated in azole resistant C. glabrata clinical isolates [55], being one of the main
responses to azole exposure. However, in a study of 7 posaconazole resistant clinical isolates, the
upregulation of CgCDR1 and CgCDR2 genes was not observed [42].
Although ABC drug efflux pumps are commonly related to fluconazole, voriconazole and
clotrimazole resistance, some MFS transporters appear to have more specific roles in azole
resistance. Indeed, in a reported case, fluconazole resistance was achieved by the overexpression of
a MFS transporter, Mdr1, in a C. albicans clinical isolate, but the same did not happen for
voriconazole [51] or clotrimazole [54], [56]. However, in a petite mutant of C. albicans, the
overexpression of this MFS transporter revealed an increase in resistance for both fluconazole and
voriconazole [52]. These two observations show that Mdr1 may act more specifically in fluconazole
efflux. Furthermore, the comparison between these two studies appears to suggest that there are
different paths of development of resistance to a certain antifungal agent.
In the context of specific azole resistance mechanisms, another interesting case is that of the
CgQdr2 transporter, in C. glabrata. CgQdr2 was shown to be involved in the acquisition of resistance
to clotrimazole and other imidazoles, while the same was not observed for fluconazole [57]. Again, we
have a particular molecular mechanism developed only for certain azoles.
CgQDR2, CgCDR1 and CgCDR2 genes were shown to be regulated by the same
transcription factor, CgPdr1, which upon GOF mutations may lead to a upregulation of these and other
genes important for the development of azole resistance [12], [16], [20], [57], [59], [60]. This important
role of CgPdr1 shows that a more general response is behind the acquisition of azole resistance,
since this transcription factor is responsible for the upregulation of several genes that lead to a
different development of resistance. However, it remains to be fully determined the specific effect of
each GOF mutation of CgPdr1 in the acquisition of resistance to each azole drug.
Other different responses to azoles have been detected in certain Candida spp. isolates,
accordingly to alterations in the ERG11 gene, involved in the ergosterol biosynthesis. For instance,
while some amino acid substitutions within ERG11 gene are responsible for the development of
fluconazole, voriconazole and itraconazole resistance (Y132F, Y132H, K143R, G307S, S405F,
G448E, G448V, and G450E), it was detected a new amino acid substitution, Y447H, which was only
led to the development of fluconazole and itraconazole resistance in C. albicans isolates [31]. On the
other hand, while fluconazole and clotrimazole resistance may be achieved by single Erg11 amino
acid substitutions [54], isolates exhibiting posaconazole resistance were found to have developed
multiple mutations in ERG11 [42]. These observations show that the development of resistance can
be very particular for a certain azole, although some mutations seem to be involved in the acquisition
of resistance for more than one of the azoles studied herein. It appears reasonable to assume that
Erg11 mutations may bring conformational changes that alter the affinity of the protein for a specific
azole drug, but not to other azoles. In this way, specific mutations would eventually be responsible for
the acquisition of resistance for a unique azole. However, more studies have to be performed to
unravel which mutations are the main responsible for the resistance to each azole drug, which may be
difficult due to the similarity of structures of azole drugs. These associations would be very interesting
for the development of new therapeutic approaches for the treatment of azole resistant candidiasis.
15
Altogether, is possible to conclude that, although not being a general rule, some of the
described mechanisms of azole drug resistance work specifically against certain azoles and not
others, as summarized in Table 3.
Table 3. Molecular mechanisms present in the development of resistant to azoles, for Candida species [26], [31], [46], [49]–[51],
[57], [61].
Molecular Mechanism Resistance Candida
spp. Reference
Amico acid substitution Y447H Fluconazole and itraconazole but not voriconazole C. albicans Morio et al.,
2010
GOF mutation in MRR1 gene Fluconazole but not voriconazole C. albicans Eddouzi et al.,
2013
DHA CgQdr2 Clotrimazole but not fluconazole C. glabrata Costa et al.,
2013
Amino acid substitution P230L Posaconazole and itraconazole but not voriconazole C. albicans Li et al., 2004
Upregulation of CgCDR1 and
CgCDR2
Fluconazole, voriconazole and clotrimazole but not
posaconazole Candida spp.
Li et al., 2004;
Vermitsky and
Edlind, 2004;
Torelli et al.,
2008; Redding
et al., 2003;
White et al.,
2002
The challenge is to distinguish mechanisms that are specific to a given azole from those that
are general for most of azoles. Thereby, specific therapeutics could be developed for the eradication
of Candida infections exhibiting specific patterns of azole resistance.
1.5. Possible new mechanisms of azole drug resistance explored in
this study
Clinical evidences show a higher level of azole resistance in infections with C. glabrata when
compared to other Candida species [3]. This observation suggests that new strategies have to be
developed to deal with this fungal pathogen, including a deeper analysis on the mechanisms
developed by C. glabrata that make it particularly resistant to azole drugs.
Based on the results described in this master thesis, two new players in azole drug resistance
were unravelled: adhesins and eisosomes. The known role of these proteins/structures in C. glabrata
is thus briefly reviewed in the following subsections, with emphasis on their participation in cell biology,
host-interaction and drug resistance.
16
1.5.1. Role of Candida glabrata adhesins as virulence and antifungal drug
resistance determinants
Cell wall components mediate tissue adhesion, invasion, protection against host defence
reactions, biofilm formation, trigger the host immune response, and may also confer resistance to
antifungal drugs [62]. Therefore the components of the cell wall of C. glabrata strains are important for
its successful survival and infection.
The C. glabrata cell wall is richer in protein content (6%) than the cell wall from S. cerevisiae
or C. albicans, but has a lower relative level of total glucan and a higher ratio of mannose/glucose [62].
The high protein content is mostly related to adhesion, a crucial process for the occurrence of infection
in human hosts, constituting one of the virulence factors used by this species. The main step to
understand adhesion is to identify the players responsible for the process. According to different
reports, the main responsible components for this event are adhesins, a group of proteins with the
specific function to adhere to different ligands found in host cells. This ligation allows the pathogen, C.
glabrata, to adhere to host cells [62]–[64].
Adhesins are specialized cell wall proteins which bind to amino acid or sugar residues on the
surface of other cells. They can also mediate the ligation to abiotic surfaces. All adhesins have a
three-domain structure: C-terminal containing GPI-anchor addition site binding the adhesin to the cell
wall; N-terminal contains carbohydrates or peptide binding domain; the middle and larger domain is
composed by serine- and threonine-rich repeats which allows a variability between adhesins [65].
One type of adhesins belongs to a class of proteins called glycosylphosphatidylinositol-
dependent cell wall proteins (GPI-CWP), which are in fact mannoproteins. The proteins belonging to
this class have N-terminal signal peptides and C-terminal features (Ser/Thr-rich domain) that mediate
GPI membrane anchor addition. Other structures determine the attachment to 1,6-β-glucan on the cell
wall [62], [63], [66], [67]. 106 putative GPI proteins were report from a systematic identification in silico,
from which 51 had features of adhesin-like CWPs [13], and 23 covalently bound adhesin-like proteins
were identified by tandem mass spectrometry [62], proving that C. glabrata strains have a large group
of proteins that can be incorporated in the cell wall to adapt and adhere in different conditions. These
mannoproteins are linked to β-1,3-glucan via β-1,6-glucan [62]. Besides adhesion other functions have
been associated with these proteins, such as cell shape maintenance, limiting permeability,
hydrophobicity, cell wall biosynthesis and remodelling, biofilm formation and antigenicity [13].
Although there is a high genetic variability of adhesin-like proteins, the incorporation of
GPI-CWP in the cell wall depends on cell cycle phase, environmental conditions, growth phase and
morphology of the cells [62].
Until now, several adhesin-like proteins have been found and grouped according to their
properties and features (Figure 4). The major group of adhesin-like proteins belongs to the EPA
family.
17
Figure 4. Multiple subfamilies of adhesin-like proteins in C. glabrata represented in a neighbour-joining phylogenetic tree, with
bootstrap values added (1,000 bootstraps performed), based on the putative functional domains (the 300 N-terminal amino
acids or fewer in cases where the N-terminal ORF fragment is shorter) of the ORFs is shown (Adapted from Groot et al., 2008
[62])
18
Epa1 is one of the GPI-CWP and the most known significant adhesin in the EPA family, due to
its effective capacity to adhere. Its N-terminal domain has slight homology to S. cerevisiae flocculin
Flop1, a Ca2+-dependent lectin. Epa1 is also a Ca2+-dependent lectin since adherent cells can be
removed with EGTA or EGTA titrated with Mg2+ (but not titrated with Ca2+). EPA1 gene deletion led to
a 95% decrease in yeast cell adherence to human laryngeal carcinoma (Hep2) cell line.
Epa1-dependent adherence is inhibited by lactose and N-acetyl-lactosamine [68].
Nevertheless, despite prove of CgEpa1 effective adherence, studies revealed that in murine
vaginal and stomach tissues, this adhesin is not necessary for infection of C. glabrata to occur.
Probably in these models N-acetyl-lactosamine-glycoconjugates were not exposed to the surface of
host cells or other adhesins were responsible for the observed adherence [68].
Other important adhesins are CgEpa6 and CgEpa7, which also mediate the adherence to
epithelial cells [69]. CgEpa1, CgEpa6 and CgEpa7 have been shown to be involved in kidney
colonization of C. glabrata [69], [70]. Another adhesin, CgEpa3, has been shown to be important in
adhesion to epithelial cells and biofilm formation. Indeed, the expression of CgEPA3 was found to be
up regulated in C. glabrata biofilm cells [71].
The regulation of adherence happening in C. glabrata cells is mediated by transcriptional
silencing at telomeres. This process is initiated by Rap1 and Hdf1 proteins which associate with the
telomeres. Their function is to recruit a complex of proteins: Sir2, Sir3 and Sir4. Sir2 is the catalytic
activity of the Sir complex, which is a NAD+-dependent histone deacetylase that deacetylates histones
H3 and H4 of a targeted nucleosome. Moreover, Sir2 provides high affinity binding sites to Sir3 and
Sir4. The capacity of Sir complex to bind to hypoacetylated histones allows its spread along the
telomere until it reaches the sub-telomeric region as adjacent nucleosomes are sequentially
deacetylated by Sir2 and are bound by all complex [72]. Mutants with insertions in SIR3 and RIF1
genes showed increased adherence of C. glabrata to epithelial cells. Rif1 is a protein which is
necessary for the control of telomere length. The increased adherence in both mutants was due to the
increased transcription of CgEPA1 gene and the induction of CgEPA6 and CgEPA7 genes, which are
normally silent [69].
The regulation of EPA genes is also involved with environmental conditions as was already
referred. For instance, C. glabrata is auxotrophic for pyridoxine, thiamine and nicotinic acid (NA).
Consequently, cells depend on the environment to obtain these vitamins. NA is a precursor of NAD+
necessary for Sir2 activity. For this reason, when the environment does not provide NA, the silencing
of EPA genes does not occur, in order to enable the cells to attach to host tissues capable of providing
this vitamin. Also, it was possible to observe that the induction of CgEPA6 gene expression is
triggered by NA limitation. It seems that other EPA genes like CgEPA1 and CgEPA7, are also
regulated by Sir2 activity dependent on NA [73].
In particular, the transcription regulation of CgEPA1 gene is controlled negatively and
positively, since cells are non-adherent in stationary phase and long-term log phase, and also limiting
adherent in lag phase. Therefore, C. glabrata cells control adhesion according to different
environmental conditions. The repression of CgEPA1 gene expression can be activated by two
different mechanisms. The first is performed at subtelomeric level, where Sir complex plays the main
19
role. The second mechanism is based on a cis-acting negative regulatory element (200-bp fragment)
located at 300 bp downstream from the stop codon of CgEPA1 gene in the intergenic region between
CgEPA1 and CgEPA2 genes. This repression by the negative element is dependent on yKu70 and
yKu80 proteins. Regarding the positive regulation, there’s still a lot to unravel although the
transcription factors Flo8 and Mss1 seem to be good Candidates to activators [70], [74].
Also interesting regarding CgEPA1 gene expression is the presence of a high cell-to-cell
heterogeneity. A given population of C. glabrata cells expressing CgEPA1 gene can easily, in a few
generations, have a mixed population where this expression is different. These differences are related
to environmental changes [75]. Consistent with this, are the observations of a study were transcript
levels of several adhesins (CgEPA1, CgEPA3, CgEPA6, CgEPA7 and CgEPA22, and CgAWP1-7),
were measured in biofilms formed in different medium: YPED and a semi-defined medium containing
0.3% (w/v) yeast extract and 18 mM glucose. It was observed that different adhesins were expressed
in the two medium. For instance, CgEPA3 gene was the only Epa adhesin overexpressed in YPED
medium, while CgEPA3, CgEPA1, CgEPA7 and CgEPA22 genes were overexpressed in the other
medium [71].
The shift from adherent to non-adherent and vice-versa allows cells to adapt to different
stresses and environmental conditions, but also creates a variability of the cell wall useful as a
pathogen [65].
A particular study revealed that Kex2 is a protein involved in processing proteins that are
essential for cell surface integrity. Therefore, when C. glabrata deletion mutants Δhex2 were tested
with different antifungal drugs, hypersensitivity was observed when exposure to drugs that target cell
surface was assessed. CgEpa1 is one of the adhesins that need this endoproteinase in order to be
able to exert its functions [76].
Although not much is known for C. glabrata, in S. cerevisiae and C. albicans several signalling
pathways seem to be behind the signal transduction to activate or repress an adherent phenotype.
Examples of these pathways are Ras-cAMP pathway, mitogen-activated protein (MAP) kinase-
dependent filamentous growth pathway and Target of Rapamycin (TOR) pathway [65].
Besides those belonging to the EPA family, other adhesins are also involved in the adherence
process in C. glabrata. A report of the interaction of C. glabrata with human umbilical vein endothelial
cells, showed the importance of other two adhesins CgPwp7 and CgAed1, in vitro. Comparing the
adhesion observed in the wild-type BG4 strain, the deletion mutants Δpwp7 and Δaed1 had less 66%
and 50% of adhesion to the epithelial cells in study. These adhesins are mostly expressed in
stationary phase [77].
Besides adhesins, there are other proteins important in the cell wall integrity, adherence to
mammalian cells and virulence. This is the case of Yps proteases, which are overexpressed in C.
glabrata strains internalized by macrophages, allowing their survival. Interestingly, these proteases are
directly involved in adherence since several deletion mutants of YPS genes are hyper adherent,
mostly due to the presence of CgEpa1. Therefore, it seems that CgEpa1, as probably other Epa
adhesins, is a substrate for Yps proteases [78].
20
Adhesion is usually followed by biofilm formation, another virulence factor. Biofilm formation
allows tolerance to antifungal therapy by limiting the penetration of different drugs through the ECM
formed. The biofilm formation is dependent on environmental conditions, and its formation is
associated with infection with higher mortality rates [64], [67]. It is important to consider the differences
between the biofilm formation in vitro and in vivo since a recent study demonstrated that the
expression of adhesins is different in these two conditions. In fact, when in vitro biofilm formation is
assessed only the non-Epa adhesins (CgAwp1-7) overexpressed in C. glabrata. When biofilm
formation was assessed in vivo, the overexpression of CgEpa3 and CgEpa6 adhesins was observed
together with CgAwp2, CgAwp3 and CgAwp5 adhesins [79].
One particular study gives evidence of the intrinsic relationship between adhesion and biofilm
formation. As referred before, CgEpa6 is detected as an important adhesin for biofilm formation, since
Δepa6 deletion mutant revealed a significant decreased in biofilm formation, but also, CgEPA7
transcripts were found overexpressed in C. glabrata biofilm formation [80]. According to this study,
both genes, CgEPA6 and CgEPA7, are regulated by Yak1 in biofilm conditions. In turn, Yak1 acts by a
mechanism involved in subtelomeric silencing [80].
Adhesion followed by biofilm formation usually allows pathogens to resist to several
administered drugs. In C. glabrata, resistance to azole drugs, as already discussed herein, can be
developed due to GOF mutations in CgPDR1 gene. Interestingly, one study allowed to observe that
these mutations have also a role in the adhesion to epithelial cells and macrophages. In fact, GOF
mutations in CgPDR1 gene, with hyperactive alleles, leads to a decrease in adherence and
incorporation by macrophages, and to an increased adherence to epithelial cell layers [81]. Therefore,
it seems that this transcription factor modulates several mechanisms within C. glabrata cells involved
with resistance and virulence.
1.5.2. Eisosomes as determinants of resistance to antifungal drugs
The cellular membrane is compartmentalized in several domains which enable the
development of different functions, such as signal transduction and protein trafficking. One of the
domains that integrate the cellular membrane is the membrane compartment of Can1 (MCC), which is
an arginine permease. There are about 30-50 small MCC per cell, evenly distributed, which
correspond to furrow-like invaginations in the plasma membrane that are about 200 to 300 nm long
and 50 nm deep. These domains are occupied by members of the Sur7/PalI family and several
nutrient H+ symporters, having a specific protein and lipid composition [82]–[85]. Besides MCC
domains, the cellular membrane has other domains such as the membrane compartment of Pma1
(MCP) and the membrane compartment of TORC2 (MCT). The MCP is mainly occupied by the plasma
membrane H+ ATPase, while the MCT is occupied by the TORC2 kinase complex, which regulates cell
polarity and sphingolipid synthesis [82].
21
The MCC is correlated with eisosomes since both are parts of the same overall structure. The
eisosome structure corresponds to an assembly of its major components Pil1/Lsp1. The membrane
patches enriched in ergosterol, where these assemblies are co-localized, correspond to the MCC
domains [86]. The eisosomes are formed in a polar wave in buds that have grown beyond a critical
size, beginning in the bud neck. The eisosomes are assembled de novo and immediately immobile
[83], [85].
In S. cerevisiae several proteins belong to eisosomes structure (Table 4), although Pil1 and
Lsp1 are the core components of eisosomes. These components are responsible for the
MCC/eisosome formation, allowing the formation of filaments and binding of membranes through their
Bin/amphiphysin/Rvs (BAR) domains, which correspond to 50% of these proteins. The BAR domains
bind preferentially to liposomes containing phosphatidylinositol 4,5 biphosphate (PI(4,5)P2) [82], [84].
In fact, the Pil1 protein is essential to eisosomes formation since the deletion of the PIL1 gene
leads to the absence of the furrow-like invaginations. This protein is also responsible for the size and
number of eisosomes in the cell. The PIL1 gene is directly regulated by the cell cycle since its
promoter has a binding site for the transcription factor Swi5. This factor activates the transcription of
genes in G2 phase and the G2/M boundary after phosphorylation by Cdc28 kinase. The cell cycle
regulation of PIL1 gene leads to a synchronized eisosome assembly with the membrane expansion
[85].
The Lsp1 protein, is a paralog of Pil1, although it binds less efficiently to the plasma
membrane and does not have the same functions of Pil1 protein, since the Δlsp1 cells show normal
MCC/eisosomes [87].
Besides these two major components, Seg1 protein is also required for eisosome formation.
This protein precedes Pil1/Lsp1 assemblies during eisosome formation and determines the eisosome
length [86]. These three components are membrane associated proteins [84].
Other proteins, such as a number of integral membrane proteins, are considered part of the
MCC [82]. Examples of these proteins are Sur7 protein and its paralogs Fmp45, Pun1 and Ynl194c, or
Nce102 and Fhn1 from another family [82], [84]. Nce102 is necessary for the de novo formation of
eisosomes and controls the association of several transporters to the MCC [88], being a protein with
four-transmembrane-helix domains termed MARVEL [89].
Figure 5. Schematic representation of the MCC, MCP and eisosomes (Adapted from Mollinedo, 2012 [108]).
22
Table 4. MCC/eisosome proteins in S. cerevisiae (adapted from Douglas and Konopka, 2014 [82]).
Protein Function M
CC
pro
tein
s
Sur7 Sur7 family tetraspanner
Fmp45 Sur7 family tetraspanner
Pun1 Sur7 family tetraspanner
Ynl94c Sur7 family tetraspanner
Nce102 Nce102 family tetraspanner
Fhn1 Nce102 family tetraspanner
Can1 H+ -driven Arg permease
Fur4 H+ -driven uracil permease
Tat2 H+ -driven Trp and Tyr permease
Eis
osom
e p
rote
ins
Pil1 BAR domain
Lsp1 BAR domain
Pkh1 Ser/Thr protein kinase
Pkh2 Ser/Thr protein kinase
Eis1 Unknown
Slm1 BAR domain and PH domain
Slm2 BAR domain and PH domain
Seg1 Unknown
Mdg1 Unknown
Ygr130c Unknown
Pst2 Similar to flavodoxin-like protein
Rfs1 Similar to flavodoxin-like protein
Ycp4 Similar to flavodoxin-like protein
Msc3 Protein of unknown function
The eisosome assembly is regulated by two functional homologs of the mammalian
phosphoinositide-dependent kinase 1 (PDK1): Pkh1 and Pkh2. These kinases phosphorylate Pil1 and
Lsp1 controlling eisosome assembly. Nevertheless, it is still unknown if this phosphorylation promotes
eisosome assembly or disassembly [82].
Another model has been proposed for the regulation of eisosome formation. In this model, the
Nce102 protein inhibits the Pkh1 and Pkh2 kinases, when the membrane has a high content of
sphingolipids. Therefore, the Pil1 and Lsp1 components are not phosphorylated, promoting the
eisosome formation [90]. Interestingly, mutations in these Pkh kinases or in sphingolipid biosynthetic
enzymes has led to the observation of blocked endocytosis [83], which connects the eisosomes with
this process.
Other studies have proposed another regulation for the Pil1 and Lsp1 eisosome’s
components, by SUMO, an ubiquitin-like post-translational modification. It seems that SUMO can
attach to the Lys-63 residue of Pil1 protein, highly conserved in Pil1 and Lsp1 [91].
Moreover, other two proteins also seem to have a role in the regulation of eisosome assembly,
Slm1 and Slm2. In cells lacking SLM1 and SLM2 genes is possible to observe a decrease in the
number of eisosomes formed and the accumulation of Pil1 in the cytoplasm. These deletion mutants
23
showed defects in the ability to form polarized cortical F-actin and cytoplasmic actin cables [92]. In
addition, a study revealed that upon membrane stress, caused by inhibition of sphingolipid metabolism
or stretching of the plasma membrane, leads to the redistribution of Slm proteins, which activate the
TORC2 complex, responsible for the regulation of sphingolipid metabolism. Since eisosomes are only
localized in zones with high levels of sphingolipid content, this system of regulation seems to bring a
homeostatic mechanism for the formation of eisosomes and regulation of lipids in the plasma
membrane [93] (Figure 6).
Figure 6. MCC/eisosome representation in S. cerevisiae (adapted from Douglas and Konopka, 2014 [82]).
The functions associated with the MCC/eisosomes are not yet clear since more studies and
techniques have to be developed in order to further unravel the importance of these structures.
Nevertheless, some observations in different reports have led to some suggestions, like a role in
endocytosis. For instance, the deletion of PIL1, LSP1 genes or both has led to a decrease in the rate
of endocytosis compared to wild-type cells in S. cerevisiae [83]. This observation suggests that
eisosomes may be involved in the endocytosis process. Another study revealed that the basal
turnover of Can1 and Fur4, two permeases, is faster in the deletion mutants Δnce102 and Δpil1 when
compared to the wild-type of S. cerevisiae. The degradation of these permeases is performed by
endocytosis [88], which reveals that these eisosome’s components seem again to be involved in this
process.
The Pkh1/2 proteins are needed for endocytosis and regulation of the deadenylation-
dependent mRNA decay in S. cerevisiae, through Pkc1. This suggests that Pkh1/2-Pkc1 signalling
pathway may coordinate mRNA decay monitoring nutrient availability and other environmental
stresses [87].
The study of the expression of PIL1 gene in C. albicans biofilms also allowed some interesting
discoveries in the understanding of the function of this protein. The expression of PIL1 gene was
significantly higher in adhered cells and biofilms, when compared to planktonic growing cells. In
24
addition, this expression was reduced when the cells were exposed to caspofungin and
amphotericin B. These observations led to the hypothesis that PIL1 is associated with the β-1,3-glucan
synthase, playing a role in its regulation [94]. Nevertheless, its overexpression in C. albicans biofilms
suggests a role in biofilm formation.
Another study regarding the Nce102 protein revealed that it has a minor role in the regulation
of MCC/eisosomes in C. albicans and, also, importance in the hyphal formation and actin organization.
The Nce102 protein is involved in the virulence of C. albicans cells since the Δnce102 mutants were
less virulent, taking a longer period of time to developed disease and having a defect in hyphal
formation, in a mouse model of hematogenously disseminated candidiasis [89].
Another functional role related to eisosomes seems to be osmotic shock and dehydration. In
hyperosmotic conditions, alterations in the plasma membrane have been observed, which revealed
that a redistribution of Sur7-green fluorescence protein (GFP), suggesting a reorganization of the
MCC/eisosomes in these conditions [87].
Some particular studies have focused on the Sur7 protein. This integral membrane protein has
shown to be necessary for proper localization of actin, morphogenesis, cell wall synthesis, decreased
virulence in a mouse model of systemic candidiasis and defective in endocytosis [95], [96]. The
decreased in virulence seemed to be due to increased susceptibility to oxidation, copper and cell wall
stress. These conclusions were taken upon experiments using Δsur7 cells, which also revealed that
Sur7 protein is necessary to resist to several stress conditions present in a macrophage phagosome,
such as oxidation conditions [96]. Moreover, Δsur7 cells are more sensitive to sodium dodecyl sulfate
(SDS), chitin-binding agent Calcofluor White, inhibitors of the synthesis of cell wall chitin (nikkomycin
Z) and the cell wall β-1,3-glucan (caspofungin) and to the cercosporamide drug, which inhibits Pkc1
from inducing cell wall repair genes [87]. Since Δsur7 cells have less levels of β-1,3-glucan, the Sur7
protein may be also involved in the synthesis of this component of the cell wall that confers rigidity.
These results have implications in antifungal therapy, since it can lead to the development of
new strategies based on the targeting of MCC/eisosomes. In fact, the Δsur7 mutant revealed to have
increased susceptibility to fluconazole (8-fold increased), 2-fold increased sensitivity to caspofungin
and 8-fold increased sensitivity to cercosporamide when compared to the wild-type [87], [95].
According to this, drugs targeting the Sur7 protein could lead to higher sensitivity to different drugs,
helping in the treatment of patients infected with drug resistant strains. Furthermore, targeting the
MCC/eisosomes domains also helps arresting a wide range of virulence factors. Altogether, is
possible to conclude that MCC/eisosomes have important roles in C. albicans cells, which might be
studied from a perspective that would help discover new therapeutic approaches for the treatment of
infections by Candida spp.
25
Figure 7. Fluconazole in vitro induction of a C. glabrata 044 clinical isolate. Minimal inhibitory concentrations were measure for
fluconazole (◊), voriconazole (□), posaconazole (Δ) and clotrimazole (×) along the total time of induction (days).
0
8
16
24
32
40
48
56
64
72
0 5 10 15 20 25 30 35 40 45 50 55 60 70 R(-30)
Min
ima
l In
hib
ito
ry C
on
ce
ntr
atio
n (
µg/m
L)
Induction Time (days)
1.6. Motivation and thesis outline
The major goal of this master thesis is to contribute to unravel new molecular mechanisms
responsible for the acquisition of azole resistance, especially those that may be responsible for the
acquisition of resistance to specific azole drugs. To pursue this goal, a specific case-study was
selected.
A C. glabrata clinical isolate, denominated clinical isolate 044, found to exhibit azole
susceptibility, was obtained from a patient attending the Centro Hospitalar of S. João, Porto, in
collaboration with the team led by Prof. Acácio Rodrigues. This clinical isolate was exposed to a
constant concentration of fluconazole (16 µg/mL), corresponding to therapeutic serum levels obtained
during antifungal treatment [97]. Exposure was maintained to force its directed evolution towards a
fluconazole resistance phenotype. The fluconazole resistance induction was followed by measuring
the MIC of the cell population throughout the total induction time, for four azole drugs: posaconazole,
clotrimazole, fluconazole and voriconazole.
This evaluation was carried out by Dr. Ana Silva Dias, Dr. Isabel Miranda and Prof. Acácio
Rodrigues, from Faculdade de Medicina da Universidade do Porto.
The 044 clinical isolate remained susceptible to all four azoles in the first 20 days of
fluconazole induction (Figure 7). Upon 21 days, the clinical isolate became resistant to posaconazole
(044Fluco21), but not to the remaining azoles tested. Then, after 31 days, clotrimazole resistance was
acquired by this clinical isolate (044Fluco31), followed by fluconazole resistance acquisition at day 44
and voriconazole resistance at day 45 (044Fluco45) (Figure 7). The observation of the sequential
acquisition of resistance to the different azoles is quite interesting per se. First, it is clear that
fluconazole exposure led to increased resistance to several azole drugs. Second, the fluconazole
exposed cells first acquired posaconazole and clotrimazole resistance and, only later, fluconazole and
26
voriconazole resistance, suggesting a strong potential for azole drugs to induce cross-resistance
within the remaining members of this drug family. The observation that it was possible to obtain a
posaconazole resistant strain, that is not resistant to the remaining azole drugs, or a
posaconazole/clotrimazole resistant strain, that is not resistant to the remaining azole drugs, highlights
the fact that there must be mechanisms of resistance to the azole drugs which are azole drug-specific.
This fact convinced us that the in depth comparative analysis of these isolates could bring light into
new factors underlying resistance to azole drugs in general, but also to individual azoles.
In collaboration with the team led by Prof. Acácio Rodrigues, alterations in the sequence of the
PDR1 and ERG11 genes were evaluated, as they can be responsible for the development of azole
resistance in the 044 clinical isolate. The results obtained show a single mutation in PDR1 gene, in the
044Fluco45 strain, posaconazole/clotrimazole/fluconazole/voriconazole resistant.
From this starting point, the 044 clinical isolate and the evolved strains obtained upon
exposure to a fluconazole inhibitory concentration, were further studied to understand which
mechanisms were behind of each acquisition of azole resistance observed over time, using
transcriptomics analysis carried out using microarray hybridization. The Results and Discussion
section begin with the bioinformatics analysis of these global results.
The second part of the work was based on the transcriptomics analysis results. From the
expression analysis of several genes regarding drug resistance, pathogenesis, cell wall and lipid
metabolism, it was observed a higher overexpression of known drug transporters in the
posaconazole/clotrimazole/fluconazole/voriconazole resistant strain. Based on these results,
clotrimazole accumulation assays were developed to assess the relevance of this overexpression in
the efflux of clotrimazole in the clinical isolate 044 and all the evolved strains. Additionally, an ABC-like
protein that also exhibited an overexpression in the 044Fluco45 strain was investigated about its
possible role in azole resistance. Moreover, the expression analysis showed an overexpression of
CgERG11 gene, in the posaconazole/clotrimazole resistant strain, although the same was not
observed for the posaconazole/clotrimazole/fluconazole/voriconazole resistant strain. This interesting
observation led to the evaluation of ergosterol content in the 044 clinical isolate and evolved strains, in
order to assess the importance of ergosterol in the acquisition of posaconazole/clotrimazole
resistance, with overexpression of CgERG11 gene, in comparison to the 044Fluco45 strain. Still
regarding the transcriptomics analysis results, the possible role of eisosomes in the acquisition of
azole resistance was evaluated. According to susceptibility assays, Pil1, component of eisosomes,
showed to have a role in clotrimazole, ketoconazole and tioconazole resistance. Therefore, the role of
Pil1 in the efflux of azole drugs was investigated in clotrimazole accumulation assays, and ergosterol
content was evaluated in the Δpil1 mutant. Finally, the aggregation cell-to-cell and biofilm formation
were studied in the 044 clinical isolate and evolved strains, since the overexpression of several
adhesins was detected in the posaconazole/clotrimazole resistant strain. Also, susceptibility assays
and biofilm formation were evaluated in the Δepa1, Δepa3 and Δepa10 mutants.
The thesis ends with a Final Discussion, focusing on the most significant aspects of our
findings, and in the still not answered questions regarding azole resistance in these strains.
27
2. Experimental Procedures
2.1. Cell cultures
2.1.1. Candida glabrata strains
The C. glabrata strains used in this master this are described in Table 5.
Table 5. C. glabrata strains used in this study.
Strain Genotype/Description Source
044 clinical isolate Azole susceptible Prof. Acácio Rodrigues, harvested from a
patient, in Centro Hospitalar of S.João, Porto,
044Fluco21 Posaconazole resistant Prof. Acácio Rodrigues, Centro Hospitalar of
S.João, Porto,
044Fluco31 Posaconazole/clotrimazole
resistant Prof. Acácio Rodrigues, Centro Hospitalar of
S.João, Porto,
044Fluco45 Posaconazole/clotrimazole/
fluconazole/voriconazole resistant
Prof. Acácio Rodrigues, Centro Hospitalar of S.João, Porto,
KUE100 Wild-type Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
ΔCAGL0G05093g KUE100_
ΔCAGL0G05093g
Prof. Hiroji Chibana, Medical Mycology Research Center, Chiba University, Chipa,
Japan
Δcgpil1 KUE100_Δpil1 Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
Δcglsp1 KUE100_Δlsp1 Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
Δcgseg1 KUE100_Δseg1 Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
Δcgepa1 KUE100_Δepa1 Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
Δcgepa3 KUE100_Δepa3 Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
Δcgepa10 KUE100_Δepa10 Prof. Hiroji Chibana, Medical Mycology
Research Center, Chiba University, Chipa, Japan
2.1.2. Growth media Cells were batch-cultured at 30ºC with orbital agitation (250 rpm) in different growth media
according to the following protocols. The yeast extract peptone dextrose (YEPD) growth media was
used as a rich medium, with the following composition (per liter): 20 g glucose (Merck), 20 g yeast
extract (Difco) and 10 g bacterial-peptone (LioChem). The minimal growth medium (MMG) used
28
contained per liter: 20 g glucose (Merck); 2.7 g (NH4)2SO4 (Merck); 1.7 g yeast nitrogen base without
amino acids or (NH4)2SO4 (Difco). Also used was Sabouraud’s dextrose broth (SDB) containing 40 g
glucose (Merck) and 10 g peptone (LioChem) per liter.
2.1.3. Antifungal drugs
The stock solutions of antifungal drugs used in the studies present herein, were obtained from
Sigma and dissolved in Dimethyl Sulfoxide (DMSO) also from Sigma. The stock solutions were
prepared in order to have the concentrations present in Table 12.
2.2. Transcriptomic analysis
2.2.1. RNA extraction
The pre-inoculum for the 044 clinical isolate was grown overnight, following the preparation of
the inoculum, which was incubated for 5 h in order to obtain the final optical density (OD) of 0.8. The
cells were recovered using the J2-MC centrifuge, Beckman, following their resuspension in 1.5 mL of
medium. Another centrifugation was performed in eppendorfs, in the Scanspeed mini centrifuge,
Labogene. The supernatant was removed and the cells were frozen at -80ºC.
RNA extraction was performed using the RiboPure™ RNA Isolation Kit (Ambion, Life
Technologies, California, USA). The recovered cell pellet was resuspended in 480 μL of lysis buffer.
After this 48 μl of SDS and 480 μl of a mixture of Phenol:Chloroform:IAA were added to the mixture
and the suspension was transferred to one of tubes containing 750 μL cold Zirconia Beads prepared
previously. The sample tubes were horizontally positioned on the vortex. The vortex was set at
maximum speed, for 10 min. The lysate obtained from this disruption process was centrifuged for
5 min at 16,100 g at room temperature, in order to separate the aqueous phase, containing the RNA,
from the organic phase. The aqueous phase was collected and added to 1.90 ml of Binding Buffer and
1.25 mL of cold 100% Ethanol. The total volume was centrifuged through a filter cartridge and washed
with 700 μL of Wash Solution 1. After new centrifugation, the filter was washed two times with 500 μL
of Wash Solution 2/3 followed by an extra min to ensure the complete removal of wash solution. Total
RNA obtained was eluted in two times 50 μL of Elution Solution, previously heated at 95°C. The
isolated RNA was treated with DNase I to remove traces of chromosomal DNA. Therefore, 100 μl RNA
sample (50 μl + 50 μl) was added to 8 U of DNase I and 10 μl of 10X DNase I Buffer. The mixture was
incubated at 37°C during 30 min. After this incubation, 10 μl of DNase Inactivation Reagent were
added to the mixture, which was then vortexed and left for 5 min at room temperature. The purified
RNA (in the supernatant fraction) was collected into a fresh tube by centrifugation (>10000 rpm,
3 min).
2.2.2. Microarray data analysis
At each fluconazole induction time for which the C. glabrata clinical isolate acquired resistance
to each azole drug, the RNA extraction was performed and a transcriptomics analysis was assessed
in collaboration with Geraldine Butler, from University College Dublin. Therefore, a sample of RNA
29
was obtained at the 21st day of fluconazole induction corresponding to the gained of posaconazole
resistance, following a sample at the 31st day of fluconazole induction, concerning clotrimazole
resistance, and finally, a RNA sample at the 45th day was performed, for which the isolate had already
acquired fluconazole and voriconazole resistance. The microarray analysis was conducted for these 3
RNA samples and each sample was analysed in comparison with a RNA sample from the initial
susceptible isolate (control). In Table 6 are represented by letters the several samples and respective
controls considered in the microarray analysis performed for each acquired resistance.
Table 6. RNA samples and respective controls of C. glabrata 044 clinical isolate considered in the microarrays analysis relative
to each resistance acquisition of the clinical isolate. Respective fluconazole induction time (days).
Clinical Isolate Azole Resistance Induction Time (days) Samples Controls
Posaconazole 21 D, E, F A1, B1, C1
Clotrimazole 31 G, H A2, B2
Fluconazole and Voriconazole 45 J, K, L A3, B3, C3
The microarray data was analysed for each resistance case, selecting the up regulated and
down regulated genes according to two criteria. The first criterion was based on the p-value of each
hybridization, which was established as being ≤ 0.05. The second criterion established that the
logarithm to base 2 of the fold change of the two probes for each gene could not differ more than 30%.
With the selection performed, the several up regulated and down regulated genes of each time
of induction were submitted to several analysis using different databases and bioinformatic tools.
2.2.2.1. GOToolBox analysis The analysis using the bioinformatic tools, GO-Proxy and GO-Stats from the GOToolBox web
server [98], was performed for each group of up regulated and down regulated genes, regarding each
time of fluconazole induction when the isolate acquired resistance. Therefore, for each group a
dataset was created in this web server according to the homologues genes names in S. cerevisiae,
following its analysis through the two bioinformatic tools mentioned. This allowed the determination of
the main Gene Ontology (GO) terms to which the genes are related. The selection of the central GO
terms was performed with a single criterion which determined a p-value < 0.05.
2.2.2.2. KEGG Mapper analysis The bioinformatic tool KEGG Mapper was used to analyse the main metabolic pathways to
which the groups of genes selected belonged. The up regulated genes ID were entered according to
the colour code green, while the down regulated genes ID had the colour code red. The KEGG
organism code chosen was “cgr” for Candida glabrata. From the several pathways obtained as a
result of the bioinformatic tool used, only the ones with 5 or more number of genes with altered
expression were selected as having significant relevance.
2.2.2.3. Expression profiles analysis From all the up regulated and down regulated genes selected previously, the genes were
grouped according to the cellular functions in which they belong. From this organization, the genes
concerning multiple drug resistance (MDR), cell wall and lipid metabolism were selected in order to
30
development an evaluation of their expression profiles over the time of induction, considering the fold
change of each gene, at the each specific acquisition of azole resistance.
2.3. Gene expression analysis
The quantitative real time polymerase chain reaction (RT-PCR) technique was used in order to
estimate the expression levels of different genes of C. glabrata clinical isolates, by visualizing the
abundance of mRNA transcripts in each sample.
The 044 clinical isolate of C. glabrata and the respective evolved strains were grown in YEPD
medium, at 30ºC, with an orbital agitation of 250 rpm until an O.D.600nm of 0.8±0.08 was achieved. The
cultures were conducted in triplicates. Afterwards, the cells were harvested with a centrifugation of
7000 rpm, at 4ºC for 8 min, obtaining the desired pellets. Then, the pellets were resuspended in 1 mL
of supernatant and centrifuged at 9000 rpm for 2 min, in 1.5 mL eppendorfs. The pellets obtained were
stored at -80ºC until further use.
2.3.1. Total RNA extraction and quantification
The total RNA extraction was performed for C. glabrata 044 clinical isolate and evolved strains
cells according to the Hot-phenol method described by Kohrer & Domdey [99]. For the first step of this
method, the pellets were resuspended in 900 µL of AE buffer (50mM NaAc (Sigma), 10mM EDTA
(Aldritch), pH=5.3; 0.1% DEPC treated) and transferred into 2 mL eppendorfs. Afterwards, it was
added 90 µL of SDS 10% (w/v) (Sigma) and 800 µL of phenol, following a short vortex of 5 sec. Then,
samples were incubated at 65ºC for 4 min and transferred into dry ice until the formation of crystals
was identified. The mixtures were centrifuged at 15000 rpm, at 4ºC for 5 min. The upper phase was
collected to new eppendorfs. Subsequently, a two-step extraction with phenol was performed where
for each step 400 µL of a 25:24:1 phenol/chloroform/isoamilic acid solution (Sigma) was added. A
short vortex was carried out, following a centrifugation at 15000 rpm, at 4ºC for 5 min. The top phase
was collected to new eppendorfs. Then, a final extraction was performed, using 800 μL of 24:1
chloroform/isoamilic acid solution (Sigma), following vortex and centrifugation in the same conditions,
finishing with the collection of the top phase.
After this stage, a 1/10 of the final volume of the mixture obtained by centrifugation of sodium
acetate 3 M (Merck, pH=5.3, 0.1% diethylpyrocarbonate (DEPC) treated) was added. Then a
purification step was performed by adding 1 mL of cold ethanol 100%. After a short vortex, the
samples were stored in -20˚C for 20 min. Then, a prolonged centrifugation was carried out at 15000
rpm, at 4ºC for 20 min. The liquid phase was discarded and the remaining precipitates were washed
with 750 μL of cold ethanol 70% (v/v) and centrifuged at 15000 rpm, at 4ºC for 20 min. The liquid
phase was carefully discarded, and afterwards, in order to preserve the formed precipitates, a drying
step at Speed Vacuum Concentrator Plus (Eppendorf) was performed for 15 min. Then, the material
was resuspended in 50 μL of sterile deionized water 0.1% DEPC treated and the volume was divided
by two aliquots of 10 μL and 40 μL. The aliquots of 10 μL were used to assess the purity and quantify
total RNA concentration in a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies).
31
Finally the samples were diluted in order to have a concentration of 500 ng/μL for the real time RT-
PCR.
2.3.2. Real Time RT-PCR
The real time RT-PCR technique allows the quantification of mRNA transcript levels from
specific genes, based on a reverse transcription followed by real time measurement of DNA
amplification during polymerase chain reaction (PCR). In order to accomplish this, it is necessary the
use of specific fluorophores like, in this case, SYBR® Green, which binds to double-stranded DNA,
becoming fluorescent. In each thermal cycle of RT-PCR, the DNA is denatured and while extension
happens, the primers anneal and DNA is produced with the binding of the dye to the double-stranded
DNA. The fluorescence is detected by the instrument, following the registration performed by the
software 7500 Systems SDS Software from Applied Biosystems in the amplification plot. The detection
is considered at a threshold level when the signal is slightly greater than the background. The purpose
is to find the number of cycles (Ct) necessary to achieve a given level of fluorescence above the
threshold [100].
Therefore, the signal level is registered in an amplification plot, from which Ct is estimated by
the intersection between exponential phase curve and threshold line. The normalization of the Ct
values is performed using an internal control as shown in equation 1.
∆𝐶𝑡 = 𝐶𝑡(𝑡𝑎𝑟𝑔𝑒𝑡) − 𝐶𝑡(𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
(Equation 1)
Afterwards, each normalized value correspondent to each gene is compared with the
physiological calibrator considered, as demonstrated in Equation 2.
∆∆𝐶𝑡 = ∆𝐶𝑡(𝑠𝑎𝑚𝑝𝑙𝑒)−∆𝐶𝑡(𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑜𝑟)
(Equation 2)
Then, the gene expression level can be estimated using the equation 3.
2−∆∆𝐶𝑡
(Equation 3)
In order to start this technique, it is necessary to synthesize cDNA from the total RNA
extracted from C. glabrata strains. In this first step of the procedure, a reaction using MultiScribeTM
reverse transcriptase according to the mixture present in Table 7 was performed in the conditions
described in Table 8.
32
Table 7. Reaction mixture for the first step of real time RT-PCR (Applied Biosystems).
Component Volume per reaction (µL)
TaqMan RT buffer (10x) 1.0
MgCl2 (25mM) 2.2
dNTP’s (2.5 mM) 2.0
Random hexamers (50µL) 0.5
RNase inhibitor (20 U/L) 0.2
MultiScribeTM reverse transcriptase (50 U/µL) 0.25
RNA sample (500 ng/ µL) 2.0
ddH2O DEPC treated 1.85
Total 10.0
Table 8. Thermal cycling parameters for the first step of the real time RT-PCR (Applied Biosystems).
Step Time (min) Temperature (ºC)
Incubation 10 25
Reverse Transcription 30 48
Reverse transcriptase inactivation 5 95
After the first step was completed, the cDNA samples were stored at -20ºC. Afterwards, each
sample was diluted 1:4.
For the second step of RT-PCR, it is necessary to consider a housekeeping gene like
CgACT1, which encodes actin, in order to have an internal control. For the preparation of this second
step, a mixture for each reaction was prepared according the internal control and CgEPA1 gene (See
Table 9).
Table 9. Reaction mixture for the second step of real time RT-PCR (Applied Biosystems).
Component Volume per reaction (µL)
SYBR®Green PCR Master Mix (2x) 12.5
Forward Primer (4 pmol/µL) 2.5
Reverse Primer (4 pmol/µL) 2.5
cDNA sample 2.5
ddH2O 5
Total 25
Each reaction of the second step was performed in a thermal cycler block (7500 Real-Time
PCR System – Applied Biosystems), according to the parameters present in Table 10.
Table 10. Thermal cycling parameters for the second step of the real time RT-PCR (Applied Biosystems).
Step Time Temperature (ºC)
AmpliTaq gold® DNA polymerase activation 10 min 95
PCR (40 cycles)
Reverse Transcription 15 sec 95
Reverse Transcription Inactivation 1 min 60
33
The primers used in the second step of RT-PCR are present in Table 11.
Table 11. Primers for CgACT1 and CgEPA1 genes.
Gene Primer Sequence
CgACT1
Forward 5’-AGAGCCGTCTTCCCTTCCAT-3’
Reverse 5’-TTGACCCATACCGACCATGA-3’
CgEPA1
Forward 5’-TTGATTGCTGCAGAAGGGATT-3’
Reverse 5’-ATGGCGTAGGCTTGATAATTTCC-3’
2.4. 3H-clotrimazole accumulation assays
In order to assess whether azole drug resistance was related to an efficient export of azole
drugs, several strains in study were evaluated regarding the intracellular accumulation of
3H-clotrimazole. The accumulation assays were started by growing the cells in MMG medium at 30ºC,
with an orbital agitation of 250 rpm. Achieving an O.D.600nm of 1±0.08, cells were harvested by filtration
and resuspended in MMG medium with vortex, obtaining an O.D.600nm of 0.7. Afterwards, 30 mg/L of
cold clotrimazole (Sigma) and 0.1 µM 3H-clotrimazole (Moravek Biochemicals) were added to the
cellular suspension, which was incubated at 30ºC for a period of 30 min with orbital agitation of 180
rpm. In this period, measurements of the intracellular and extracellular concentrations of the
3H-clotrimazole drug were performed at certain time-points.
For the evaluation of intracellular accumulation of 3H-clotrimazole, 200 µL of the cellular
suspension were collected by filtration using pre-wetted glass microfibers (Whatman, GF/C) at each
time-point. Each filter was washed with 10 mL of ice cold TM buffer at pH 4.5 and immersed in 7 mL of
scintillation liquid (Beckman).
In the case of extracellular accumulation of 3H-clotrimazole, 70 µL of the cellular suspension
were collected at each time-point and centrifuged at 13200 rpm for 1 min. The supernatant was
harvested and immersed in 7 mL of scintillation liquid (Beckman).
The radioactivity for each sample of intracellular and extracellular accumulation, at each time-
point, was measured in the Beckman LS 5000TD scintillation counter.
2.5. Quantification of Biofilm Formation
The crystal-violet method [101] was used to study the capacity of biofilm formation in the C.
glabrata strains. Cells were grown in SDB medium and collected by centrifugation at mid-exponential
phase. Cells were then inoculated in 96-well polystyrene titter plates (Greiner), which were previously
filled with the appropriated medium, SDB or RPMI at pH 4, in order to have an initial
34
OD600nm = 0.05±0.005. Afterwards, cells were cultivated at mild orbital shaking (70 rpm), for 15 h, at
30ºC.
Subsequently, each well was washed three times with 200 µL of deionized water to remove
the cells that were not attached to the formed biofilm. After a washing step, 200 µL of 1% crystal-violet
(Merk) alcoholic solution was added in each well in order to stain the formed biofilm (15 min of
incubation). Then, each well was washed with 250 µL of deionized water. Finally, in each well 200 µL
of 96% (v/v) ethanol was added, to elute the stained biofilm, following absorbance reading in a
microplate reader at the wavelength of 590 nm (SPECTROstar Nano, BMG Labtech).
2.6. Quantification of total cellular ergosterol
Total ergosterol content was extracted from C. glabrata cells using the method of physical
disruption [102] with some adjustments. Cells were cultivated in 100 mL of YEPD and with an orbital
agitation of 250 rpm until stationary phase was reached. Cells were harvested by centrifugation and
ressuspended in 5 mL of methanol. Colesterol, used as an internal standard to allow quantification of
the yield of ergosterol extraction, was added in order to have a final concentration of 1.25 mg/mL in
each sample. Afterwards, glass beads were added approximately in the same weight as the cell pellet.
Then, each sample was homogenized in 30 sec, following an orbital agitation of 320 rpm for 1 h. The
samples were centrifuged at 8000 rpm for 7 min at 4ºC. 1.7 mL of supernatant was extracted to an
eppendorf, following another centrifugation at 11000 rpm for 10 min at 4ºC. 1 mL of the supernatant
was then collected and stored until analysis.
The extracts obtained were analysed by High Pressure Liquid Chromatography with a
250 mm x 4 mm C18 column (LiChroCART Purospher STAR RP-18 end- capped 5 mm) at 30ºC. The
samples were eluted in 100% methanol at a flow rate of 1 mL methanol per min. Colesterol was
detected at 210 nm corresponding to a retention time of 13.77±0.67 min. Ergosterol was detected at
282 nm with a retention time of 11.33±0.18 min.
The corresponding results are presented as the ratio between the average concentration of
ergosterol of the KUE100 strain or the clinical isolate, according to each case, and the concentration
of the other samples tested.
2.7. Susceptibility Assays
The susceptibility of the 044 clinical isolate, the evolved strains, the wild-type KUE100 and
derived mutants: Δpil1, Δlsp1, Δseg1, Δepa1, Δepa3, Δepa10 and ΔCAGL0G05093g was assessed to
all antifungal drugs prepared by spot assays. The cell suspensions of the clinical strains were batch-
cultured at 30ºC with orbital agitation (250 rpm) in MMG liquid medium until the standardized culture
OD600nm of 0.6±0.05 was reached in the absence of antifungal drugs. Afterwards, the cell suspensions
were diluted to a standardized OD600nm of 0.05±0.005 in 1 mL of deionised water, following sequential
dilutions of 1:5 and 1:25. The cellular suspensions were applied as spots (4 μL) onto the surface of the
agarized MMG medium plates, supplemented with adequate concentration of the antifungal drugs
tested. Each plate was prepared adding a precise volume of the stock solution to 25 mL of MMG
35
medium, in order to have the desired concentration. The range of drug concentrations tested, as well
as the concentration of the stock solutions used are present in table 12.
Table 12. Range of drug concentrations used in the spot assays.
Antifungal Drug Concentration of the Stock
Solution Range of the drug
concentration (µg/mL)
Amphotericin B 10mg/10mL 1-1.5
5-Flucytosine 10mg/10mL 0.01
Clotrimazole 10mg/250µL 25-45
Miconazole 10mg/10mL 0.65-0.75
Tioconazole 10mg/10mL 0.5-2
Fluconazole 10mg/mL 200-220
Ketoconazole 10mg/mL 60-100
Following the inoculation, the plates were incubated at 30ºC for 2-5 days.
36
37
3. Results and Discussion
3.1. Stepwise evolution of the 044 clinical isolate to fluconazole
resistance
The azole susceptible C. glabrata 044 clinical isolate, obtained from a patient attending the
Centro Hospitalar of S. João, Porto, in collaboration with the team led by Prof. Acácio Rodrigues, as
well as the derived azole resistant strains 044Fluco21, 044Fluco31 and 044Fluco45 were the main
object of study in this work.
Following the initial study described in section 1.6., the 044 clinical isolate and the evolved
strains 044Fluco21, 044Fluco31 and 044Fluco45 were further studied in order to gain a deeper
understanding on how azole resistance was developed. In order to evaluate whether the strains
obtained were also resistant to other antifungal drugs, susceptibility was evaluated through spot
assays (Figure 8).
38
Figure 8. Spot assays comparing the antifungal resistance profile of the 044 clinical isolate and the strains evolved from it, through prolonged exposure to fluconazole: A)
Comparison of the susceptibility to imidazole drugs, at the indicated concentrations, of C. glabrata 044 clinical isolate and evolved strains 044Fluco21 (posaconazole resistant),
044Fluco31 (posaconazole/clotrimazole resistant), 044Fluco45 (posaconazole/clotrimazole/fluconazole/voriconazole resistant); B) Comparison of the susceptibility to fluconazole,
at the indicated concentrations, of C. glabrata 044 clinical isolate and evolved strains 044Fluco21 (posaconazole resistant), 044Fluco31 (posaconazole/clotrimazole resistant),
044Fluco45 (posaconazole/clotrimazole/fluconazole/voriconazole resistant); C) Comparison of the susceptibility to 5-flucytosine and amphotericin B, at the indicated
concentrations, of C. glabrata 044 clinical isolate and evolved strains 044Fluco21 (posaconazole resistant), 044Fluco31 (posaconazole/clotrimazole resistant), 044Fluco45
(posaconazole/clotrimazole/fluconazole/voriconazole resistant). All assays were performed on MMG agar plates. Images are representative of those obtained in at least 3
independent experiments.
39
The obtained results show that the original 044 clinical isolate is more susceptible to
fluconazole, clotrimazole, ketoconazole, miconazole and tioconazole, when compared to the evolved
strains. Along the directed evolution of this isolate, it appears to have progressively led to a stepwise
increased resistance to each of these azoles. This is consistent with the MIC values obtained for
clotrimazole and fluconazole. The 044 clinical isolate was also found to be more resistant to the
antifungal drug 5-flucytosine. Interestingly, strain 044Fluco45, was found to exhibit slightly higher
resistance to amphotericin B, than the remaining strains, suggesting that in this case fluconazole
exposure led to increased resistance to all the other tested azole drugs and also to cross-resistance
against amphotericin B.
3.2. Identification of transcriptome-wide changes occurring in a
clinical isolate of Candida glabrata, subject to fluconazole
stress: general features
In order to understand the phenotypic changes undergone by the 044 C. glabrata clinical
isolate leading to differential acquisition of resistance to four azoles, a transcriptomics analysis was
performed in collaboration with Prof. Geraldine Butler, from University College Dublin. The
transcriptomes of cells collected at the 21st, 31st and 45th day of fluconazole induction, corresponding
to cells exhibiting posaconazole, posaconazole/clotrimazole and
posaconazole/clotrimazole/fluconazole/voriconazole resistance, respectively, were analysed by
microarray hybridization. Each sample was analysed in comparison with the azole susceptible C.
glabrata 044 clinical isolate (control), in triplicates. The obtained microarray data was analysed for
each comparison (posaconazole resistant vs control, posazonazole/clotrimazole resistant vs control or
posaconazole/clotrimazole/fluconazole/voriconazole resistant vs control), enabling the identification of
the up and down regulated genes, and taking into consideration that for each gene, two expression
level measurements were obtained, as the microarray design included two probes for each gene in the
C. glabrata genome [103]. The total number of genes whose transcript levels was two-fold up or down
regulated in the resistant strains when compared to the azole susceptible strain, with an associated
p-value<0.05, are present in Table 13.
Table 13. Total number of up or down regulated genes in the resistant C. glabrata evolved strains, when compared to the azole
susceptible one.
Clinical Isolate Azole Resistance Down regulated Genes Up regulated genes
Posaconazole 355 299
Clotrimazole/ Posaconazole 73 199
Fluconazole/Voriconazole/ Clotrimazole/ Posaconazole 6 27
40
Aiming the analysis of the genes exhibiting altered expression in evolved azole resistant
strains when compared to the original azole susceptible 044 clinical isolate, online databases and
bioinformatics tools were used to highlight the biological processes or biochemical pathways that
appear to be the most relevant in the adaptation to azole resistance by the 044 isolate.
3.2.1. Analysis of posaconazole resistance acquisition
For the analysis of the list of up and down regulated genes in the posaconazole resistant
strain, obtained by 21 days of fluconazole exposure, when compared to the azole susceptible parental
strain, two bioinformatic tools where used, GOToolBox and KEGG Mapper, in order to infer about the
major biological processes and biochemical pathways that may underlie the developed resistance.
The results regarding the major biological processes found in the set of up and down regulated genes
are present in Figure 9 for all evolved strains.
41
Figure 9. Frequency of genes of C. glabrata 044 clinical isolate and evolved strains associated to the displayed GO terms (determined by GO Toolbox). RF – Reference Frequency; DF –
Dataset Frequency. A) Frequency of up regulated genes of C. glabrata posaconazole resistant strain; B) Frequency of up regulated genes of C. glabrata posaconazole/clotrimazole resistant
strain; C) Frequency of up regulated genes of C. glabrata posaconazole/clotrimazole/fluconazole/voriconazole resistant strain; D) Frequency of down regulated genes of C. glabrata
posaconazole resistant strain; E) Frequency of down regulated genes of C. glabrata posaconazole/clotrimazole resistant strain; F) Frequency of down regulated genes of C. glabrata
posaconazole/clotrimazole/fluconazole/voriconazole resistant strain. 1 Nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; 2 Mitochondrial ATP synthesis coupled electron
transport; 3 Mitochondrial electron transport, cytochrome c to oxygen; 4 Generation of precursor metabolites and energy; 5 Flocculation via cell wall protein-carbohydrate interaction; 6 Purine
ribonucleoside triphosphate biosynthetic process; 7 Cellular amino acid and derivative metabolic process; 8 Energy derivation by oxidation of organic compounds; 9 Cell wall mannoprotein
biosynthetic process.
42
The first assessment performed in order to evaluate which biological processes are related to
the several lists of genes, was conducted based on the web server GOToolBox.
Starting with the up regulated genes in the posaconazole resistant strain, the identified
over-represented GO terms show that the genes up regulated are related to “transcription,
DNA-dependent”, “RNA processing”, RNA metabolic process”, “nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process”, “DNA packaging” and “ribosome biogenesis”, “cell cycle” and
“establishment of cell polarity” (Figure 9A). Overall, these GO terms suggest an augmentation of
protein synthesis in the posaconazole resistant strain when compared to the parental strain.
Regarding the genes with down regulated expression in the posaconazole resistant strain, the
GOToolBox analysis identifies the following over-represented GO terms: “response to chemical
stimulus”, “response to stress” and “response to heat”, relative to stress responses, as well as
“carbohydrate metabolic process”, “cellular amino acid and derivative metabolic process”, “lipid
metabolism”, “signal transduction” and others (Figure 9D). This result suggests that the posaconazole
resistant strain exhibits decreased stress response, carbohydrates and energy metabolism, amino
acid metabolism and lipid metabolism.
The KEGG Mapper results for the down regulated genes revealed a prevalence of pathways
concerning carbon metabolism, glycolysis/gluconeogenesis, pentose phosphate pathway and others
pathways related to carbohydrate metabolism. It is also possible to observe the presence of pathways
regarding amino acid metabolism, like cysteine and methionine metabolism and histidine metabolism
(Figure 10). All these results suggest again that the posaconazole resistant strain exhibits inhibited
carbohydrate and energy metabolism and amino acid metabolism.
In summary, this global view of the transcriptomics data suggests that the main mechanisms
underlying posaconazole resistance acquisition by this strain correspond to increased protein
synthesis, DNA damage response and cell cycle control, and to decreased carbon, energy and lipid
metabolism.
43
Figure 10. Number of down regulated genes of C. glabrata clinical isolate resistant to posaconazole present in each indicated
pathway, resulting from the analysis using the bioinformatic tool KEGG Mapper.
3.2.2. Analysis of posaconazole/clotrimazole resistance acquisition
After 31 days of fluconazole induction, the clinical isolate of C. glabrata acquired additionally
resistance to clotrimazole. The transcriptome analysis of this strain, in comparison to the parental
strain, was performed as for the posaconazole resistant strain, resorting to the same bioinformatic
tools (Figure 9 B and E).
The over-represented GO terms associated to the list of genes up regulated in the
posaconazole/clotrimazole resistant strain when compared to its parental azole susceptible strain
include: “transcription, DNA-dependent”, “RNA processing”, “RNA metabolic processes”, “nucleobase,
nucleoside, nucleotide and nucleic acid metabolic process” and “cell cycle”. These terms were also
found to be over-represented in the posaconazole resistant strain. Nevertheless, some new GO terms
are also over-represented: “oxidative phosphorylation”, “response to drug” and “histone acetylation”
43
24
15119
98
8
7
7
7
66 6
55 5 5
Biosynthesis of secondary metabolites Carbon metabolism
Starch and sucrose metabolism Glycolysis/Gluconeogenesis
Pyruvate metabolism Purine metabolism
Cysteine and methionine metabolism Pentose phosphate pathway
Histidine metabolism Citrate cycle (TCA cycle)
Glyoxylate and dicaboxylate metabolism Amino sugar and nucleotide sugar metabolism
Galactose metabolism Meiosis
Selenocompound metabolism 2-Oxocarboxylic acid metabolism
Alanine, aspartate and glutamate metabolism Fructose and mannose metabolism
44
(Figure 9B). The “response to drug” GO term makes perfect sense in this context, representing an
evolution more consistent with the acquisition of clotrimazole resistance, when compared to the
previous acquisition of posaconazole resistance.
Focusing on the genes down regulated in the posaconazole/clotrimazole resistant strain, when
compared to the parental strain, several GO terms found to be over-represented, including
“mitochondrial DNA replication”, “generation of precursor metabolites and energy”, “electron transport
chain” (Figure 9E). These GO terms suggest a decreased respiration rate, consistent with anaerobic
metabolism within the isolate, eventually representative of a petite phenotype. The down regulated
genes were further involved in “cellular homeostasis”, “oxidation reduction” and “response to stress”.
Overall, the posaconazole/clotrimazole resistant strain appears to have increased activity of
transcription and translation related proteins, while other molecular mechanisms, such as aerobic
respiration and cellular homeostasis are inhibited in this strain.
3.2.3. Analysis of posaconazole/clotrimazole/fluconazole/voriconazole
resistance acquisition
The acquisition of fluconazole and voriconazole resistance in the 044 clinical isolate was
observed after 44 and 45 days, respectively. The transcriptome analysis regarding the
posaconazole/clotrimazole/fluconazole/voriconazole strain, at 45th day, was conducted in the same
manner as for posaconazole and posaconazole/clotrimazole resistant strains. The results regarding
the up regulated and down regulated genes analysis through GOToolBox are present in Figure 9 C
and F.
The GO terms over-represented in the list of up regulated genes in the
posaconazole/clotrimazole/fluconazole/voriconazole resistant strain, when compared to the azole
susceptible parental strain include: “aerobic respiration”, “generation of precursors metabolites and
energy”, “mitochondrial ATP synthesis coupled electron transport”, “mitochondrial electron transport
cytochrome c to oxygen” and “oxidative phosphorylation” (Figure 9C). These results suggest a shift to
an aerobic metabolism from the posaconazole/clotrimazole resistant strain to the
posaconazole/clotrimazole/fluconazole/voriconazole resistant strain. Besides the molecular
mechanisms relative to oxidative phosphorylation, another GO terms were find to be associated to the
up regulated genes in this strain: “purine ribonucleoside triphosphate biosynthetic process”, “response
to drug”, “flocculation via cell wall protein-carbohydrate interaction”, “phosphate metabolic process”.
Like in the posaconazole/clotrimazole resistant strain, molecular mechanisms regarding a response to
drug exposure are up regulated in this resistant strain.
The GOToolBox analysis performed for the down regulated genes in the
posaconazole/clotrimazole/fluconazole/voriconazole resistant strain revealed the following GO terms:
“transmembrane transport”, “cell wall mannoprotein biosynthetic process”, “mannan metabolic
45
process”, “cellular zinc ion homeostasis”, and “phospholipid translocation” (Figure 9F). These
processes were not suppressed in the strains resistant to posaconazole or posaconazole/clotrimazole.
In a few words, the posaconazole/clotrimazole/fluconazole/voriconazole resistant strain
appears to display an increased level of response to drug exposure and stress, aerobic metabolism
and an activation of processes like flocculation and phosphate metabolism. The cellular mechanisms
that are repressed by the strain are involved in transmembrane transport and mannoprotein
processes.
Taking into account the evolution from the susceptible isolate to the fully azole resistance
population, the clinical isolate gained posaconazole resistance developing molecular mechanisms that
seem to be related with protein synthesis, regarding mostly transcription and ribosome biogenesis, cell
cycle, DNA damaged response and cell polarity. At the same time, the isolate is repressing several
mechanisms involved in carbon, energy and lipid metabolism. All these mechanisms allowed
posaconazole resistance acquisition at the 21st day. The absence of any change concerning the
expression of ABC transporters CgCdr1 and CgCdr2, as well as the CgMdr1 MFS transporter is
concordant with a report where seven isolates were harvested from AIDS patients, although treated
with posaconazole and not fluconazole [61].
Nonetheless, after 10 more days of fluconazole exposure, the isolate became clotrimazole
resistant. At this point, the posaconazole/clotrimazole resistant strain had kept some of the molecular
mechanisms present in the previous posaconazole resistant strain, such as up regulated transcription,
ribosome biogenesis and cell cycle related genes. However, new molecular mechanisms regarding
response to drug exposure were now being developed by the isolate. Meanwhile, this strain appears
to have the aerobic metabolism repressed.
At the 45th day, the clinical isolate exposed to fluconazole had further acquired fluconazole
and voriconazole resistance. This strain exhibited up regulated genes related to response to drug
exposure, new mechanisms developed by this strain that were not present in the posaconazole and
posaconazole/clotrimazole resistant strains. Additional mechanisms include what appears to be
increased aerobic metabolism, flocculation process, phosphate metabolic process and stress
response.
3.3. Decreased accumulation of azole drugs and ergosterol content
during the evolution of the Candida glabrata 044 clinical isolate
towards fluconazole resistance
After the general analysis, a manual classification of the up or down regulated genes in each
considered strain was performed. For this analysis, the up regulated and down regulated genes
expressed in each acquisition of resistance were grouped according to the main cellular functions to
which they belong. This organization can be visualized in detail in the Tables S1, S2, S3, S4, S5 and
46
S6 from the Annexe. This analysis led to the identification of the genes involved in several biological
processes relevant in the context of drug resistance, pathogenesis, cell wall and lipid metabolism,
whose expression exhibits significant variation from strain to strain (Table S7).
The evaluation of the expression profiles of the genes involved in these 3 cellular functions
was based on the fold change of each gene selected (Table S7) and for each time of fluconazole
induction (at the 21st, 31st and 45th day).
Focusing first on the genes involved in MDR (Figure 11), the expression profiles show that the
GAGL0M01760g and GAGL0M07293g genes, homologues to PDR5 and PDR12 from S. cerevisiae,
which are ABC transporters with a role in MDR, have a similar expression profile, with a minimum fold
change correspondent to the 31st day of fluconazole resistant and a maximum of expression at
45th day of induction. Also, CAGL0F02717g and CAGL0E03674g genes, homologues to S. cerevisiae
PDR15 and TPO1, have a similar expression profile in which the expression increases along the
induction days. These two genes also encode for transporters involved in the development of multiple
drug resistance. Interestingly, in a transcriptome analysis of C. glabrata oropharyngeal isolates
exhibiting a GOF mutation in CgPdr1 transcription factor, which gained azole resistance when
exposed to fluconazole, the homologues of PDR5 and PDR15 genes exhibited an increase of
expression consistent with the results present herein [20]. For all these four transporters, their fold
change is maximal at the time correspondent to the acquisition of fluconazole and voriconazole
resistance. Nonetheless, the CAGL0G05093g gene, which encodes a protein with similarity to ABC
transporter family members, has a maximum fold change corresponding to the acquisition of
clotrimazole resistance, becoming an interesting object of study in the context of azole drug resistance
in C. glabrata. In general, it is possible to conclude that the expression of transporters is mainly
observed for the posaconazole/clotrimazole/fluconazole/voriconazole strain, probably helping the
acquisition of azole resistance in the 044 clinical isolate. Therefore, since most of these transporters
0
0.5
1
1.5
2
2.5
3
3.5
0 10 20 30 40 50
Fo
ld C
ha
ng
e
Time (days)
PDR5 (CAGL0M01760g)
PDR15 (CAGL0F02717g)
PDR12 (CAGL0M07293g)
TPO1 (CAGL0E03674g)
YDR061W (CAGL0G05093g)
PPH3 (CAGL0K10208g)
Figure 11. Multiple drug resistance genes expression profile of C. glabrata 044 clinical isolate with the respective fold change
for each fluconazole induction time correspondent to the acquisition of posaconazole, clotrimazole and fluconazole and
voriconazole resistance.
47
Figure 12. Time-course accumulation of 3H-clotrimazole in C. glabrata 044 clinical isolate (●) and evolved strains 044Fluco21
(■), 044Fluco31 (▲) and 044Fluco45 (▼). The indicated values are averages of at least three independent experiments. Error
bars represent the corresponding standard deviations. *p<0.05; **p<0.01.
are involved in the export of azole drugs, 3H-clotrimazole accumulation assays were performed for the
044 clinical isolate and the resistant strains 044Fluco21, 044Fluco31 and 044Fluco45, in order to
compare the capacity of each strain to decrease the accumulation of azole drugs.
Based on the time-course accumulation of 3H-clotrimazole, it is possible to conclude that C.
glabrata 044 clinical isolate accumulates 5- to 10-fold more azole drugs than the evolved strains
(Figure 12). After 21 days of fluconazole exposure, when only resistance to posaconazole had been
reached, 3H-clotrimazole accumulation was already 5-fold lower in the evolved 044Fluco21 strain than
that registered in the parental strain. Strains 044Fluco31 (resistant to posaconazole and clotrimazole)
and 044Fluco45 (resistant to posaconazole, clotrimazole, fluconazole and voriconazole) displayed an
even lower level of 3H-clotrimazole accumulation (Figure 12). These results show that azole resistant
strains have indeed lower accumulation of this drug, as expected. Nevertheless, since 044Fluco45
strain is the only one exhibiting higher expression of multidrug transporter encoding genes, it would be
interesting to understand which molecular mechanisms allow decreased accumulation of azole drug in
the remaining azole resistant strains.
According to the expression profiles studied regarding the genes involved in the ergosterol
biosynthesis is possible to observed an increase of expression of the CgERG11 gene present in the
posaconazole/clotrimazole strain (Figure 13). The fold change of CgERG11 gene drastically
decreases when fluconazole and voriconazole resistance is further acquired. Also, all the other ERG
genes whose expression did not change significantly seem to exhibit slightly decreased expression in
the posaconazole/clotrimazole/fluconazole/voriconazole strain (Figure 13). However, one particular
study describes a clinical isolate which is resistant to fluconazole, voriconazole and amphotericin B,
48
0
0.5
1
1.5
2
2.5
3
0 5 10 15 20 25 30 35 40 45 50
Fo
ld C
ha
ng
e
Time (days)
CgERG13 CgERG11 CgERG1 CgERG2 CgERG20 CgERG4
CgERG24 CgERG8 CgERG27 CgERG9 CgERG26 CgERG5
CgERG10 CgERG28 CgERG13 CgERG25 CgERG29 CgERG12
CgERG3 CgERG6 CgERG7
Figure 13. Ergosterol biosynthesis genes expression profile of C. glabrata 044 clinical isolate with the respective fold change
for each fluconazole induction time correspondent to the acquisition of posaconazole, clotrimazole and fluconazole and
voriconazole resistance.
and deficient in ergosterol content. This isolate exhibited a single-amino-acid substitution in CgERG11
gene, causing the loss of function of CgErg11 protein. When supplemented with cholesterol, this
isolate exhibited sterol uptake, which allowed a higher resistance to the previous antifungal agents
[33]. According to this report, the sterol uptake and alterations in membrane composition might be the
key mechanisms allowing azole resistance in ergosterol deficient conditions. These observations are
not in accordance with other reports where CgERG11 gene is described as up regulated in clinical
isolates of C. glabrata when induced with fluconazole [36], [104], [105].
From the expression profile analysis, ergosterol biosynthesis seems to be slightly
overexpressed in the 044Fluco31 strain, while in the 044Fluco45, this synthesis appears to be down
regulated. Since ergosterol content in yeast has been linked to different domains on the membrane,
which might confer increased membrane stability and impermeability [95], [96], the differences in
ergosterol content along the temporal evolution of the 044 clinical isolate could be related to the
acquisition of azole resistance observed during fluconazole exposure.
49
As an attempt to better understand the differences between the evolved strains and the clinical
isolate analysed in the transcriptomics analysis, the total ergosterol content of the strains was
quantified (Figure 14). The results only show a significant difference between the 044 clinical isolate
and the 044Fluco45 strain, which exhibits a decreased ergosterol content when compared with the
first. This is consistent with the expression profile regarding ergosterol biosynthesis, showing that the
strain resistant to all four azoles in study has, indeed, less ergosterol content.
Afterwards, the possible role of the CAGL0G05093g gene, exhibiting similarity to ABC
transporter family members, in 044Fluco45 azole resistance was further inspected. In line with
Figure 11, this gene has a maximum overexpression in the 044Fluco31 strain, this overexpression
being maintained in the 044Fluco45 strain.
The effect of the CAGL0G05093g gene expression in 3H-clotrimazole accumulation was
analysed. The accumulation of this azole drug was basically found to be very similar in the
ΔCAGL0G05093g deletion mutant, kindly provided by Professor Hiroji Chibana, and in the KUE100
parental strain (Figure 15).
Figure 14. Temporal evolution of ergosterol content in the C. glabrata 044 clinical isolate during azole resistance in vitro
induction assay. The cells of the 044 clinical isolate and the evolved strains were harvested after 15h of growth in YPED
medium, following the extraction and quantification through HPLC of total ergosterol. Relative ergosterol content was calculated
using ergosterol content of the initial 044 clinical isolate as a reference. In the scatter dot plot represented each dot corresponds
to ergosterol content (µg) per mg of cells harvested in each sample. The average of ergosterol content per cells is indicated by a
black line (-) corresponds to at least 3 independent experiments. *p<0.05
50
Figure 15. Time-course accumulation of 3H-clotrimazole in C. glabrata KUE100 wild-type strain (●) and ΔCAGL0G05093g
(■).The indicated values are averages of at least three independent experiments. Error bars represent the corresponding
standard deviations.
Indeed, comparing the 3H-clotrimazole accumulation of the ΔCAGL0G05093g mutant with the
KUE100 wild-type strain, it seems that the mutant accumulates slightly less drug, although in fact that
are no statistically significant differences. Therefore, the results show that this ABC-like protein does
not appear to affect drug accumulation. Indeed, the predicted topology of the protein indicates no
transmembrane domains, but only what may constitute a small membrane docking region.
Nonetheless, the fact that its transcript level is up regulated in the 044Fluco45 strain raised the
hypothesis that it may still be indirectly related to azole resistance. To test the relevance of this protein
in the resistance to several antifungal drugs, susceptibility assays were performed. However, the
absence of CAGL0G05093g gene did not appear to affect the resistance to any of the tested
antifungal drugs (Figure 16).
51
Figure 16. Spot assays for the evaluation of the importance of CAGL0G05093g gene in the resistance to antifungal drugs in C. glabrata. Comparison of the susceptibility to: A) imidazole drugs; B)
triazole drugs; C) 5-flucytosine and amphotericin B, at the indicated concentrations, of C. glabrata KUE100 wild-type strain with the deletion mutant ΔCAGL0G05093g. All the assays were
performed in MMG agar plates. Images are representative of those obtained in at least 3 independent experiments.
52
0
0.5
1
1.5
2
2.5
3
0 10 20 30 40 50
Fo
ld C
ha
ng
e
Time (days)
CgPIL1
CgLSP1
CgSEG1
3.4. Screening for the possible role of eisosomes in the acquisition
of azole resistance in the Candida glabrata 044 clinical isolate
Among the genes found to be up regulated in the 044Fluco45 strain, when compared to the
parental strain, is CgPIL1 (Figure 17), encoding an essential component of eisosomes, microdomains
in the cellular membrane which are rich in ergosterol and involved in the stability of a few
transmembrane transporters [82]. The expression levels of the remaining constituents of eisosomes,
encoded by CgLSP1 and CgSEG1 genes, suffered no alterations during the same period of
fluconazole induction (Figure 17).
Figure 17. Eisosome’s components genes expression profile of C. glabrata 044 clinical isolate with the respective fold change
for each fluconazole induction time correspondent to the acquisition of posaconazole, clotrimazole and fluconazole and
voriconazole resistance.
In order to assess the importance of these genes in antifungal resistance in C. glabrata, the
susceptibility to antifungal drugs of the corresponding deletion mutants Δpil1, Δlsp1 and Δseg1, kindly
provided by Professor Hiroji Chibana, was compared to that of the parental KUE100 wild-type strain
(Figure 18).
53
Figure 18. Spot assays for the evaluation of the importance of CgPIL1, CgLSP1 and CgSEG1 genes in the resistance to antifungal drugs. Comparison of the susceptibility to A) imidazole drugs; B)
triazole drugs; C) 5-flucytosine, at the indicated concentrations, of C. glabrata KUE100 wild-type strain with the deletion mutants Δpil1, Δlsp1, Δseg1. All the assays were performed in MMG agar
plates. Images are representative of those obtained in at least 3 independent experiments.
54
Figure 19. Time-course accumulation of 3H-clotrimazole in C. glabrata KUE100 wild-type strain (●) and Δpil1 (■). The indicated
values are averages of at least three independent experiments. Error bars represent the corresponding standard deviations.
*p<0.05; **p<0.01.
The results show that CgPIL1 is important for C. glabrata resistance to clotrimazole,
ketoconazole and tioconazole. The deletion of the genes encoding the remaining key constituents of
the eisosomes, CgLsp1 and CgSeg1, appears to have no significant effect in azole drug resistance,
since the susceptibility of the deletion mutants was similar to the growth of the wild-type strain.
Based on the susceptibility assays, the role of CgPil1 in 3H-clotrimazole accumulation was
analysed (Figure 19), as well as the ergosterol content in the deletion mutant Δpil1 (Figure 20).
The Δpil1 deletion mutant was observed to exhibit a higher accumulation of 3H-clotrimazole
than the wild-type KUE100 strain (Figure 19). According to these results, the role of CgPIL1 gene in
clotrimazole resistance may correlate with its direct or indirect involvement in controlling the
intracellular concentration of clotrimazole in C. glabrata.
55
Figure 20. Ergosterol content in the C. glabrata KUE100 wild-type strain and the deletion mutant Δpil1. The cells were
harvested after 15h of growth in YPED medium, following the extraction and quantification through HPLC of total ergosterol.
Relative ergosterol content was calculated using ergosterol content of KUE100 wild-type strain as a reference. In the scatter
dot plot represented each dot corresponds to ergosterol content (µg) per mg of cells harvested in each sample. The average of
ergosterol content per cells is indicated by a black line (-) corresponds to at least 3 independent experiments. *p<0.05
A significant increase in ergosterol content was observed for the Δpil1 deletion mutant, when
compared to the wild-type strain (Figure 20). According to this observation, the absence of CgPIL1
gene leads cells to increased ergosterol accumulation, while its overexpression in the 044Fluco45
strain appears to correlate with decreased ergosterol levels.
3.5. Screening for the possible role of adhesins in the acquisition of
azole resistance in the Candida glabrata 044 clinical isolate
Among the observations in the transcriptomics analysis, 12 adhesin encoding genes where
found to be overexpressed in the 044Fluco31, posaconazole/clotrimazole resistant strain, when
compared to the 044 parental strain. Interestingly, the expression levels of these genes dropped back
to nearly basal values in the 044Fluco45 resistant strain (Figure 21).
56
0123456789
1011121314
0 5 10 15 20 25 30 35 40 45 50
Fo
ld C
ha
ng
e
Time (days)
CgEPA1 CgEPA10 CgPWP1
CgEPA9 CgPWP4 CgPWP3
CgEPA3 FLO5 (CAGL0G10219g) FLO1 (CAGL0H10626g)
YOL155C (CAGL0C00968g) STA1 (CAGL0H00110g) CAGL0E00231g
Figure 21. Adhesins expression profile of C. glabrata 044 clinical isolate with the respective fold change for each fluconazole
induction time correspondent to the acquisition of posaconazole, clotrimazole and fluconazole and voriconazole resistance.
Most of the adhesins present in this analysis are homologues to the Flo family of adhesins of
S. cerevisiae known for the adherence to abiotic surfaces, such as agar and plastic [106]. Some of
these adhesins are CgEpa3, CgEpa9 and CgEpa10 that belong to the Epa family, which is known to
be involved in the adherence to mammalian cells in C. glabrata [106].
The hypothesis that adhesion may correlate with the development of azole resistance was
then analysed. For this reason, the study of the role of particular adhesins found to be overexpressed
in 044Fluco31 strain in the resistance to azoles was undertaken.
3.5.1. Screening the role of Epa1, Epa3 and Epa10 adhesins in azole
resistance in Candida glabrata
From the group of adhesins found overexpressed in the 044Fluco31 strain, three were
selected for further analysis: CgEpa1, CgEpa3 and CgEpa10; in order to assess their role in the
acquisition of azole resistance.
As a first step, the evaluation of the transcript levels of CgEPA1 gene in the 044 clinical isolate
and the derived azole resistant strains was undertaken, as a validation of the obtained transcriptomics
data. The expression of CgEPA1 gene was confirmed to be significantly higher in the 044Fluco31
strain, when compared to the 044 clinical isolate and the remaining strains under analysis (Figure 22).
57
Figure 22. Comparison of the transcript levels of CgEPA1 gene in the 044 clinical isolate and the evolved strains 044Fluco21,
044Fluco31 and 044Fluco45. The indicated values correspond to the averages obtained by two independent experiments of
quantitative real-time PCR. The error bars correspond to the standard deviations. *p<0.05.
After this confirmation, the study of the adhesive properties in the 044 clinical isolate and
evolved strains was evaluated. Since adhesion is the first step in biofilm formation, it was
hypothesized that these adhesins were overexpressed in the 044Fluco31 strain to enable biofilm
formation, and consequently, increase clotrimazole resistance levels.
Biofilm formation was, subsequently, assessed in the 044 clinical isolate and in the
044Fluco21, 044Fluco31 and 044Fluco45 derived strains, on a polystyrene surface, using the crystal
violet staining method (Figure 23).
58
Figure 23. Biofilm formation, followed by crystal violet staining and measurements of absorbance at 590 nm, for the 044 clinical
isolate and the evolved strains 044Fluco21, 044Fluco31 and 044Fluco45. Cells were grown for 15 h. The experiment was performed
in SDB medium pH 5.6. In the scatter dot plot represented each dot corresponds to the level of biofilm formed in each sample. The
average level of formed biofilm indicated by a black line (-) corresponds to at least 4 independent experiments.
According to the results obtained in SDB medium, there are not significant differences in
biofilm formation between the 044 clinical isolate and the evolved strains 044Fluco21, 044Fluco31 and
044Fluco45. These results were not expected given the massive overexpression of adhesin encoding
genes in the 044Fluco31 strain.
However, it is important to remember that several adhesins overexpressed in the 044Fluco31
strain are encoded by EPA genes which are involved in adherence to mammalian cells and not plastic
structures [68], [72]. In the future, it would be very interesting to test the adhesion and biofilm
formation ability of these C. glabrata strains to the human epithelium or in a surface coated with
human proteins, such as fibronectin and laminin.
To assess the variability of cell-to-cell aggregation suggested by the expression profile
registered for the adhesion encoding genes CgEPA1, CgEPA3 and CgEPA10, microscopic
observation of the 044 clinical isolate and the evolved strains was performed, and the number of
aggregates and the number of cells per aggregate was quantified (Figure 24). For this analysis, it was
considered that an aggregate is a set of 10 or more cells.
59
Figure 24. Temporal evolution of the C. glabrata 044 clinical isolate and evolved strains obtained after fluconazole induction at day 0 (044 clinical isolate), day 21 (044Fluco21 - posaconazole
resistant), day 31 (044Fluco31 – posaconazole/clotrimazole resistant), day 45 (044Fluco45 – posaconazole/clotrimazole/fluconazole/voriconazole): A) microscopic visualization of the aggregation
process in each strain; B) scatter dot plot of percentage of aggregates; C) scatter dot plot of number of cells per aggregate. For this evaluation it was considered that an aggregate was equal to the
aggregation of 10 cells. Standard deviations are represented by **p<0.01; ****p<0.0001.
A)
B) C)
60
Upon exposure of the C. glabrata 044 clinical isolate to an inhibitory concentration of
fluconazole cell aggregation was seen to remain stable after 21 days of incubation, but to increase
significantly after 31 days of fluconazole exposure. This is very clear from the representative
microscopic images (Figure 24A), and also by the quantification of number of cell aggregates and
number of cells per aggregate (Figures 24 B and C). However, after 45 days of fluconazole exposure,
the level of cell aggregation decreases, being similar to the one observed at days 0 and 21.
These observations are consistent with the transcriptomics data which shows an up
regulation of the expression of several adhesion encoding genes in the evolved strain after 31 days of
fluconazole exposure, when compared to the original 044 clinical isolate and the remaining strains.
According to these last results, it is possible to hypothesize that the adhesins overexpressed
in the 044Fluco31 strain allow a higher cell-to-cell aggregation but not an increase in the biofilm
formation in polystyrene when compared to the initial 044 clinical isolate.
In order to further seek the specific role of the adhesins selected, CgEpa1, CgEpa3 and
CgEpa10, the susceptibility of the deletion mutants Δepa1, Δepa3 and Δepa10, kindly provided by
Professor Hiroji Chibana, Chiba University, Japan, to antifungal drugs was compared to that of the
parental wild-type KUE100 strain (Figure 25).
61
Figure 25. Spot assays for the evaluation of the importance of CgEPA1, CgEPA3 and CgEPA10 genes in the resistance to antifungal drugs in C. glabrata. Comparison of the susceptibility to A)
imidazole drugs; B) triazole drugs; C) 5-flucytosine and amphotericin B, at the indicated concentrations, of C. glabrata KUE100 wild-type strain with the deletion mutants Δepa1, Δepa3 and Δepa10.
All the assays were performed in MMG agar plates. Images are representative of those obtained in at least 3 independent experiments.
62
Figure 26. Biofilm formation followed by crystal violet staining and measurements of absorbance at 590 nm for the KUE100
wild-type strain and deletion mutants Δepa1, Δepa3, and Δepa10. Cells were grown for 15 h and the experiment was
performed in SDB medium pH 5.6. In the scatter dot plot represented each dot corresponds to the level of biofilm formed in
each sample. The average level of formed biofilm indicated by a black line (-) corresponds to at least 4 independent
experiments. Standard deviations are represented by *p<0.05.
According to the results obtained by the susceptibility assays, CgEPA1 and CgEPA10 genes
appear to not be involved in antifungal resistance, since their deletion does not seem to affect
susceptibility against any of the tested drugs. On the other hand, the Δepa3 deletion mutant was found
to exhibit a decreased resistance against all the antifungal drugs tested, except amphotericin B, when
compared to the wild-type strain, providing evidence that CgEpa3 has a role in azole resistance in C.
glabrata.
Given their natural role, the effect of the deletion of CgEPA1, CgEPA3 or CgEPA10 gene in
biofilm formation was also analysed, in a polystyrene surface (Figure 26). As before, biofilm formation
was assessed using the crystal violet staining procedure.
The relative amount of biofilm formation in the deletion mutant Δepa3 is significantly lower
than that registered for the wild-type strain. These results suggest that this adhesin plays an important
role in biofilm formation on a polystyrene surface. In fact, other studies have reported the increased
expression of CgEPA3 gene in C. glabrata biofilms [71], [79].
63
Since the previous results highlight the importance of the adhesin CgEpa3 in antifungal
resistance and biofilm formation, its role in 3H-clotrimazole intracellular accumulation was then
analysed (Figure 27).
Figure 27. Time-course accumulation of 3H-clotrimazole in C. glabrata KUE100 wild-type strain (●) and the deletion mutant
Δepa3 (■).The indicated values are averages of at least three independent experiments. Error bars represent the corresponding
standard deviations. *p<0.05.
The time-course accumulation of 3H-clotrimazole in Figure 27 exhibits a clear difference
between the C. glabrata KUE100 wild-type strain and Δepa3 mutant, the mutant showing a higher
accumulation of the drug. In fact, there are statistically significant differences between the wild and the
mutant that suggests once again the importance of this adhesin in the resistance phenotype observed
in the 044Fluco31 strain, which acquired resistance to clotrimazole.
In the future, it would be interesting to study the possible role in azole resistance of more of
the adhesins whose expression was found to increase in the clotrimazole resistant 044Fluco31 strain.
It appears to be likely that as CgEpa3, others adhesins, as well as the ability to grow as cell
aggregates, might be related to the resistant phenotype observed herein.
64
65
4. Final Discussion
This thesis describes the in depth analysis of the evolution of a C. glabrata clinical isolate,
from azole susceptibility to azole resistance, induced by longstanding incubation with a serum
therapeutic fluconazole concentration. This set of strains were selected based on their unusual
progression, given that, in this case, fluconazole exposure led first to posaconazole resistance, after
21 days, then to clotrimazole resistance, after 31 days, and only then to fluconazole and voriconazole
resistance, after 45 days of fluconazole exposure. In the first part of this work, transcriptomics
analysis, based on microarray hybridization, was used to obtain a global insight into the molecular
mechanisms underlying the observed phenotypic evolution. As a second step, and guide by the
transcriptomics results, the role of specific processes and proteins in azole drug resistance acquisition
was evaluated, such as those controlling azole drug accumulation, and ergosterol homeostasis.
Additionally, the participation of adhesins and eisosome components in azole drug resistance was
further inspected.
Based on the transcriptomics data, posaconazole resistance acquisition, reached after 21
days of fluconazole exposure, was found to be based on increased transcript levels of genes related
with protein synthesis, cell cycle, establishment of cell polarity and DNA damage response, but
apparently not with the increase of cellular responses to drug or stress. Still, the overexpression of two
mannoproteins was observed. One of these mannoproteins is coded by CgTIR2 gene, which belongs
to the Srp1p/Tip1p family of serine-alanine-rich proteins. Interestingly, another member of this family in
C. glabrata, mannoprotein CgTir3p, has been described as having an important role regarding the
sterol uptake [107]. Therefore, it would be interesting to appraise the significance of these
mannoproteins, especially since their fold change of expression is also increased in the 044Fluco45
strain, which has less ergosterol content as will be discussed further on. Despite this observation, the
intracellular accumulation of azole drugs was found to be 5-fold lower in these cells, than in the azole
susceptible 044 clinical isolate, although there is no clear molecular mechanisms responsible for the
posaconazole resistance in this strain.
The posaconazole/clotrimazole resistant strain, obtained after 31 days of fluconazole
exposure, although keeping some of the transcriptional profile present in the previous posaconazole
resistant strain, was found to exhibit increased expression of genes related to azole drug response,
including the up regulation of the MDR transporters CgCdr2p and CgTpo1, and of the CgERG11 gene.
This observation appears to correlate with the observed ability of these strains to accumulate 10-fold
less radiolabelled clotrimazole than the 044 clinical isolate. Despite the observed overexpression of
the CgERG11 gene, the ergosterol concentration in these cells remained unchanged, when compared
to the parental strain. Another interesting feature found during the transcriptomics analysis of the
posaconazole/clotrimazole resistant strain was the marked increase in the expression of several
adhesin encoding genes. Interestingly, these cells were found to display higher cell-to-cell
aggregation, but not an increased ability to form biofilm in polystyrene microplates, when compared to
the remaining strains. The eventual role of three selected adhesins encoding genes in azole drug
66
resistance was then inspected, and indeed CgEPA3 was found to confer resistance to clotrimazole
and other azoles, but apparently not to amphotericin B. As expected based on its predicted function,
CgEPA3 expression was further found to enhance the ability of C. glabrata cells to form biofilm and to
promote cell-to-cell aggregation. Given that significant differences in azole accumulation could be
observed when comparing the wild-type strain and the Δepa3 deletion mutant, we hypothesize that the
role of the increased expression of CgEPA3 and other adhesins in clotrimazole resistance, as found in
the 044Fluco31 strain, may be to protect the cells from the extracellular concentration of clotrimazole
by promoting cell aggregation.
Finally, in the posaconazole/clotrimazole/fluconazole/voriconazole resistant strain,
044Fluco45, the transcriptional response appears to have reached a more clear response to
fluconazole exposure, limited to the up or down regulation of a few genes. These include CgCDR1,
CgCDR2, CgPDR12 and CgTPO1, whose expression was significantly up regulated, which appears
consistent with the observed emergence of a CgPDR1 mutation in this final strain. It would be
important to assess the role of this mutation in the acquisition of azole resistance in clinical isolates of
C. glabrata. Strongly correlated with the up regulation of the referred MDR transporters, a clear ability
to accumulate lower concentrations of clotrimazole is exhibited by these multiazole resistance cells.
Surprisingly, however, the fluconazole resistant 044Fluco45 strain was found to exhibit
decreased ergosterol content. This observation is consistent with the slight decrease in several ERG
genes observed for these cells in the transcriptomics analysis. However, this result was not expected
since azole resistant strains exhibit usually higher expression levels of CgERG11 or other ERG genes
[36], [104], [105]. Nevertheless, in a particular study, an azole resistant clinical isolate was described
as being ergosterol-deficient, resulting from a single-amino-acid loss of function mutation in CgERG11
gene [33]. In this case study, since the primary target of azoles is no longer exhibiting function, azoles
have low or no affinity for this enzyme. Additionally, the authors suggest that this isolate might be able
to survive through growth on lanosterol-type sterols and/or perform sterol uptake, with changes in
membrane composition. It would be interesting to explore the causes behind the decrease in
ergosterol content, and whether this decrease may have a positive impact in azole resistance in C.
glabrata.
Finally, the possible role of eisosomes in azole resistance was also considered for study, since
the CgPIL1 gene was found to be up regulated in the 044Fluco45 strain. In fact, CgPil1 was shown to
be important for ketoconazole, clotrimazole and tioconazole resistance, and appears to be involved,
direct or indirectly, in clotrimazole efflux. None of the eisosome-embeded transporters identified so far
is directly linked to drug extrusion, but rather to the import of amino acids and nucleotides [84]. Thus it
would be interesting to gain further insights into how eisosomes affect the intracellular concentration of
azole drugs. Since eisosomes are localized in membrane domains rich in ergosterol, the ergosterol
content in the Δpil1 mutant was quantified when compared to the KUE100 wild-type strain.
Surprisingly, the Δpil1 mutant was found to exhibit higher ergosterol content, which might be
eventually due to a different membrane organization exhibited by these cells [85], an observation that
does not help to explain the azole resistance phenotype exhibited by these cells. Nonetheless, it is
67
worth pointing out that while the deletion of CgPIL1 gene leads cells to increased ergosterol
accumulation, the overexpression of this gene in the 044Fluco45 strain appears to correlate with
decreased ergosterol levels.
68
Figure 28. Model of the temporal evolution of the C. glabrata 044 clinical isolate and evolved strains obtained after fluconazole induction and the principal molecular mechanisms involved in the
acquisition of azole resistance, according to the microarray data and the experimentally demonstrated features.
69
Altogether, this study shows the global transcriptional alterations that were experienced by a
cell population as it adapted to multiazole resistance (Figure 28). Azole drug resistance grew
progressively along the direct evolution experience, as the transcriptional response became more and
more simple and specific. The final transcriptional profile reached by the multiazole resistant strain
highlights the important role of MDR transporters in this context. However, this study further points out
to other players in the context of azole drug resistance, such as the adhesin CgEpa3 and the
eisosome component CgPil1, reinforcing the notion that drug resistance is a multifactorial process,
being reachable by C. glabrata cells using several combinations of factors, all of which must be
considered in the design of better suited ways to fight fungal infections.
70
71
5. References
[1] C. J. Calderone, Richard A. and Clancy, Candida and Candidiasis. 2012.
[2] P. L. Fidel and J. A. Vazquez, “Candida glabrata : Review of Epidemiology , Pathogenesis ,
and Clinical Disease with Comparison to C . albicans,” Clin. Microbiol. Rev., vol. 12, no. 1, pp.
80–96, 1999.
[3] S. Brun, C. Aubry, O. Lima, R. Filmon, T. Berge, D. Chabasse, and J. Bouchara, “Relationships
between Respiration and Susceptibility to Azole Antifungals in Candida glabrata,” Antimicrob.
Agents Chemother., vol. 47, no. 3, pp. 847–853, 2003.
[4] E. Bouza and P. Muñoz, “Epidemiology of candidemia in intensive care units,” Int. J.
Antimicrob. Agents, vol. 32, no. SUPPL. 2, pp. 87–91, 2008.
[5] J. Morschhäuser, “The genetic basis of fluconazole resistance development in Candida
albicans,” Biochim. Biophys. Acta - Mol. Basis Dis., vol. 1587, no. 2–3, pp. 240–248, 2002.
[6] M. Tscherner, T. Schwarzmüller, and K. Kuchler, “Pathogenesis and Antifungal Drug
Resistance of the Human Fungal Pathogen Candida glabrata,” Pharmaceuticals, vol. 4, pp.
169–186, 2011.
[7] E. M. Kojic and R. O. Darouiche, “Candida Infections of Medical Devices,” Clin. Microbiol. Revi,
vol. 17, no. 2, pp. 255–267, 2004.
[8] R. E. Lewis, D. P. Kontoyiannis, R. O. Darouiche, I. I. Raad, and R. a Prince, “Antifungal
activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida
catheter-related bloodstream infection.,” Antimicrob. Agents Chemother., vol. 46, no. 11, pp.
3499–505, 2002.
[9] K. I. M. Lewis, “Riddle of Biofilm Resistance,” Antimicrob. Agents Chemother., vol. 45, no. 4,
pp. 999–1007, 2001.
[10] S. Ferrari, M. Sanguinetti, F. De Bernardis, R. Torelli, B. Posteraro, P. Vandeputte, and D.
Sanglard, “Loss of mitochondrial functions associated with azole resistance in Candida
glabrata results in enhanced virulence in mice.,” Antimicrob. Agents Chemother., vol. 55, no. 5,
pp. 1852–60, May 2011.
[11] N. Papon, V. Courdavault, M. Clastre, and R. J. Bennett, “Emerging and Emerged Pathogenic
Candida Species: Beyond the Candida albicans Paradigm,” PLoS Pathog., vol. 9, no. 9, p.
e1003550, 2013.
[12] J.-P. Vermitsky, K. D. Earhart, W. L. Smith, R. Homayouni, T. D. Edlind, and P. D. Rogers,
“Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide
expression studies.,” Mol. Microbiol., vol. 61, no. 3, pp. 704–22, Aug. 2006.
[13] M. Weig, L. Jänsch, U. Groß, C. G. De Koster, F. M. Klis, and P. W. J. De Groot, “Systematic
identification in silico of covalently bound cell wall proteins and analysis of protein-
polysaccharide linkages of the human pathogen Candida glabrata,” Microbiology, vol. 150, no.
10, pp. 3129–3144, 2004.
[14] D. J. Krysan, E. L. Ting, C. Abeijon, R. S. Fuller, and L. Kroos, “Yapsins Are a Family of
Aspartyl Proteases Required for Cell Wall Integrity in Saccharomyces cerevisiae Yapsins Are a
Family of Aspartyl Proteases Required for Cell Wall Integrity in Saccharomyces cerevisiae,”
vol. 4, no. 8, pp. 1364–1374, 2005.
[15] S. a. Lachke, S. Joly, K. Daniels, and D. R. Soll, “Phenotypic switching and filamentation in
Candida glabrata,” Microbiology, vol. 148, no. 9, pp. 2661–2674, 2002.
72
[16] S. Ferrari, M. Sanguinetti, R. Torelli, B. Posteraro, and D. Sanglard, “Contribution of CgPDR1-
regulated genes in enhanced virulence of azole-resistant Candida glabrata,” PLoS One, vol. 6,
no. 3, p. e17589, Jan. 2011.
[17] S. Abbes, C. Mary, H. Sellami, A. Michel-Nguyen, A. Ayadi, and S. Ranque, “Interactions
between copy number and expression level of genes involved in fluconazole resistance in
Candida glabrata.,” Front. Cell. Infect. Microbiol., vol. 3, no. November, p. 74, Jan. 2013.
[18] R. Kaur, I. Castaño, and B. P. Cormack, “Functional genomic analysis of fluconazole
susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and
mitochondria.,” Antimicrob. Agents Chemother., vol. 48, no. 5, pp. 1600–13, May 2004.
[19] J. K. Strzelczyk, A. Slemp-Migiel, M. Rother, K. Gołąbek, and A. Wiczkowski, “Nucleotide
substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant
clinical isolates.,” Acta Biochim. Pol., vol. 60, no. 4, pp. 547–52, Jan. 2013.
[20] H.-F. Tsai, L. R. Sammons, X. Zhang, S. D. Suffis, Q. Su, T. G. Myers, K. a Marr, and J. E.
Bennett, “Microarray and molecular analyses of the azole resistance mechanism in Candida
glabrata oropharyngeal isolates.,” Antimicrob. Agents Chemother., vol. 54, no. 8, pp. 3308–17,
Aug. 2010.
[21] M. A. Ribeiro and C. R. Paula, “Up-regulation of ERG11 gene among fluconazole-resistant
Candida albicans generated in vitro: is there any clinical implication?,” Diagn. Microbiol. Infect.
Dis., vol. 57, no. 1, pp. 71–5, Jan. 2007.
[22] M. Bard, A. M. Sturm, C. a Pierson, S. Brown, K. M. Rogers, S. Nabinger, J. Eckstein, R.
Barbuch, N. D. Lees, S. a Howell, and K. C. Hazen, “Sterol uptake in Candida glabrata: rescue
of sterol auxotrophic strains.,” Diagn. Microbiol. Infect. Dis., vol. 52, no. 4, pp. 285–93, Aug.
2005.
[23] P. D. Crowley and H. C. Gallagher, “Clotrimazole as a pharmaceutical: Past, present and
future.,” J. Appl. Microbiol., pp. 611–617, 2014.
[24] M. I. Morris, “Posaconazole: A new oral antifungal agent with an expanded spectrum of
activity,” Am. J. Heal. Pharm., vol. 66, no. 3, pp. 225–236, 2009.
[25] T. C. Chen, Y. H. Chen, Y. C. Chen, and P. L. Lu, “Fluconazole exposure rather than clonal
spreading is correlated with the emergence of Candida glabrata with cross-resistance to
triazole antifungal agents,” Kaohsiung J. Med. Sci., vol. 28, no. 6, pp. 306–315, Jun. 2012.
[26] T. C. White, S. Holleman, F. Dy, L. F. Mirels, and D. a. Stevens, “Resistance Mechanisms in
Clinical Isolates of Candida albicans,” Antimicrob. Agents Chemother., vol. 46, no. 6, pp. 1704–
1713, Jun. 2002.
[27] R. Ben-Ami, Y. Hilerowicz, A. Novikov, and M. Giladi, “The impact of new epidemiological
cutoff values on Candida glabrata resistance rates and concordance between testing
methods,” Diagn. Microbiol. Infect. Dis., vol. 79, no. 2, pp. 209–213, Jun. 2014.
[28] E. Cantón, J. Pemán, C. Iñiguez, D. Hervás, J. L. Lopez-Hontangas, C. Pina-Vaz, J. J.
Camarena, I. Campos-Herrero, I. García-García, A. M. García-Tapia, R. Guna, P. Merino, L.
Pérez del Molino, C. Rubio, and A. Suárez, “Epidemiological cutoff values for fluconazole,
itraconazole, posaconazole, and voriconazole for six Candida species as determined by the
colorimetric Sensititre YeastOne method.,” J. Clin. Microbiol., vol. 51, no. 8, pp. 2691–5, Aug.
2013.
[29] M. A. Pfaller, S. A. Messer, L. N. Woosley, R. N. Jones, and M. Castanheira, “Echinocandin
and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates
Collected from 2010 to 2011 : Application of New CLSI Clinical Breakpoints and
Epidemiological Cutoff Values for Characterization of Geographic,” vol. 51, no. 8, pp. 2571–
2581, 2013.
73
[30] F. Li, L. Wu, B. Cao, Y. Zhang, X. Li, and Y. Liu, “Surveillance of the prevalence, antibiotic
susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in
China between 2006 to 2011.,” BMC Infect. Dis., vol. 13, no. 1, p. 353, Jan. 2013.
[31] F. Morio, C. Loge, B. Besse, C. Hennequin, and P. Le Pape, “Screening for amino acid
substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant
clinical isolates: new substitutions and a review of the literature.,” Diagn. Microbiol. Infect. Dis.,
vol. 66, no. 4, pp. 373–84, Apr. 2010.
[32] P. Marichal, L. Koymans, S. Willemsens, D. Bellens, P. Verhasselt, W. Luyten, M. Borgers, F.
C. S. Ramaekers, F. C. Odds, and H. Vanden Bossche, “Contribution of mutations in the
cytochrome azole resistance in Candida albicans,” Microbiology, vol. 145, pp. 2701–2713,
1999.
[33] C. M. Hull, J. E. Parker, O. Bader, M. Weig, U. Gross, A. G. S. Warrilow, D. E. Kelly, and S. L.
Kelly, “Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata
harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and
amphotericin B,” Antimicrob. Agents Chemother., vol. 56, no. 8, pp. 4223–4232, Aug. 2012.
[34] S. Brun, T. Bergès, P. Poupard, C. Vauzelle-Moreau, G. Renier, D. Chabasse, and J.-P.
Bouchara, “Mechanisms of azole resistance in petite mutants of Candida glabrata.,”
Antimicrob. Agents Chemother., vol. 48, no. 5, pp. 1788–96, May 2004.
[35] M. Sanguinetti, B. Posteraro, B. Fiori, S. Ranno, R. Torelli, and G. Fadda, “Mechanisms of
azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of
antifungal resistance.,” Antimicrob. Agents Chemother., vol. 49, no. 2, pp. 668–79, Feb. 2005.
[36] K. W. Henry, J. T. Nickels, and T. D. Edlind, “Upregulation of ERG genes in Candida species
by azoles and other sterol biosynthesis inhibitors.,” Antimicrob. Agents Chemother., vol. 44, no.
10, pp. 2693–700, Oct. 2000.
[37] P. Marichal, H. Vanden Bossche, F. C. Odds, G. Nobels, D. W. Warnock, V. Timmerman, C. V.
A. N. Broeckhoven, S. Fay, and P. Mose-larsen, “Molecular Biological Characterization of an
Azole-Resistant Candida glabrata Isolate,” vol. 41, no. 10, pp. 2229–2237, 1997.
[38] T. C. White, “The Presence of an R467K Amino Acid Substitution and Loss of Allelic Variation
Correlate with an Azole-Resistant Lanosterol 14 ␣ Demethylase in Candida albicans,” vol. 41,
no. 7, pp. 1488–1494, 1997.
[39] D. C. Lamb, D. E. Kelly, W. Schunck, A. Z. Shyadehi, M. Akhtar, D. J. Lowe, B. C. Baldwin,
and S. L. Kelly, “The Mutation T315A in Candida albicans Sterol 14 ␣ -Demethylase Causes
Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity *,” vol. 272,
no. 9, pp. 5682–5688, 1997.
[40] J. Il Yoo, C. W. Choi, K. M. Lee, and Y. S. Lee, “Gene Expression and Identification Related to
Fluconazole Resistance of Candida glabrata Strains,” Osong Public Heal. Res. Perspect., vol.
1, no. 1, pp. 36–41, 2010.
[41] A. Geber, C. A. Hitchcock, J. E. Swartz, F. S. Pullen, K. E. Marsden, K. J. Kwon-chung, and J.
E. Bennett, “Deletion of the Candida glabrata ERG3 and ERG11 Genes : Effect on Cell Viability
, Cell Growth , Sterol Composition , and Antifungal Susceptibility,” Antimicrob. Agents
Chemother., vol. 39, no. 12, pp. 2708–2717, 1995.
[42] X. Li, N. Brown, A. S. Chau, J. L. López-Ribot, M. T. Ruesga, G. Quindos, C. a Mendrick, R. S.
Hare, D. Loebenberg, B. DiDomenico, and P. M. McNicholas, “Changes in susceptibility to
posaconazole in clinical isolates of Candida albicans.,” J. Antimicrob. Chemother., vol. 53, no.
1, pp. 74–80, Jan. 2004.
74
[43] Z. Khan, S. Ahmad, L. Joseph, and K. Al-obaid, “Isolation of cholesterol-dependent , multidrug-
resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait,” BMC
Infect. Dis., vol. 14, no. 1, pp. 1–6, 2014.
[44] A. Defontaine, J. P. Bouchara, P. Declerk, C. Planchenault, D. Chabasse, and J. N. Hallet, “In-
vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata,” J.
Med. Microbiol., vol. 48, no. 7, pp. 663–670, 1999.
[45] M. Batova, S. Borecka-Melkusova, M. Simockova, V. Dzugasova, E. Goffa, and J. Subik,
“Functional characterization of the CgPGS1 gene reveals a link between mitochondrial
phospholipid homeostasis and drug resistance in Candida glabrata,” Curr. Genet., vol. 53, no.
5, pp. 313–322, May 2008.
[46] J.-P. Vermitsky and T. D. Edlind, “Azole resistance in Candida glabrata: coordinate
upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.,”
Antimicrob. Agents Chemother., vol. 48, no. 10, pp. 3773–81, Oct. 2004.
[47] D. Sanglard, O. Ischer, D. Calabrese, P. A. Majcherczyk, I. De Microbiologie, I. Diseases, C.
Hospitalier, and U. Vaudois, “The ATP Binding Cassette Transporter Gene CgCDR1 from
Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents,”
Antimicrob. Agents Chemother., vol. 43, no. 11, pp. 2753–2765, 1999.
[48] H. Miyazaki, Y. Miyazaki, A. Geber, T. Parkinson, C. Hitchcock, D. J. Falconer, D. J. Ward, K.
Marsden, and J. E. Bennett, “Fluconazole Resistance Associated with Drug Efflux and
Increased Transcription of a Drug Transporter Gene , PDH1 , in Candida glabrata,” Antimicrob.
Agents Chemother., vol. 42, no. 7, pp. 1695–1701, 1998.
[49] R. Torelli, B. Posteraro, S. Ferrari, M. La Sorda, G. Fadda, D. Sanglard, and M. Sanguinetti,
“The ATP-binding cassette transporter – encoding gene CgSNQ2 is contributing to the
CgPDR1-dependent azole resistance of Candida glabrata,” Mol. Microbiol., vol. 68, no.
February, pp. 186–201, 2008.
[50] S. W. Redding, W. R. Kirkpatrick, S. Saville, B. J. Coco, W. White, A. Fothergill, M. Rinaldi, T.
Eng, T. F. Patterson, and J. Lopez-Ribot, “Multiple patterns of resistance to fluconazole in
Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and
neck radiation,” J. Clin. Microbiol., vol. 41, no. 2, pp. 619–622, 2003.
[51] J. Eddouzi, J. E. Parker, L. a Vale-Silva, A. Coste, F. Ischer, S. Kelly, M. Manai, and D.
Sanglard, “Molecular mechanisms of drug resistance in clinical Candida species isolated from
Tunisian hospitals.,” Antimicrob. Agents Chemother., vol. 57, no. 7, pp. 3182–93, Jul. 2013.
[52] S. Cheng, C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen, “A Candida albicans petite
mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has
diminished susceptibility to fluconazole and voriconazole.,” Antimicrob. Agents Chemother.,
vol. 51, no. 5, pp. 1855–8, May 2007.
[53] D. Calabrese, J. Bille, and D. Sanglard, “A novel multidrug efflux transporter gene of the major
facilitator superfamily from Candida albicans ( FLU1 ) conferring resistance to fluconazole,” pp.
2743–2754, 2000.
[54] T. C. White, S. Holleman, F. Dy, L. F. Mirels, and D. a Stevens, “Resistance mechanisms in
clinical isolates of Candida albicans.,” Antimicrob. Agents Chemother., vol. 46, no. 6, pp. 1704–
13, Jun. 2002.
[55] A. Borst, M. T. Raimer, D. W. Warnock, C. J. Morrison, and B. a Arthington-Skaggs, “Rapid
acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical
introduction of fluconazole.,” Antimicrob. Agents Chemother., vol. 49, no. 2, pp. 783–7, Feb.
2005.
[56] R. Prasad, J. Morschha, F. Barchiesi, and E. Borowski, “Voriconazole and multidrug resistance
in Candida albicans,” pp. 109–115, 2007.
75
[57] C. Costa, C. Pires, T. R. Cabrito, A. Renaudin, M. Ohno, H. Chibana, I. Sá-Correia, and M. C.
Teixeira, “Candida glabrata drug:H+ antiporter CgQdr2 confers imidazole drug resistance,
being activated by transcription factor CgPdr1.,” Antimicrob. Agents Chemother., vol. 57, no. 7,
pp. 3159–67, Jul. 2013.
[58] C. Costa, J. Nunes, A. Henriques, N. P. Mira, H. Nakayama, H. Chibana, and M. C. Teixeira,
“Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug
resistance and polyamine homeostasis.,” J. Antimicrob. Chemother., vol. 69, no. 7, pp. 1767–
76, Jul. 2014.
[59] K. E. Caudle, K. S. Barker, N. P. Wiederhold, L. Xu, R. Homayouni, and P. D. Rogers,
“Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon.,” Eukaryot.
Cell, vol. 10, no. 3, pp. 373–83, Mar. 2011.
[60] D. Calabrese, B. Posteraro, and M. Sanguinetti, “Gain of Function Mutations in CgPDR1 of
Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence,” PLoS
Pathog., vol. 5, no. 1, pp. 1–17, 2009.
[61] X. Li, N. Brown, A. S. Chau, J. L. López-Ribot, M. T. Ruesga, G. Quindos, C. a Mendrick, R. S.
Hare, D. Loebenberg, B. DiDomenico, and P. M. McNicholas, “Changes in susceptibility to
posaconazole in clinical isolates of Candida albicans.,” J. Antimicrob. Chemother., vol. 53, no.
1, pp. 74–80, Jan. 2004.
[62] P. W. J. De Groot, E. a. Kraneveld, Y. Y. Qing, H. L. Dekker, U. Groß, W. Crielaard, C. G. De
Koster, O. Bader, F. M. Klis, and M. Weig, “The cell wall of the human pathogen Candida
glabrata: Differential incorporation of novel adhesin-like wall proteins,” Eukaryot. Cell, vol. 7,
no. 11, pp. 1951–1964, 2008.
[63] P. Sundstrom, “Adhesion in Candida spp,” Cell. Microbiol., vol. 4, pp. 461–469, 2002.
[64] S. Silva, M. Negri, M. Henriques, R. Oliveira, D. W. Williams, and J. Azeredo, “Adherence and
biofilm formation of non-Candida albicans Candida species,” Trends Microbiol., vol. 19, no. 5,
pp. 241–247, 2011.
[65] K. J. Verstrepen and F. M. Klis, “Flocculation, adhesion and biofilm formation in yeasts,” Mol.
Microbiol., vol. 60, no. 1, pp. 5–15, 2006.
[66] M. B. Frieman, J. M. McCaffery, and B. P. Cormack, “Modular domain structure in the Candida
glabrata adhesin Epa1p, a β1,6 glucan-cross-linked cell wall protein,” Mol. Microbiol., vol. 46,
no. 2, pp. 479–492, 2002.
[67] P. W. J. de Groot, O. Bader, A. D. de Boer, M. Weig, and N. Chauhan, “Adhesins in human
fungal pathogens: Glue with plenty of stick,” Eukaryot. Cell, vol. 12, no. 4, pp. 470–481, 2013.
[68] B. P. Cormack, N. Ghori, and S. Falkow, “An adhesin of the yeast pathogen Candida glabrata
mediating adherence to human epithelial cells.,” Science, vol. 285, no. 5427, pp. 578–582,
1999.
[69] I. Castaño, S. J. Pan, M. Zupancic, C. Hennequin, B. Dujon, and B. P. Cormack, “Telomere
length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata,”
Mol. Microbiol., vol. 55, no. 4, pp. 1246–1258, 2005.
[70] A. D. Las Peñas, S. Pan, I. Castaño, J. Alder, R. Cregg, and B. P. Cormack, “Virulence-related
surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric
clusters and subject to RAP1 - and SIR -dependent transcriptional silencing,” pp. 2245–2258,
2003.
[71] E. a. Kraneveld, J. J. de Soet, D. M. Deng, H. L. Dekker, C. G. de Koster, F. M. Klis, W.
Crielaard, and P. W. J. de Groot, “Identification and Differential Gene Expression of Adhesin-
Like Wall Proteins in Candida glabrata Biofilms,” Mycopathologia, vol. 172, no. 6, pp. 415–427,
2011.
76
[72] R. Kaur, R. Domergue, M. L. Zupancic, and B. P. Cormack, “A yeast by any other name:
Candida glabrata and its interaction with the host,” Curr. Opin. Microbiol., vol. 8, no. 4, pp. 378–
384, 2005.
[73] R. Domergue, I. Castaño, A. De Las Peñas, M. Zupancic, V. Lockatell, J. R. Hebel, D.
Johnson, and B. P. Cormack, “Nicotinic acid limitation regulates silencing of Candida adhesins
during UTI.,” Science, vol. 308, no. 5723, pp. 866–870, 2005.
[74] V. Gallegos-García, S. J. Pan, J. Juárez-Cepeda, C. Y. Ramírez-Zavaleta, M. B. Martin-del-
Campo, V. Martínez-Jiménez, I. Castaño, B. Cormack, and A. D. Las Peñas, “A novel
downstream regulatory element cooperates with the silencing machinery to repress EPA1
expression in Candida glabrata,” Genetics, vol. 190, no. 4, pp. 1285–1297, 2012.
[75] S. C. Halliwell, M. C. a Smith, P. Muston, S. L. Holland, and S. V. Avery, “Heterogeneous
expression of the virulence-related adhesin epa1 between individual cells and strains of the
pathogen Candida Glabrata,” Eukaryot. Cell, vol. 11, no. 2, pp. 141–150, 2012.
[76] O. Bader, M. Schaller, S. Klein, J. Kukula, K. Haack, F. Mu, H. C. Korting, W. Scha, and B.
Hube, “The KEX2 gene of Candida glabrata is required for cell surface integrity,” vol. 41, pp.
1431–1444, 2001.
[77] C. Desai, J. Mavrianos, and N. Chauhan, “Candida glabrata Pwp7p and Aed1p are required for
Adherence to Human Endothelial Cells,” FEMS Yeast Res., vol. 11, no. 7, pp. 595–601, 2011.
[78] R. Kaur, B. Ma, and B. P. Cormack, “A family of glycosylphosphatidylinositol-linked aspartyl
proteases is required for virulence of Candida glabrata.,” Proc. Natl. Acad. Sci. U. S. A., vol.
104, no. 18, pp. 7628–7633, 2007.
[79] S. Kucharikova, B. Neirinck, N. Sharma, J. Vleugels, K. Lagrou, and P. Van Dijck, “In vivo
Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model,” J.
Antimicrob. Chemother., vol. 70, no. 3, pp. 846–856, 2014.
[80] I. Iraqui, S. Garcia-Sanchez, S. Aubert, F. Dromer, J. M. Ghigo, C. D’Enfert, and G. Janbon,
“The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata
in a Sir4p-dependent pathway,” Mol. Microbiol., vol. 55, no. 4, pp. 1259–1271, 2005.
[81] L. Vale-Silva, F. Ischer, S. Leibundgut-Landmann, and D. Sanglard, “Gain-of-function
mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control
adherence to host cells,” Infect. Immun., vol. 81, no. 5, pp. 1709–1720, 2013.
[82] L. M. . K. J. B. Douglas, “Fungal Membrane Organization: The Eisosome Concept,” Annu. Rev.
od Microbiol., vol. 68, pp. 377–393, 2014.
[83] T. C. Walther, J. H. Brickner, P. S. Aguilar, S. Bernales, C. Pantoja, and P. Walter, “Eisosomes
mark static sites of endocytosis.,” Nature, vol. 439, no. 7079, pp. 998–1003, Feb. 2006.
[84] A. Olivera-Couto and P. S. Aguilar, “Eisosomes and plasma membrane organization.,” Mol.
Genet. Genomics, vol. 287, no. 8, pp. 607–20, Aug. 2012.
[85] K. E. Moreira, T. C. Walther, P. S. Aguilar, and P. Walter, “Pil1 Controls Eisosome Biogenesis,”
vol. 20, pp. 809–818, 2009.
[86] K. E. Moreira, S. Schuck, B. Schrul, F. Fröhlich, J. B. Moseley, T. C. Walther, and P. Walter,
“Seg1 controls eisosome assembly and shape.,” J. Cell Biol., vol. 198, no. 3, pp. 405–20, Aug.
2012.
[87] L. M. Douglas, H. X. Wang, L. Li, and J. B. Konopka, “Membrane Compartment Occupied by
Can1 (MCC) and Eisosome Subdomains of the Fungal Plasma Membrane.,” Membranes
(Basel)., vol. 1, no. 4, pp. 394–411, Dec. 2011.
77
[88] G. Grossmann, J. Malinsky, W. Stahlschmidt, M. Loibl, I. Weig-Meckl, W. B. Frommer, M.
Opekarová, and W. Tanner, “Plasma membrane microdomains regulate turnover of transport
proteins in yeast.,” J. Cell Biol., vol. 183, no. 6, pp. 1075–88, Dec. 2008.
[89] L. M. Douglas, H. X. Wang, and J. B. Konopka, “The MARVEL Domain Protein Nce102
Regulates Actin Organization and Invasive Growth of Candida albicans,” vol. 4, no. 6, pp. 1–
12, 2013.
[90] F. Fröhlich, K. Moreira, P. S. Aguilar, N. C. Hubner, M. Mann, P. Walter, and T. C. Walther, “A
genome-wide screen for genes affecting eisosomes reveals Nce102 function in sphingolipid
signaling.,” J. Cell Biol., vol. 185, no. 7, pp. 1227–42, Jun. 2009.
[91] M. D. Leach, D. a Stead, E. Argo, and A. J. P. Brown, “Identification of sumoylation targets,
combined with inactivation of SMT3, reveals the impact of sumoylation upon growth,
morphology, and stress resistance in the pathogen Candida albicans.,” Mol. Biol. Cell, vol. 22,
no. 5, pp. 687–702, Mar. 2011.
[92] C. Kamble, S. Jain, E. Murphy, and K. Kim, “Requirements of Slm proteins for proper eisosome
organization, endocytic trafficking and recycling in the yeast Saccharomyces cerevisiae,” J.
Biosci., vol. 36, no. 1, pp. 79–96, Apr. 2011.
[93] D. Berchtold, M. Piccolis, N. Chiaruttini, I. Riezman, H. Riezman, A. Roux, T. C. Walther, and
R. Loewith, “Plasma membrane stress induces relocalization of Slm proteins and activation of
TORC2 to promote sphingolipid synthesis.,” Nat. Cell Biol., vol. 14, no. 5, pp. 542–7, May
2012.
[94] T. Watamoto, L. P. Samaranayake, H. Egusa, H. Yatani, and C. J. Seneviratne,
“Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to
antifungals,” J. Med. Microbiol., vol. 60, no. 9, pp. 1241–1247, Apr. 2011.
[95] F. J. Alvarez, L. M. Douglas, A. Rosebrock, and J. B. Konopka, “The Sur7 Protein Regulates
Plasma Membrane Organization and Prevents Intracellular Cell Wall Growth in Candida
albicans,” vol. 19, no. December, pp. 5214–5225, 2008.
[96] L. M. Douglas, H. X. Wang, S. Keppler-ross, N. Dean, and J. B. Konopka, “Sur7 Promotes
Plasma Membrane Organization and Is Needed for Resistance to Stressful Conditions and to
the Invasive Growth and Virulence of Candida albicans,” vol. 3, no. 1, pp. 1–12, 2012.
[97] A. T. Pinto e Silva, S. Costa-de-Oliveira, A. Silva-Dias, C. Pina-Vaz, and A. G. Rodrigues,
“Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles,”
FEMS Yeast Res., vol. 9, no. 4, pp. 626–633, 2009.
[98] D. Martin, C. Brun, E. Remy, P. Mouren, D. Thieffry, and B. Jacq, “GOToolBox : functional
analysis of gene datasets based on Gene,” vol. 5, no. 12, 2004.
[99] Karl Kohrer and Horst Domdey, “Preparation of High Molecular Weight RNA,” Methods
Enzymol., vol. 194, pp. 398–405, 1991.
[100] J. Lee and J. Roche, “Validating Microarray Data Using RT2 Real-Time PCR,” BMC Mol. …,
2010.
[101] A. K. Pathak, S. Sharma, and P. Shrivastva, “Multi-species biofilm of Candida albicans and
non-Candida albicans Candida species on acrylic substrate,” J. Appl Oral Sci., vol. 20, no. 1,
pp. 70–75, 2012.
[102] P. Gong, X. Guan, and E. Witter, “Short communication A rapid method to extract ergosterol
from soil by physical disruption,” Appl. Soil Ecol., vol. 17, pp. 285–289, 2001.
[103] A. Roetzer, C. Gregori, A. M. Jennings, J. Quintin, D. Ferrandon, G. Butler, K. Kuchler, G.
Ammerer, and C. Schüller, “Candida glabrata environmental stress response involves
78
Saccharomyces cerevisiae Msn2/4 orthologous transcription factors,” Mol. Microbiol., vol. 69,
no. 3, pp. 603–620, 2008.
[104] J. Cernicka and J. Subik, “Resistance mechanisms in fluconazole-resistant Candida albicans
isolates from vaginal candidiasis.,” Int. J. Antimicrob. Agents, vol. 27, no. 5, pp. 403–8, May
2006.
[105] M. A. Ribeiro and C. R. Paula, “Up-regulation of ERG11 gene among fluconazole-resistant
Candida albicans generated in vitro: is there any clinical implication?,” Diagn. Microbiol. Infect.
Dis., vol. 57, no. 1, pp. 71–5, Jan. 2007.
[106] K. J. Verstrepen and F. M. Klis, “Flocculation , adhesion and biofilm formation in yeasts,” vol.
60, pp. 5–15, 2006.
[107] T. Inukai, M. Nagi, A. Morita, K. Tanabe, T. Aoyama, Y. Miyazaki, M. Bard, and H. Nakayama,
“The mannoprotein TIR3 (CAGL0C03872g) is required for sterol uptake in Candida glabrata.,”
Biochim. Biophys. Acta, vol. 1851, no. 2, pp. 141–51, Feb. 2015.
[108] F. Mollinedo, “Lipid raft involvement in yeast cell growth and death.,” Front. Oncol., vol. 2, no.
October, p. 140, Jan. 2012.
79
6. Annexe
Table S1 – Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days.
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Energ
y a
nd C
arb
ohydra
te m
eta
bolis
m
CAGL0L05236g MDH1 Mitochondrial malate dehydrogenase, catalyzes interconversion of malate and oxaloacetate; involved in the tricarboxylic
acid (TCA) cycle; phosphorylated -0,765023431
CAGL0M13937g GLC8 Regulatory subunit of protein phosphatase 1 (Glc7p), involved in glycogen metabolism and chromosome segregation;
proposed to regulate Glc7p activity via conformational alteration; ortholog of the mammalian protein phosphatase inhibitor 2
-0,7900289
CAGL0F08107g LSC2 Beta subunit of succinyl-CoA ligase, which is a mitochondrial enzyme of the TCA cycle that catalyzes the nucleotide-
dependent conversion of succinyl-CoA to succinate -0,822082635
CAGL0J08976g COA4 Protein that localizes to the mitochondrial intermembrane space via the Mia40p-Erv1p system; mutants exhibit glycogen
storage defects and growth defects on a non-fermentable carbon source; contains twin cysteine-x9-cysteine motifs -0,892087747
CAGL0J07612g ZWF1 Glucose-6-phosphate dehydrogenase (G6PD), catalyzes the first step of the pentose phosphate pathway; involved in
adapting to oxidatve stress; homolog of the human G6PD which is deficient in patients with hemolytic anemia -0,923166466
CAGL0H06633g PCK1 Phosphoenolpyruvate carboxykinase, key enzyme in gluconeogenesis, catalyzes early reaction in carbohydrate
biosynthesis, glucose represses transcription and accelerates mRNA degradation, regulated by Mcm1p and Cat8p, located in the cytosol
-0,854410582
CAGL0M02981g PGM3 Phosphoglucomutase, catalyzes interconversion of glucose-1-phosphate and glucose-6-phospate; transcription induced in response to stress; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and nucleus; non-essential
-0,871701807
CAGL0D04356g GCV1 T subunit of the mitochondrial glycine decarboxylase complex, required for the catabolism of glycine to 5,10-methylene-
THF; expression is regulated by levels of levels of 5,10-methylene-THF in the cytoplasm -0,995045757
CAGL0F06061g ARA2 NAD-dependent arabinose dehydrogenase, involved in biosynthesis of dehydro-D-arabinono-1,4-lactone; similar to plant
L-galactose dehydrogenase -1,028643254
CAGL0L06798g MDH3 Peroxisomal malate dehydrogenase, catalyzes interconversion of malate and oxaloacetate; involved in the glyoxylate
cycle -0,926337069
CAGL0I01122g GRE3 Aldose reductase involved in methylglyoxal, d-xylose, arabinose, and galactose metabolism; stress induced (osmotic,
ionic, oxidative, heat shock, starvation and heavy metals); regulated by the HOG pathway -1,008088198
CAGL0H01089g INM2 Inositol monophosphatase, involved in biosynthesis of inositol; enzymatic activity requires magnesium ions and is inhibited
by lithium and sodium ions; inm1 inm2 double mutant lacks inositol auxotrophy -1,072162666
CAGL0I02024g OYE2 Putative NADPH dehydrogenase; protein abundance increased in ace2 mutant cells -0,966795987
CAGL0L01177g OSM1
(FRDS1) Soluble fumarate reductase, required with isoenzyme Osm1p for anaerobic growth; may interact with ribosomes, based on co-purification experiments; authentic, non-tagged protein is detected in purified mitochondria in high-throughput studies
-1,100104991
CAGL0G05335g TPS2 Phosphatase subunit of the trehalose-6-phosphate synthase/phosphatase complex, which synthesizes the storage
carbohydrate trehalose; expression is induced by stress conditions and repressed by the Ras-cAMP pathway -1,075294853
CAGL0F06941g PYC1 Pyruvate carboxylase isoform, cytoplasmic enzyme that converts pyruvate to oxaloacetate; highly similar to isoform Pyc2p
but differentially regulated; mutations in the human homolog are associated with lactic acidosis -1,164530351
CAGL0G08712g KGD1 Component of the mitochondrial alpha-ketoglutarate dehydrogenase complex, which catalyzes a key step in the
tricarboxylic acid (TCA) cycle, the oxidative decarboxylation of alpha-ketoglutarate to form succinyl-CoA -1,184751296
CAGL0L03982g MLS1 Malate synthase, enzyme of the glyoxylate cycle, involved in utilization of non-fermentable carbon sources; expression is
subject to carbon catabolite repression; localizes in peroxisomes during growth in oleic acid medium -1,260576823
80
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Energ
y a
nd C
arb
ohydra
te m
eta
bolis
m
CAGL0H02695g GLG1 Self-glucosylating initiator of glycogen synthesis, also glucosylates n-dodecyl-beta-D-maltoside; similar to mammalian
glycogenin -1,16947752
CAGL0I04048g FBP1 Fructose-1,6-bisphosphatase, key regulatory enzyme in the gluconeogenesis pathway, required for glucose metabolism; undergoes either proteasome-mediated or autophagy-mediated degradation depending on growth conditions; interacts
with Vid30p -1,148286448
CAGL0K07480g PGM1 Phosphoglucomutase, minor isoform; catalyzes the conversion from glucose-1-phosphate to glucose-6-phosphate, which
is a key step in hexose metabolism -1,199126423
CAGL0K10736g CYB2 Cytochrome b2 (L-lactate cytochrome-c oxidoreductase), component of the mitochondrial intermembrane space, required
for lactate utilization; expression is repressed by glucose and anaerobic conditions -1,180479684
CAGL0A04829g HXK1 Hexokinase isoenzyme 1, a cytosolic protein that catalyzes phosphorylation of glucose during glucose metabolism;
expression is highest during growth on non-glucose carbon sources; glucose-induced repression involves the hexokinase Hxk2p
-1,243670576
CAGL0L01925g UGP1 UDP-glucose pyrophosphorylase (UGPase), catalyses the reversible formation of UDP-Glc from glucose 1-phosphate and
UTP, involved in a wide variety of metabolic pathways, expression modulated by Pho85p through Pho4p -1,319555344
CAGL0J04268g ACH1 Protein with CoA transferase activity, particularly for CoASH transfer from succinyl-CoA to acetate; has minor acetyl-CoA-
hydrolase activity; phosphorylated; required for acetate utilization and for diploid pseudohyphal growth -1,309041642
CAGL0K10626g GSY1 Glycogen synthase with similarity to Gsy2p, the more highly expressed yeast homolog; expression induced by glucose
limitation, nitrogen starvation, environmental stress, and entry into stationary phase -1,227126152
CAGL0I01100g GCY1 Putative NADP(+) coupled glycerol dehydrogenase, proposed to be involved in an alternative pathway for glycerol
catabolism; member of the aldo-keto reductase (AKR) family -1,34703927
CAGL0M03377g GLC3 Glycogen branching enzyme, involved in glycogen accumulation; green fluorescent protein (GFP)-fusion protein localizes
to the cytoplasm in a punctate pattern -1,358507913
CAGL0J09812g TPS1 Synthase subunit of trehalose-6-phosphate synthase/phosphatase complex, which synthesizes the storage carbohydrate
trehalose; also found in a monomeric form; expression is induced by the stress response and repressed by the Ras-cAMP pathway
-1,33081654
CAGL0H04939g FBP1 Fructose-1,6-bisphosphatase, key regulatory enzyme in the gluconeogenesis pathway, required for glucose metabolism; undergoes either proteasome-mediated or autophagy-mediated degradation depending on growth conditions; interacts
with Vid30p -1,28483549
CAGL0M10439g NTH1 Neutral trehalase, degrades trehalose; required for thermotolerance and may mediate resistance to other cellular stresses;
may be phosphorylated by Cdc28p -1,41267812
CAGL0F07777g ALD3 Cytoplasmic aldehyde dehydrogenase, involved in beta-alanine synthesis; uses NAD+ as the preferred coenzyme; very
similar to Ald2p; expression is induced by stress and repressed by glucose -1,54947698
CAGL0J02904g GIP2 Putative regulatory subunit of the protein phosphatase Glc7p, involved in glycogen metabolism; contains a conserved
motif (GVNK motif) that is also found in Gac1p, Pig1p, and Pig2p -1,632914402
CAGL0C01397g PFK26 6-phosphofructo-2-kinase, inhibited by phosphoenolpyruvate and sn-glycerol 3-phosphate; has negligible fructose-2,6-
bisphosphatase activity; transcriptional regulation involves protein kinase A -1,652280743
CAGL0I05148g DLD1 D-lactate dehydrogenase, oxidizes D-lactate to pyruvate, transcription is heme-dependent, repressed by glucose, and
derepressed in ethanol or lactate; located in the mitochondrial inner membrane -1,661098429
81
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Energ
y a
nd C
arb
ohydra
te m
eta
bolis
m
CAGL0F04895g GPH1 Non-essential glycogen phosphorylase required for the mobilization of glycogen, activity is regulated by cyclic AMP-
mediated phosphorylation, expression is regulated by stress-response elements and by the HOG MAP kinase pathway -1,543861408
CAGL0K05247g CSR2 Nuclear protein proposed to regulate utilization of nonfermentable carbon sources and endocytosis of plasma membrane proteins; overproduction suppresses chs5 spa2 lethality at high temp; ubiquitinated by Rsp5p, deubiquitinated by Ubp2p
-1,718483453
CAGL0F08745g STF2 Protein involved in regulation of the mitochondrial F1F0-ATP synthase; Stf1p and Stf2p may act as stabilizing factors that
enhance inhibitory action of the Inh1p protein -1,757972127
CAGL0J03058g ICL1 Isocitrate lyase, catalyzes the formation of succinate and glyoxylate from isocitrate, a key reaction of the glyoxylate cycle;
expression of ICL1 is induced by growth on ethanol and repressed by growth on glucose -1,493117687
CAGL0F08261g ENO1 Enolase I, a phosphopyruvate hydratase that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate
during glycolysis and the reverse reaction during gluconeogenesis; expression is repressed in response to glucose -1,859390066
CAGL0H02387g TPS3 Regulatory subunit of trehalose-6-phosphate synthase/phosphatase complex, which synthesizes the storage carbohydrate
trehalose; expression is induced by stress conditions and repressed by the Ras-cAMP pathway -1,856675941
CAGL0F04719g GSY2 Glycogen synthase, similar to Gsy1p; expression induced by glucose limitation, nitrogen starvation, heat shock, and stationary phase; activity regulated by cAMP-dependent, Snf1p and Pho85p kinases as well as by the Gac1p-Glc7p
phosphatase -1,942902783
CAGL0L00803g PIG2 Putative type-1 protein phosphatase targeting subunit that tethers Glc7p type-1 protein phosphatase to Gsy2p glycogen
synthase -2,005153785
CAGL0J00451g TDH3 Putative glyceraldehyde-3-phosphate dehydrogenase; protein differentially expressed in azole resistant strain; expression
downregulated in biofilm vs planktonic cell culture -2,367934105
CAGL0K03421g PGM2 Phosphoglucomutase, catalyzes the conversion from glucose-1-phosphate to glucose-6-phosphate, which is a key step in
hexose metabolism; functions as the acceptor for a Glc-phosphotransferase -2,452707206
CAGL0B03663g CIT2 Citrate synthase, catalyzes the condensation of acetyl coenzyme A and oxaloacetate to form citrate, peroxisomal isozyme
involved in glyoxylate cycle; expression is controlled by Rtg1p and Rtg2p transcription factors -1,809557076
Nitro
gen M
eta
bolis
m
CAGL0J10494g APT2 Apparent pseudogene, not transcribed or translated under normal conditions; encodes a protein with similarity to adenine
phosphoribosyltransferase, but artificially expressed protein exhibits no enzymatic activity -0,842191834
CAGL0L03267g GAP1 General amino acid permease; localization to the plasma membrane is regulated by nitrogen source -0,847413811
CAGL0I04444g ADE1 N-succinyl-5-aminoimidazole-4-carboxamide ribotide (SAICAR) synthetase, required for 'de novo' purine nucleotide
biosynthesis; red pigment accumulates in mutant cells deprived of adenine -0,906347555
CAGL0I04994g MET6 Cobalamin-independent methionine synthase, involved in methionine biosynthesis and regeneration; requires a minimum
of two glutamates on the methyltetrahydrofolate substrate, similar to bacterial metE homologs -0,973613551
CAGL0K10340g ADE2 Phosphoribosylaminoimidazole carboxylase, catalyzes a step in the 'de novo' purine nucleotide biosynthetic pathway; red
pigment accumulates in mutant cells deprived of adenine -0,87382311
CAGL0C01243g HIS5 Histidinol-phosphate aminotransferase, catalyzes the seventh step in histidine biosynthesis; responsive to general control
of amino acid biosynthesis; mutations cause histidine auxotrophy and sensitivity to Cu, Co, and Ni salts -0,979287826
CAGL0B03839g MET3 ATP sulfurylase, catalyzes the primary step of intracellular sulfate activation, essential for assimilatory reduction of sulfate
to sulfide, involved in methionine metabolism -0,932953767
82
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Nitro
gen M
eta
bolis
m
CAGL0C03443g LYS9 Saccharopine dehydrogenase (NADP+, L-glutamate-forming); catalyzes the formation of saccharopine from alpha-
aminoadipate 6-semialdehyde, the seventh step in lysine biosynthesis pathway; exhibits genetic and physical interactions with TRM112
-1,007345375
CAGL0H07887g ADE5,7 Bifunctional enzyme of the 'de novo' purine nucleotide biosynthetic pathway, contains aminoimidazole ribotide synthetase
and glycinamide ribotide synthetase activities -0,933392739
CAGL0J03146g RNR1 One of two large regulatory subunits of ribonucleotide-diphosphate reductase; the RNR complex catalyzes rate-limiting step in dNTP synthesis, regulated by DNA replication and DNA damage checkpoint pathways via localization of small
subunits -0,942291612
CAGL0K10978g LYS4 Homoaconitase, catalyzes the conversion of homocitrate to homoisocitrate, which is a step in the lysine biosynthesis
pathway -0,981546591
CAGL0L04598g DCS2 Non-essential, stress induced regulatory protein containing a HIT (histidine triad) motif; modulates m7G-
oligoribonucleotide metabolism; inhibits Dcs1p; regulated by Msn2p, Msn4p, and the Ras-cAMP-cAPK signaling pathway, similar to Dcs1p,
-1,051202802
CAGL0G06732g LEU9 Alpha-isopropylmalate synthase II (2-isopropylmalate synthase), catalyzes the first step in the leucine biosynthesis
pathway; the minor isozyme, responsible for the residual alpha-IPMS activity detected in a leu4 null mutant -1,111410487
CAGL0H03795g LEU2 Beta-isopropylmalate dehydrogenase (IMDH), catalyzes the third step in the leucine biosynthesis pathway -1,108379647
CAGL0K04499g ADE6 Formylglycinamidine-ribonucleotide (FGAM)-synthetase, catalyzes a step in the 'de novo' purine nucleotide biosynthetic
pathway -1,169062249
CAGL0L12254g ALT1 Alanine transaminase (glutamic pyruvic transaminase); involved in alanine biosynthetic and catabolic processes; the
authentic, non-tagged protein is detected in highly purified mitochondria in high-throughput studies -1,10754701
CAGL0C01595g HIS7 Imidazole glycerol phosphate synthase (glutamine amidotransferase:cyclase), catalyzes the fifth and sixth steps of
histidine biosynthesis and also produces 5-aminoimidazole-4-carboxamide ribotide (AICAR), a purine precursor -1,172211998
CAGL0J08316g MET2 L-homoserine-O-acetyltransferase, catalyzes the conversion of homoserine to O-acetyl homoserine which is the first step
of the methionine biosynthetic pathway -1,232322968
CAGL0I06116g SSY5 Serine protease of SPS plasma membrane amino acid sensor system (Ssy1p-Ptr3p-Ssy5p); contains an inhibitory domain that dissociates in response to extracellular amino acids, freeing a catalytic domain to activate transcription factor Stp1p
-1,02337602
CAGL0G01903g MET1 S-adenosyl-L-methionine uroporphyrinogen III transmethylase, involved in the biosynthesis of siroheme, a prosthetic group
used by sulfite reductase; required for sulfate assimilation and methionine biosynthesis -1,119064661
CAGL0B00902g HIS4 Multifunctional enzyme containing phosphoribosyl-ATP pyrophosphatase, phosphoribosyl-AMP cyclohydrolase, and
histidinol dehydrogenase activities; catalyzes the second, third, ninth and tenth steps in histidine biosynthesis -1,283742
CAGL0D03982g PUT2 Delta-1-pyrroline-5-carboxylate dehydrogenase, nuclear-encoded mitochondrial protein involved in utilization of proline as sole nitrogen source; deficiency of the human homolog causes HPII, an autosomal recessive inborn error of metabolism
-1,229827804
CAGL0L00759g HIS1 ATP phosphoribosyltransferase, a hexameric enzyme, catalyzes the first step in histidine biosynthesis; mutations cause
histidine auxotrophy and sensitivity to Cu, Co, and Ni salts; transcription is regulated by general amino acid control -1,234877063
CAGL0D06402g MET17 Methionine and cysteine synthase (O-acetyl homoserine-O-acetyl serine sulfhydrylase), required for sulfur amino acid
synthesis -1,275608755
CAGL0C04191g UGA2 Succinate semialdehyde dehydrogenase involved in the utilization of gamma-aminobutyrate (GABA) as a nitrogen source;
part of the 4-aminobutyrate and glutamate degradation pathways; localized to the cytoplasm -1,330180622
83
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Nitro
gen M
eta
bolis
m
CAGL0D04026g UGA1 Gamma-aminobutyrate (GABA) transaminase (4-aminobutyrate aminotransferase) involved in the 4-aminobutyrate and
glutamate degradation pathways; required for normal oxidative stress tolerance and nitrogen utilization -1,390903245
CAGL0I09009g HIS2 Histidinolphosphatase, catalyzes the eighth step in histidine biosynthesis; mutations cause histidine auxotrophy and
sensitivity to Cu, Co, and Ni salts; transcription is regulated by general amino acid control -1,608841246
CAGL0L12012g TMT1 Trans-aconitate methyltransferase, cytosolic enzyme that catalyzes the methyl esterification of 3-isopropylmalate, an
intermediate of the leucine biosynthetic pathway, and trans-aconitate, which inhibits the citric acid cycle -1,581370009
CAGL0L02937g HIS3 Imidazoleglycerol-phosphate dehydratase, catalyzes the sixth step in histidine biosynthesis; mutations cause histidine auxotrophy and sensitivity to Cu, Co, and Ni salts; transcription is regulated by general amino acid control via Gcn4p
-1,678565277
CAGL0A01716g PNC1 Nicotinamidase that converts nicotinamide to nicotinic acid as part of the NAD(+) salvage pathway, required for life span
extension by calorie restriction; PNC1 expression responds to all known stimuli that extend replicative life span -1,589261096
CAGL0M00550g STR2 Cystathionine gamma-synthase, converts cysteine into cystathionine -1,686800109
CAGL0F07029g MET13 Major isozyme of methylenetetrahydrofolate reductase, catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate in the methionine biosynthesis pathway -1,86888339
CAGL0L06094g STR3 Cystathionine beta-lyase, converts cystathionine into homocysteine -3,464926321
Lip
id M
eta
bolis
m
CAGL0M13981g TGL3 Triacylglycerol lipase of the lipid particle, responsible for all the TAG lipase activity of the lipid particle; contains the
consensus sequence motif GXSXG, which is found in lipolytic enzymes; required with Tgl4p for timely bud formation -0,815744151
CAGL0H05401g GPI2 Protein involved in the synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI), the first intermediate in the
synthesis of glycosylphosphatidylinositol (GPI) anchors; homologous to the human PIG-C protein -1,032143311
CAGL0L02167g FOX2 Multifunctional enzyme of the peroxisomal fatty acid beta-oxidation pathway; has 3-hydroxyacyl-CoA dehydrogenase and
enoyl-CoA hydratase activities -0,821624695
CAGL0J03674g DGA1 Diacylglycerol acyltransferase, catalyzes the terminal step of triacylglycerol (TAG) formation, acylates diacylglycerol using
acyl-CoA as an acyl donor, localized to lipid particles -0,846703256
CAGL0F05071g ECI1 Peroxisomal delta3,delta2-enoyl-CoA isomerase, hexameric protein that converts 3-hexenoyl-CoA to trans-2-hexenoyl-
CoA, essential for the beta-oxidation of unsaturated fatty acids, oleate-induced -0,895108473
CAGL0H09174g PEX1 AAA-peroxin that heterodimerizes with AAA-peroxin Pex6p and participates in the recycling of peroxisomal signal receptor
Pex5p from the peroxisomal membrane to the cystosol; induced by oleic acid and upregulated during anaerobiosis -0,981695466
CAGL0L03135g SPO14 Phospholipase D, catalyzes the hydrolysis of phosphatidylcholine, producing choline and phosphatidic acid; involved in Sec14p-independent secretion; required for meiosis and spore formation; differently regulated in secretion and meiosis
-0,921436297
CAGL0L11154g NTE1 Serine esterase, homolog of human neuropathy target esterase (NTE); Nte1p-mediated phosphatidylcholine turnover
influences transcription factor Opi1p localization, affecting transcriptional regulation of phospholipid biosynthesis genes -1,030132024
CAGL0L11440g TCB3 Lipid-binding protein, localized to the bud via specific mRNA transport; non-tagged protein detected in a phosphorylated state in mitochondria; GFP-fusion protein localizes to the cell periphery; C-termini of Tcb1p, Tcb2p and Tcb3p interact
-1,018002427
CAGL0A01177g PLC1 Phospholipase C, hydrolyzes phosphatidylinositol 4,5-biphosphate (PIP2) to generate the signaling molecules inositol
1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG); involved in regulating many cellular processes -1,010157986
CAGL0D05918g ATF2 Alcohol acetyltransferase, may play a role in steroid detoxification; forms volatile esters during fermentation, which is
important in brewing -1,004370652
CAGL0F07535g YJU3 Serine hydrolase with sequence similarity to monoglyceride lipase (MGL), localizes to lipid particles -1,200991925
84
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Lip
id M
eta
bolis
m
CAGL0M06347g YPC1 Alkaline ceramidase that also has reverse (CoA-independent) ceramide synthase activity, catalyzes both breakdown and
synthesis of phytoceramide; overexpression confers fumonisin B1 resistance -1,301171711
CAGL0H01309g DPL1 Dihydrosphingosine phosphate lyase, regulates intracellular levels of sphingolipid long-chain base phosphates (LCBPs),
degrades phosphorylated long chain bases, prefers C16 dihydrosphingosine-l-phosphate as a substrate -1,341677327
CAGL0K06853g PCS60 Peroxisomal AMP-binding protein, localizes to both the peroxisomal peripheral membrane and matrix, expression is highly
inducible by oleic acid, similar to E, coli long chain acyl-CoA synthetase -1,513168978
CAGL0E03201g CHO2 Phosphatidylethanolamine methyltransferase (PEMT), catalyzes the first step in the conversion of
phosphatidylethanolamine to phosphatidylcholine during the methylation pathway of phosphatidylcholine biosynthesis -1,610205893
CAGL0K01749g OSH2 Member of an oxysterol-binding protein family with seven members in S, cerevisiae; family members have overlapping,
redundant functions in sterol metabolism and collectively perform a function essential for viability -1,919989828
CAGL0K10846g PCD1 Peroxisomal nudix pyrophosphatase with specificity for coenzyme A and CoA derivatives, may function to remove potentially toxic oxidized CoA disulfide from peroxisomes to maintain the capacity for beta-oxidation of fatty acids
-2,026034692
CAGL0I06050g INO1 Inositol 1-phosphate synthase, involved in synthesis of inositol phosphates and inositol-containing phospholipids;
transcription is coregulated with other phospholipid biosynthetic genes by Ino2p and Ino4p, which bind the UASINO DNA element
-2,328076258
Cyto
skele
ton
CAGL0M12595g ARC15 Subunit of the ARP2/3 complex, which is required for the motility and integrity of cortical actin patches -0,768781742
CAGL0K01595g ARP2 Essential component of the Arp2/3 complex, which is a highly conserved actin nucleation center required for the motility
and integrity of actin patches; involved in endocytosis and membrane growth and polarity -0,846723289
CAGL0G06842g BBC1 Protein possibly involved in assembly of actin patches; interacts with an actin assembly factor Las17p and with the SH3
domains of Type I myosins Myo3p and Myo5p; localized predominantly to cortical actin patches -0,959364823
CAGL0J01287g AIP1 Actin cortical patch component, interacts with the actin depolymerizing factor cofilin; required to restrict cofilin localization
to cortical patches; contains WD repeats -0,984956263
CAGL0M01650g RVS167 Actin-associated protein, interacts with Rvs161p to regulate actin cytoskeleton, endocytosis, and viability following
starvation or osmotic stress; homolog of mammalian amphiphysin -1,192295765
CAGL0K07590g MYO3 One of two type I myosins; localizes to actin cortical patches; deletion of MYO3 has little effect on growth, but myo3 myo5
double deletion causes severe defects in growth and actin cytoskeleton organization -1,25209766
CAGL0A02145g YSC84 Actin-binding protein involved in bundling of actin filaments and endocytosis of actin cortical patches; activity stimulated by
Las17p; contains SH3 domain similar to Rvs167p -1,734161777
Cell
Wall
CAGL0H01639g SPS1 Putative protein serine/threonine kinase expressed at the end of meiosis and localized to the prospore membrane,
required for correct localization of enzymes involved in spore wall synthesis -0,768983521
CAGL0A01284g FLO1 (EPA10) Putative adhesin-like protein -0,851321757
CAGL0I10147g FLO1 (PWP1) Protein with 32 tandem repeats; putative adhesin-like protein -0,86545246
CAGL0G06072g ECM14 Putative metalloprotease with similarity to the zinc carboxypeptidase family, required for normal cell wall assembly -0,925486978
CAGL0A01366g FLO1 (EPA9) Putative adhesin -0,932836395
CAGL0I10362g FLO5 (PWP4) Cell wall adhesin; predicted GPI anchor; contains tandem repeats -1,099237477
85
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Cell
Wall
CAGL0B01925g KIN1 Serine/threonine protein kinase involved in regulation of exocytosis; localizes to the cytoplasmic face of the plasma
membrane; closely related to Kin2p -1,020726671
CAGL0C03575g AGA1 Anchorage subunit of a-agglutinin of a-cells, highly O-glycosylated protein with N-terminal secretion signal and C-terminal
signal for addition of GPI anchor to cell wall, linked to adhesion subunit Aga2p via two disulfide bonds -1,179660737
CAGL0I10200g FLO1 (PWP3) Protein with tandem repeats; putative adhesin-like protein -1,484411036
CAGL0E01815g MKC7 (YPS8) Putative aspartic protease; predicted GPI-anchor; member of a YPS gene cluster that is required for virulence in mice;
induced in response to low pH and high temperature -1,346959653
CAGL0G01738g PIL1 Primary component of eisosomes, which are large immobile cell cortex structures associated with endocytosis; null
mutants show activation of Pkc1p/Ypk1p stress resistance pathways; detected in phosphorylated state in mitochondria -1,735190833
CAGL0J09702g ACK1 Protein that functions upstream of Pkc1p in the cell wall integrity pathway; GFP-fusion protein expression is induced in
response to the DNA-damaging agent MMS; non-tagged Ack1p is detected in purified mitochondria -2,353777007
Dru
g r
esis
tance
CAGL0E03355g BPT1 ABC type transmembrane transporter of MRP/CFTR family, found in vacuolar membrane, involved in the transport of
unconjugated bilirubin and in heavy metal detoxification via glutathione conjugates, along with Ycf1p -0,817490344
CAGL0F02717g PDR15 Plasma membrane ATP binding cassette (ABC) transporter, multidrug transporter and general stress response factor
implicated in cellular detoxification; regulated by Pdr1p, Pdr3p and Pdr8p; promoter contains a PDR responsive element -0,950526067
CAGL0M07293g PDR12 Plasma membrane ATP-binding cassette (ABC) transporter, weak-acid-inducible multidrug transporter required for weak
organic acid resistance; induced by sorbate and benzoate and regulated by War1p; mutants exhibit sorbate hypersensitivity
-1,118895209
CAGL0G05093g YDR061W Protein with similarity to ATP-binding cassette (ABC) transporter family members; lacks predicted membrane-spanning
regions; transcriptionally activated by Yrm1p along with genes involved in multidrug resistance -1,428369333
Cell
Cycle
CAGL0K06699g SDS24 One of two S, cerevisiae homologs (Sds23p and Sds24p) of the S, pombe Sds23 protein, which is implicated in
APC/cyclosome regulation; involved in cell separation during budding; may play an indirect role in fluid-phase endocytosis -0,800580912
CAGL0K12562g RIM15 Glucose-repressible protein kinase involved in signal transduction during cell proliferation in response to nutrients,
specifically the establishment of stationary phase; identified as a regulator of IME2; substrate of Pho80p-Pho85p kinase -0,840444836
CAGL0C02255g YEN1 Holliday junction resolvase; localization is cell-cycle dependent and regulated by Cdc28p phosphorylation; homolog of
human GEN1 and has similarity to S, cerevisiae endonuclease Rth1p -1,119599226
CAGL0J10846g PCL5 Cyclin, interacts with and phosphorylated by Pho85p cyclin-dependent kinase (Cdk), induced by Gcn4p at level of transcription, specifically required for Gcn4p degradation, may be sensor of cellular protein biosynthetic capacity
-1,283708105
CAGL0F03261g SAE3 Meiosis specific protein involved in DMC1-dependent meiotic recombination, forms heterodimer with Mei5p; proposed to
be an assembly factor for Dmc1p -1,322360705
CAGL0L12474g PHO85 Cyclin-dependent kinase, with ten cyclin partners; involved in regulating the cellular response to nutrient levels and
environmental conditions and progression through the cell cycle -1,341168782
CAGL0M13365g SSP1 Protein involved in the control of meiotic nuclear division and coordination of meiosis with spore formation; transcription is
induced midway through meiosis -1,354793539
CAGL0B04675g DOM34 Endoribonuclease; functions in no-go mRNA decay, protein translation to promote G1 progression and differentiation,
required for meiotic cell division; similar to the eukaryotic Pelota -2,290721591
86
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Pro
tein
Degra
datio
n
CAGL0D01518g UBA3 Protein that acts together with Ula1p to activate Rub1p before its conjugation to proteins (neddylation), which may play a
role in protein degradation; GFP-fusion protein localizes to the cytoplasm in a punctate pattern -0,804689727
CAGL0J04884g UBX6 UBX (ubiquitin regulatory X) domain-containing protein that interacts with Cdc48p, transcription is repressed when cells
are grown in media containing inositol and choline -0,897977416
CAGL0L09933g CUE5 Protein containing a CUE domain that binds ubiquitin, which may facilitate intramolecular monoubiquitination; green
fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a punctate pattern -0,883623211
CAGL0A02024g LAG2 Protein involved in the determination of longevity and also in the negative regulation of SCF E3-ubiquitin ligase function;
LAG2 is preferentially expressed in young cells; overexpression extends the mean and maximum life span of cells -1,008316677
CAGL0B03311g SAF1 F-Box protein involved in proteasome-dependent degradation of Aah1p during entry of cells into quiescence; interacts with
Skp1 -0,889844675
CAGL0F04609g EDE1 Key endocytic protein involved in a network of interactions with other endocytic proteins, binds membranes in a ubiquitin-
dependent manner, may also bind ubiquitinated membrane-associated proteins -0,967268397
CAGL0M03399g UBC8 Ubiquitin-conjugating enzyme that negatively regulates gluconeogenesis by mediating the glucose-induced ubiquitination
of fructose-1,6-bisphosphatase (FBPase); cytoplasmic enzyme that catalyzes the ubiquitination of histones in vitro -1,017919209
CAGL0B01100g TFS1 Protein that interacts with and inhibits carboxypeptidase Y and Ira2p; phosphatidylethanolamine-binding protein (PEBP) family member; targets to vacuolar membranes during stationary phase; acetylated by NatB N-terminal acetyltransferase
-1,25866226
CAGL0F02101g BLM10 Proteasome activator subunit; found in association with core particles, with and without the 19S regulatory particle; required for resistance to bleomycin, may be involved in protecting against oxidative damage; similar to mammalian
PA200 -1,256457782
CAGL0B03619g PRB1 Vacuolar proteinase B (yscB), a serine protease of the subtilisin family; involved in protein degradation in the vacuole and
required for full protein degradation during sporulation -1,271869237
CAGL0M13651g PRC1 Vacuolar carboxypeptidase Y (proteinase C; CPY), broad-specificity C-terminal exopeptidase involved in non-specific
protein degradation in the vacuole; member of the serine carboxypeptidase family -1,241513982
CAGL0C00275g HSP31 Putative cysteine protease; protein differentially expressed in azole resistant strain; gene is upregulated in azole-resistant
strain -1,376004944
CAGL0D05082g UBI4 Ubiquitin, becomes conjugated to proteins, marking them for selective degradation via the ubiquitin-26S proteasome
system; essential for the cellular stress response; encoded as a polyubiquitin precursor comprised of 5 head-to-tail repeats -1,839442103
CAGL0G02563g UBP11 Has domain(s) with predicted ubiquitin thiolesterase activity and role in ubiquitin-dependent protein catabolic process -1,877645114
CAGL0G02849g UIP4 Protein that interacts with Ulp1p, a Ubl (ubiquitin-like protein)-specific protease for Smt3p protein conjugates; detected in a
phosphorylated state in the mitochondrial outer membrane; also detected in ER and nuclear envelope -2,198717724
Tra
nsport
CAGL0D02794g WSC4 ER membrane protein involved in the translocation of soluble secretory proteins and insertion of membrane proteins into
the ER membrane; may also have a role in the stress response but has only partial functional overlap with WSC1-3 -0,8539909
CAGL0J00825g GYP6 GTPase-activating protein (GAP) for the yeast Rab family member, Ypt6p; involved in vesicle mediated protein transport -0,85171524
CAGL0M10956g SOL1 Protein with a possible role in tRNA export; shows similarity to 6-phosphogluconolactonase non-catalytic domains but
does not exhibit this enzymatic activity; homologous to Sol2p, Sol3p, and Sol4p -0,835185888
CAGL0L10142g RSB1 Suppressor of sphingoid long chain base (LCB) sensitivity of an LCB-lyase mutation; putative integral membrane transporter or flippase that may transport LCBs from the cytoplasmic side toward the extracytoplasmic side of the
membrane -0,977339869
87
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Tra
nsport
CAGL0I09746g SLY41 Protein involved in ER-to-Golgi transport -0,940084425
CAGL0C02453g YPT31 GTPase of the Ypt/Rab family, very similar to Ypt32p; involved in the exocytic pathway; mediates intra-Golgi traffic or the
budding of post-Golgi vesicles from the trans-Golgi -0,966767034
CAGL0C01771g VPS73 Putative transporter, member of the sugar porter family; green fluorescent protein (GFP)-fusion protein localizes to the
vacuolar membrane; YBR241C is not an essential gene -0,997070343
CAGL0L07766g ADY2 Acetate transporter required for normal sporulation; phosphorylated in mitochondria -0,959327177
CAGL0E03674g TPO1 Polyamine transporter that recognizes spermine, putrescine, and spermidine; catalyzes uptake of polyamines at alkaline
pH and excretion at acidic pH; phosphorylation enhances activity and sorting to the plasma membrane -1,031069135
CAGL0K01771g YAT1 Outer mitochondrial carnitine acetyltransferase, minor ethanol-inducible enzyme involved in transport of activated acyl
groups from the cytoplasm into the mitochondrial matrix; phosphorylated -1,107335275
CAGL0J11308g NPR1 Protein kinase that stabilizes several plasma membrane amino acid transporters by antagonizing their ubiquitin-mediated
degradation -1,018559858
CAGL0I07271g VPS17 Subunit of the membrane-associated retromer complex essential for endosome-to-Golgi retrograde protein transport;
peripheral membrane protein that assembles onto the membrane with Vps5p to promote vesicle formation -1,018890023
CAGL0E02035g MCH4 Protein with similarity to mammalian monocarboxylate permeases, which are involved in transport of monocarboxylic acids
across the plasma membrane; mutant is not deficient in monocarboxylate transport -1,118606492
CAGL0J04114g ODC2 Mitochondrial inner membrane transporter, exports 2-oxoadipate and 2-oxoglutarate from the mitochondrial matrix to the
cytosol for use in lysine and glutamate biosynthesis and in lysine catabolism -1,093985309
CAGL0I09702g MCH5 Plasma membrane riboflavin transporter; facilitates the uptake of vitamin B2; required for FAD-dependent processes;
sequence similarity to mammalian monocarboxylate permeases, however mutants are not deficient in monocarboxylate transport
-1,317068543
CAGL0M09020g SFC1 Mitochondrial succinate-fumarate transporter, transports succinate into and fumarate out of the mitochondrion; required for
ethanol and acetate utilization -1,29886711
CAGL0E04004g MUP3 Low affinity methionine permease, similar to Mup1p -1,304955259
CAGL0L05742g MRS3 Iron transporter that mediates Fe2+ transport across the inner mitochondrial membrane; mitochondrial carrier family
member, similar to and functionally redundant with Mrs4p; active under low-iron conditions; may transport other cations -1,391576146
CAGL0A01826g HXT3 Low affinity glucose transporter of the major facilitator superfamily, expression is induced in low or high glucose conditions -1,517848417
Sorting CAGL0G06424g SNX3
Sorting nexin required to maintain late-Golgi resident enzymes in their proper location by recycling molecules from the prevacuolar compartment; contains a PX domain and sequence similarity to human Snx3p
-0,825736006
CAGL0L08888g NCR1 Vacuolar membrane protein that transits through the biosynthetic vacuolar protein sorting pathway, involved in sphingolipid
metabolism; glycoprotein and functional orthologue of human Niemann Pick C1 (NPC1) protein -0,948638409
RN
A p
rocessin
g
CAGL0E01243g CTH1 Member of the CCCH zinc finger family; has similarity to mammalian Tis11 protein, which activates transcription and also
has a role in mRNA degradation; may function with Tis11p in iron homeostasis -0,862069429
CAGL0I02860g CEX1 Cytoplasmic component of the nuclear aminoacylation-dependent tRNA export pathway; interacts with nuclear pore
component Nup116p; copurifies with tRNA export receptors Los1p and Msn5p, as well as eIF-1a and the RAN GTPase Gsp1p
-0,92468039
CAGL0J06820g RNY1 Vacuolar RNase of the T(2) family, relocalizes to the cytosol where it cleaves tRNAs upon oxidative or stationary phase
stress; promotes apoptosis under stress conditions and this function is independent of its catalytic activity -1,020215436
88
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
RN
A p
rocessin
g CAGL0G03179g ASK10
Component of the RNA polymerase II holoenzyme, phosphorylated in response to oxidative stress; has a role in destruction of Ssn8p, which relieves repression of stress-response genes
-0,97579438
CAGL0C03113g DCS1 Non-essential hydrolase involved in mRNA decapping, may function in a feedback mechanism to regulate deadenylation,
contains pyrophosphatase activity and a HIT (histidine triad) motif; interacts with neutral trehalase Nth1p -1,116865322
CAGL0J09592g CWC2 Member of the NineTeen Complex (NTC) that contains Prp19p and stabilizes U6 snRNA in catalytic forms of the
spliceosome containing U2, U5, and U6 snRNAs; binds directly to U6 snRNA; similar to S, pombe Cwf2 -1,151175697
CAGL0F08217g YGR250C Putative RNA binding protein; localizes to stress granules induced by glucose deprivation; interacts with Rbg1p in a two-
hybrid -1,288687982
Sig
nal T
ransductio
n
CAGL0H01617g AGE1 ADP-ribosylation factor (ARF) GTPase activating protein (GAP) effector, involved in the secretory and endocytic pathways;
contains C2C2H2 cysteine/histidine motif -0,918508909
CAGL0G09020g TPK2 cAMP-dependent protein kinase catalytic subunit; promotes vegetative growth in response to nutrients via the Ras-cAMP
signaling pathway; partially redundant with Tpk1p and Tpk3p; localizes to P-bodies during stationary phase -1,041914753
CAGL0G02255g HBS1 GTP binding protein with sequence similarity to the elongation factor class of G proteins, EF-1alpha and Sup35p;
associates with Dom34p, and shares a similar genetic relationship with genes that encode ribosomal protein components -1,008399373
CAGL0J07282g GPB1 Multistep regulator of cAMP-PKA signaling; inhibits PKA downstream of Gpa2p and Cyr1p, thereby increasing cAMP
dependency; inhibits Ras activity through direct interactions with Ira1p/2p; regulated by G-alpha protein Gpa2p; homolog of Gpb2p
-1,015037967
CAGL0H00737g GYP5 GTPase-activating protein (GAP) for yeast Rab family members, involved in ER to Golgi trafficking; exhibits GAP activity
toward Ypt1p that is stimulated by Gyl1p, also acts on Sec4p; interacts with Gyl1p, Rvs161p and Rvs167p -1,060435008
CAGL0A02431g YPS7 Putative GPI-anchored aspartic protease, located in the cytoplasm and endoplasmic reticulum -1,305244468
CAGL0F07117g GPG1 Proposed gamma subunit of the heterotrimeric G protein that interacts with the receptor Gpr1p; involved in regulation of
pseudohyphal growth; requires Gpb1p or Gpb2p to interact with Gpa2p; overproduction causes prion curing -1,778402484
CAGL0K10164g SED1 Major stress-induced structural GPI-cell wall glycoprotein in stationary-phase cells, associates with translating ribosomes,
possible role in mitochondrial genome maintenance; ORF contains two distinct variable minisatellites -1,868250598
CAGL0I07249g BAG7 Rho GTPase activating protein (RhoGAP), stimulates the intrinsic GTPase activity of Rho1p, which plays a role in actin
cytoskeleton organization and control of cell wall synthesis; structurally and functionally related to Sac7p -2,228888678
DN
A p
rocessin
g
CAGL0H03113g LIF1 Component of the DNA ligase IV complex that mediates nonhomologous end joining in DNA double-strand break repair;
physically interacts with Dnl4p and Nej1p; homologous to mammalian XRCC4 protein -0,839470474
CAGL0K03443g YKU80 Subunit of the telomeric Ku complex (Yku70p-Yku80p), involved in telomere length maintenance, structure and telomere
position effect; relocates to sites of double-strand cleavage to promote nonhomologous end joining during DSB repair -0,847670574
CAGL0B04785g SGF29 Probable subunit of SAGA histone acetyltransferase complex -0,959821345
CAGL0L06644g RTT107 Protein implicated in Mms22-dependent DNA repair during S phase, DNA damage induces phosphorylation by Mec1p at
one or more SQ/TQ motifs; interacts with Mms22p and Slx4p; has four BRCT domains; has a role in regulation of Ty1 transposition
-0,928122423
CAGL0K06083g NEJ1 Protein involved in regulation of nonhomologous end joining; interacts with DNA ligase IV components Dnl4p and Lif1p;
repressed by MAT heterozygosity; regulates cellular distribution of Lif1p -0,98203203
CAGL0B02387g NGL3 Putative endonuclease, has a domain similar to a magnesium-dependent endonuclease motif in mRNA deadenylase
Ccr4p; similar to Ngl1p and Ngl2p -1,119580099
89
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
DNA processing
CAGL0F07381g TAF6 Has domain(s) with predicted protein heterodimerization activity, role in DNA-dependent transcription, initiation, regulation
of sequence-specific DNA binding transcription factor activity and nucleus localization -1,204977534
CAGL0F08173g CPD1 Cyclic nucleotide phosphodiesterase, hydrolyzes ADP-ribose 1'', 2''-cyclic phosphate to ADP-ribose 1''-phosphate; may
have a role in tRNA splicing; no detectable phenotype is conferred by null mutation or by overexpression -1,065173671
CAGL0H08844g DDR48 DNA damage-responsive protein, expression is increased in response to heat-shock stress or treatments that produce
DNA lesions; contains multiple repeats of the amino acid sequence NNNDSYGS -1,769417096
Ion H
om
eosta
sis
CAGL0D03322g IZH3 Membrane protein involved in zinc ion homeostasis, member of the four-protein IZH family, expression induced by zinc deficiency; deletion reduces sensitivity to elevated zinc and shortens lag phase, overexpression reduces Zap1p activity
-0,887423097
CAGL0L09251g HAL1 Cytoplasmic protein involved in halotolerance; decreases intracellular Na+ (via Ena1p) and increases intracellular K+ by
decreasing efflux; expression repressed by Ssn6p-Tup1p and Sko1p and induced by NaCl, KCl, and sorbitol through Gcn4p
-0,881261525
CAGL0H01837g PTK2 Putative serine/threonine protein kinase involved in regulation of ion transport across plasma membrane; enhances
spermine uptake -1,255172615
CAGL0H04851g PPZ1 Serine/threonine protein phosphatase Z, isoform of Ppz2p; involved in regulation of potassium transport, which affects
osmotic stability, cell cycle progression, and halotolerance -1,174128527
CAGL0K07337g HSP30 Has domain(s) with predicted ion channel activity, role in ion transport and membrane localization -3,004063602
Tra
nscriptio
nal R
egula
tio
n
CAGL0F04081g TEC1 Transcription factor required for full Ty1 expression, Ty1-mediated gene activation, and haploid invasive and diploid
pseudohyphal growth; TEA/ATTS DNA-binding domain family member -0,860697127
CAGL0K09900g HAP5 Subunit of the heme-activated, glucose-repressed Hap2/3/4/5 CCAAT-binding complex, a transcriptional activator and
global regulator of respiratory gene expression; required for assembly and DNA binding activity of the complex -0,83295995
CAGL0C05335g RTG1 Transcription factor (bHLH) involved in interorganelle communication between mitochondria, peroxisomes, and nucleus -0,906767784
CAGL0K08756g YAP5 Basic leucine zipper (bZIP) transcription factor -0,987267297
CAGL0F08195g MGA1 Protein similar to heat shock transcription factor; multicopy suppressor of pseudohyphal growth defects of ammonium
permease mutants -0,946490943
CAGL0L09691g PUT3 Transcriptional activator of proline utilization genes, constitutively binds PUT1 and PUT2 promoter sequences and
undergoes a conformational change to form the active state; has a Zn(2)-Cys(6) binuclear cluster domain -1,03944789
CAGL0J03806g WTM1 Transcriptional modulator involved in regulation of meiosis, silencing, and expression of RNR genes; required for nuclear
localization of the ribonucleotide reductase small subunit Rnr2p and Rnr4p; contains WD repeats -1,290432679
CAGL0K08668g MET28 Basic leucine zipper (bZIP) transcriptional activator in the Cbf1p-Met4p-Met28p complex, participates in the regulation of
sulfur metabolism -1,464160646
Oxidation reduction
CAGL0L01265g YEF1 ATP-NADH kinase; phosphorylates both NAD and NADH; homooctameric structure consisting of 60-kDa subunits;
sequence similarity to Utr1p and Pos5p; overexpression complements certain pos5 phenotypes -0,872819189
CAGL0H09944g ZTA1 NADPH-dependent quinone reductase, GFP-tagged protein localizes to the cytoplasm and nucleus; has similarity to E, coli
quinone oxidoreductase and to human zeta-crystallin -0,92356748
CAGL0M07612g FMS1 Polyamine oxidase, converts spermine to spermidine, which is required for the essential hypusination modification of
translation factor eIF-5A; also involved in pantothenic acid biosynthesis -0,954518832
90
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Oxidation reduction
CAGL0M07942g FRE8 Protein with sequence similarity to iron/copper reductases, involved in iron homeostasis; deletion mutant has iron
deficiency/accumulation growth defects; expression increased in the absence of copper-responsive transcription factor Mac1p
-1,036137063
CAGL0D00198g BDH1 NAD-dependent (R,R)-butanediol dehydrogenase, catalyzes oxidation of (R,R)-2,3-butanediol to (3R)-acetoin, oxidation of meso-butanediol to (3S)-acetoin, and reduction of acetoin; enhances use of 2,3-butanediol as an aerobic carbon source
-1,259432017
Str
ess A
dapta
tio
n
CAGL0B03289g DUG2 Probable di- and tri-peptidase; forms a complex with Dug1p and Dug3p to degrade glutathione (GSH) and other peptides
containing a gamma-glu-X bond in an alternative pathway to GSH degradation by gamma-glutamyl transpeptidase (Ecm38p)
-0,881130594
CAGL0L11374g DAK1 Dihydroxyacetone kinase, required for detoxification of dihydroxyacetone (DHA); involved in stress adaptation -0,898937353
CAGL0G02101g ECM4 Omega class glutathione transferase; not essential; similar to Ygr154cp; green fluorescent protein (GFP)-fusion protein
localizes to the cytoplasm -0,92709314
CAGL0L05258g SRX1 Sulfiredoxin, contributes to oxidative stress resistance by reducing cysteine-sulfinic acid groups in the peroxiredoxins
Tsa1p and Ahp1p that are formed upon exposure to oxidants; conserved in higher eukaryotes -0,977480214
CAGL0C04323g NTH2 Putative neutral trehalase, required for thermotolerance and may mediate resistance to other cellular stresses -1,178306475
CAGL0H04037g GAC1 Regulatory subunit for Glc7p type-1 protein phosphatase (PP1), tethers Glc7p to Gsy2p glycogen synthase, binds Hsf1p
heat shock transcription factor, required for induction of some HSF-regulated genes under heat shock -1,549189994
CAGL0G03289g SSA4 Heat shock protein that is highly induced upon stress; plays a role in SRP-dependent cotranslational protein-membrane targeting and translocation; member of the HSP70 family; cytoplasmic protein that concentrates in nuclei upon starvation
-1,62437865
CAGL0L00957g CAJ1 Nuclear type II J heat shock protein of the E, coli dnaJ family, contains a leucine zipper-like motif, binds to non-native
substrates for presentation to Ssa3p, may function during protein translocation, assembly and disassembly -1,648029783
CAGL0K03459g SPG4 Protein required for survival at high temperature during stationary phase; not required for growth on nonfermentable
carbon sources -1,732194052
CAGL0H02585g GAD1 Glutamate decarboxylase, converts glutamate into gamma-aminobutyric acid (GABA) during glutamate catabolism;
involved in response to oxidative stress -1,631424515
CAGL0J11484g DUG3 Probable glutamine amidotransferase, forms a complex with Dug1p and Dug2p to degrade glutathione (GSH) and other
peptides containing a gamma-glu-X bond in an alternative pathway to GSH degradation by gamma-glutamyl transpeptidase (Ecm38p)
-1,817183956
CAGL0F07953g SPG1 Protein required for survival at high temperature during stationary phase; not required for growth on nonfermentable
carbon sources; the authentic, non-tagged protein is detected in highly purified mitochondria in high-throughput studies -1,974323084
CAGL0J04202g HSP12 Plasma membrane localized protein that protects membranes from desiccation; induced by heat shock, oxidative stress, osmostress, stationary phase entry, glucose depletion, oleate and alcohol; regulated by the HOG and Ras-Pka pathways
-1,95644287
CAGL0L11990g GRX4 Hydroperoxide and superoxide-radical responsive glutathione-dependent oxidoreductase; monothiol glutaredoxin
subfamily member along with Grx3p and Grx5p; protects cells from oxidative damage -2,259560921
91
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Mitochondria
l O
rganiz
atio
n
CAGL0D04972g TAZ1 Lyso-phosphatidylcholine acyltransferase, required for normal phospholipid content of mitochondrial membranes; may
remodel acyl groups of cardiolipin in the inner membrane; human ortholog tafazzin is implicated in Barth syndrome -0,859268715
CAGL0F01221g MIM1 Mitochondrial outer membrane protein, required for assembly of the translocase of the outer membrane (TOM) complex
and thereby for mitochondrial protein import; N terminus is exposed to the cytosol: transmembrane segment is highly conserved
-0,939193465
CAGL0M12661g FIS1 Protein involved in mitochondrial membrane fission and peroxisome abundance; required for localization of Dnm1p and
Mdv1p during mitochondrial division; mediates ethanol-induced apoptosis and ethanol-induced mitochondrial fragmentation
-0,949115157
CAGL0L00869g PKP1 Mitochondrial protein kinase involved in negative regulation of pyruvate dehydrogenase complex activity by
phosphorylating the ser-133 residue of the Pda1p subunit; acts in concert with kinase Pkp2p and phosphatases Ptc5p and Ptc6p
-0,955485251
CAGL0J02926g PET117 Protein required for assembly of cytochrome c oxidase -0,983223597
CAGL0I01980g YSP1 Mitochondrial protein with a potential role in promoting mitochondrial fragmentation during programmed cell death in
response to high levels of alpha-factor mating pheromone or the drug amiodarone -1,102152589
CAGL0M08624g MSW1 Mitochondrial tryptophanyl-tRNA synthetase -1,093813704
CAGL0B02860g ATG33 Mitochondrial mitophagy-specific protein; required primarily for mitophagy induced at the post-log phase; not required for
other types of selective autophagy or macroautophagy; conserved within fungi, but not in higher eukaryotes -1,165244129
CAGL0D04840g MSS18 Nuclear encoded protein needed for efficient splicing of mitochondrial COX1 aI5beta intron; mss18 mutations block
cleavage of 5' exon - intron junction; phenotype of intronless strain suggests additional functions -1,205698537
CAGL0M12947g PUP1 Mitochondria-localized protein; gene is upregulated in azole-resistant strain -1,183677169
CAGL0L09273g ICL2 2-methylisocitrate lyase of the mitochondrial matrix, functions in the methylcitrate cycle to catalyze the conversion of 2-
methylisocitrate to succinate and pyruvate; ICL2 transcription is repressed by glucose and induced by ethanol -1,060002095
CAGL0J04048g ISU2 Conserved protein of the mitochondrial matrix, required for synthesis of mitochondrial and cytosolic iron-sulfur proteins,
performs a scaffolding function in mitochondria during Fe/S cluster assembly; isu1 isu2 double mutant is inviable -1,270438195
CAGL0C03553g PET494 Mitochondrial translational activator specific for the COX3 mRNA, acts together with Pet54p and Pet122p; located in the
mitochondrial inner membrane -1,530976048
CAGL0F07007g PKP2 Mitochondrial protein kinase that negatively regulates activity of the pyruvate dehydrogenase complex by phosphorylating
the ser-133 residue of the Pda1p subunit; acts in concert with kinase Pkp1p and phosphatases Ptc5p and Ptc6p -1,524646174
Repro
ductio
n
CAGL0M09207g STE18 G protein gamma subunit, forms a dimer with Ste4p to activate the mating signaling pathway, forms a heterotrimer with
Gpa1p and Ste4p to dampen signaling; C-terminus is palmitoylated and farnesylated, which are required for normal signaling
-0,887194974
CAGL0D04686g AXL1 Haploid specific endoprotease that performs one of two N-terminal cleavages during maturation of a-factor mating
pheromone; required for axial budding pattern of haploid cells -0,945763751
CAGL0G02717g SGA1 Intracellular sporulation-specific glucoamylase involved in glycogen degradation; induced during starvation of a/a diploids
late in sporulation, but dispensable for sporulation -1,067423796
CAGL0H01661g SPS2 Protein expressed during sporulation, redundant with Sps22p for organization of the beta-glucan layer of the spore wall; S,
pombe ortholog is a spore wall component -1,219224591
92
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Reproduction
CAGL0G05544g HBT1 Substrate of the Hub1p ubiquitin-like protein that localizes to the shmoo tip (mating projection); mutants are defective for
mating projection formation, thereby implicating Hbt1p in polarized cell morphogenesis -1,287398011
CAGL0J04290g FUS3 Mitogen-activated serine/threonine protein kinase involved in mating; phosphoactivated by Ste7p; substrates include
Ste12p, Far1p, Bni1p, Sst2p; inhibits invasive growth during mating by phosphorylating Tec1p, promoting its degradation -1,585829622
Auto
phagy
CAGL0A04675g ATG8 Component of autophagosomes and Cvt vesicles; undergoes conjugation to phosphatidylethanolamine (PE); Atg8p-PE is
anchored to membranes, is involved in phagophore expansion, and may mediate membrane fusion during autophagosome formation
-1,088781606
CAGL0I07887g ATG19 Receptor protein specific for the cytoplasm-to-vacuole targeting (Cvt) pathway; delivers cargo proteins aminopeptidase I
(Lap4p) and alpha-mannosidase (Ams1p) to the phagophore assembly site for packaging into Cvt vesicles -1,170497954
CAGL0H06545g ATG32 Mitochondrial-anchored transmembrane receptor that interacts with the autophagy adaptor protein, Atg11p, and is
essential for mitophagy, the selective vacuolar degradation of mitochondria in response to starvation -1,206700234
CAGL0M02343g ATG5 Conserved protein involved in autophagy and the Cvt pathway; undergoes conjugation with Atg12p to form a complex involved in Atg8p lipidation; conjugated Atg12p also forms a complex with Atg16p that is essential for autophagosome
formation -1,189331646
CAGL0K08536g LAP4 Vacuolar aminopeptidase yscI; zinc metalloproteinase that belongs to the peptidase family M18; often used as a marker
protein in studies of autophagy and cytosol to vacuole targeting (CVT) pathway -1,80998654
Cofactors CAGL0F09185g FAU1 5,10-methenyltetrahydrofolate synthetase, involved in folic acid biosynthesis -0,846753938
Phosphate availability
CAGL0K07546g PMU1 (PMU2) Putative phosphate starvation inducible acid phosphatase; contains a phosphomutase-like domain; functionally
complements a S. cerevisiae pho5 mutant; transcript abundance during phosphate starvation regulated by Pho4p -1,498710548
Unkow
n F
unctio
n
CAGL0E01661g STA1 - -0,758479826
CAGL0J02508g AWP1 - -0,775939249
CAGL0L11616g RTC5 Protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm; null mutation
suppresses cdc13-1 temperature sensitivity -0,80090787
CAGL0L00227g - - -0,791853712
CAGL0J04092g DSC3 Putative protein of unknown function -0,851733329
CAGL0B03883g - YMC1 -0,823793845
CAGL0M05313g YPL077C
Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and nucleus; YBR197C is not an essential gene
-0,831331281
CAGL0D04510g YPR117W Putative protein of unknown function -0,836679255
CAGL0F04543g - - -0,863533592
CAGL0A01892g - - -0,857204778
CAGL0M14091g - - -0,869382108
CAGL0M06633g AIM19 Putative protein of unknown function; the authentic, non-tagged protein is detected in purified mitochondria in high-
throughput studies; null mutant displays reduced respiratory growth -0,90743515
93
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Unkow
n F
unctio
n
CAGL0J06270g YDL176W Protein of unknown function, predicted by computational methods to be involved in fructose-1,6-bisphosphatase (Fbp1p)
degradation; interacts with components of the GID complex; YDL176W is not an essential gene -0,933956178
CAGL0C03201g VPS13 Protein of unknown function; heterooligomeric or homooligomeric complex; peripherally associated with membranes;
homologous to human COH1; involved in sporulation, vacuolar protein sorting and protein-Golgi retention -0,850386656
CAGL0J02530g - - -0,927372778
CAGL0J05830g YNL144C Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-
throughput studies; YNL144C is not an essential gene -0,898424841
CAGL0H10032g RFS1 Protein of unknown function; member of a flavodoxin-like fold protein family that includes Pst2p and Ycp4p; green
fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a punctate pattern -0,949078262
CAGL0H03289g YPL191C
Putative protein of unknown function; predicted prenylation/proteolysis target of Afc1p and Rce1p; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and nucleus; YGL082W is not an essential gene
-0,864777362
CAGL0H10362g TMA17 Protein of unknown function that associates with ribosomes; heterozygous deletion demonstrated increases in
chromosome instability in a rad9 deletion background; protein abundance is decreased upon intracellular iron depletion -0,905055866
CAGL0K04301g FMP48 Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-
throughput studies; induced by treatment with 8-methoxypsoralen and UVA irradiation -0,959667324
CAGL0L03696g ECM3 Non-essential protein of unknown function; involved in signal transduction and the genotoxic response; induced rapidly in
response to treatment with 8-methoxypsoralen and UVA irradiation -0,903906737
CAGL0H10054g YBR053C Putative protein of unknown function; induced by cell wall perturbation -0,922103174
CAGL0I05874g GPP1 Haloacid dehalogenase-like hydrolase -1,002822571
CAGL0G05049g AIM7 Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and
nucleus; null mutant is viable and displays elevated frequency of mitochondrial genome loss -1,002231647
CAGL0F01991g YLR050C Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the endoplasmic
reticulum; YLR050C is not an essential gene -0,965544307
CAGL0C00968g YOL155C - -0,892458491
CAGL0M03179g IML2 Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and
nucleus -0,985833996
CAGL0H01111g YDR286C Putative protein of unknown function; predicted to have thiol-disulfide oxidoreductase active site -0,941439106
CAGL0G01892g YPR098C Protein of unknown function, localized to the mitochondrial outer membrane -1,030331267
CAGL0M09493g YMR160W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the membrane of the vacuole; mutant has enhanced sensitivity to overexpression of mutant huntingtin; YMR160W is not an essential gene
-1,056215475
CAGL0K01199g DSC2 Putative protein of unknown function -0,979636446
CAGL0D00704g YET3 Protein of unknown function; YET3 null mutant decreases the level of secreted invertase; homolog of human BAP31
protein -1,040046053
CAGL0G06094g IGO1 Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and
nucleus; protein abundance is decreased upon intracellular iron depletion -0,959690881
94
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Unkow
n F
unctio
n
CAGL0G07183g2
- - -1,075116644
CAGL0H02519g YMR253C Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a
punctate pattern; YMR253C is not an essential gene -1,052512125
CAGL0B04939g YLR173W Putative protein of unknown function -1,018300265
CAGL0F03267g YHR080C Protein of unknown function that may interact with ribosomes, based on co-purification experiments; the authentic, non-
tagged protein is detected in highly purified mitochondria in high-throughput studies -1,090933591
CAGL0D00396g - - -1,051803426
CAGL0H10010g YHR131C - -1,115048407
CAGL0K00891g TDA10 ATP-binding protein of unknown function; crystal structure resembles that of E,coli pantothenate kinase and other small
kinases -1,098164
CAGL0J07018g YPL109C Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-
throughput studies -1,145144628
CAGL0H10120g YBR056W Putative cytoplasmic protein of unknown function -1,08390956
CAGL0J04026g HER1 Protein of unknown function required for proliferation or remodeling of the ER that is caused by overexpression of Hmg2p;
may interact with ribosomes, based on co-purification experiments -1,142828977
CAGL0G06446g - - -1,187881933
CAGL0F04807g OM45 Protein of unknown function, major constituent of the mitochondrial outer membrane; located on the outer (cytosolic) face
of the outer membrane -1,153445851
CAGL0E03498g - - -1,211016203
CAGL0K08734g YIR014W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the vacuole; expression
directly regulated by the metabolic and meiotic transcriptional regulator Ume6p; YIR014W is a non-essential gene -1,153006776
CAGL0B01875g COX26 Putative protein of unknown function; may interact with respiratory chain complexes III (ubiquinol-cytochrome c reductase)
or IV (cytochrome c oxidase) -1,187169826
CAGL0M11902g FUN19 Non-essential protein of unknown function; expression induced in response to heat stress -1,119575346
CAGL0C00781g - - -1,116507806
CAGL0B01078g YLR177W Putative protein of unknown function; phosphorylated by Dbf2p-Mob1p in vitro; some strains contain microsatellite
polymophisms at this locus; YLR177W is not an essential gene -1,173756072
CAGL0M04675g RDL1 Protein of unknown function containing a rhodanese-like domain; localized to the mitochondrial outer membrane -1,124194481
CAGL0M13255g YET1 Endoplasmic reticulum transmembrane protein; may interact with ribosomes, based on co-purification experiments;
homolog of human BAP31 protein -1,265083674
95
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Unkow
n F
unctio
n
CAGL0F00869g RRT8 Putative protein of unknown function; identified in a screen for mutants with increased levels of rDNA transcription; green
fluorescent protein (GFP)-fusion protein localizes to lipid particles -1,119065597
CAGL0J00715g YHR022C Putative protein of unknown function; YHR022C is not an essential gene -1,276234334
CAGL0C00671g MSC3 Protein of unknown function, green fluorescent protein (GFP)-fusion protein localizes to the cell periphery; msc3 mutants
are defective in directing meiotic recombination events to homologous chromatids; potential Cdc28p substrate -1,24861834
CAGL0L04378g PNS1 Protein of unknown function; has similarity to Torpedo californica tCTL1p, which is postulated to be a choline transporter,
neither null mutation nor overexpression affects choline transport -1,257650203
CAGL0J01331g YMR090W Putative protein of unknown function with similarity to DTDP-glucose 4,6-dehydratases; GFP-fusion protein localizes to the
cytoplasm; up-regulated in response to the fungicide mancozeb; not essential for viability -1,264703394
CAGL0E05962g FMP40 Putative protein of unknown function; proposed to be involved in responding to environmental stresses; the authentic, non-
tagged protein is detected in highly purified mitochondria in high-throughput studies -1,187809782
CAGL0K04719g YNL208W Protein of unknown function; may interact with ribosomes, based on co-purification experiments; authentic, non-tagged
protein is detected in purified mitochondria in high-throughput studies; potential orthologs found in other fungi -1,192455712
Cgla_YGOB_Anc_7,478
- - -1,291169513
CAGL0C02321g PHM8 Protein of unknown function, expression is induced by low phosphate levels and by inactivation of Pho85p -1,266680944
CAGL0K05687g OYE2 - -1,323844372
CAGL0A00341g MPO1 Putative protein of unknown function; YGL010W is not an essential gene -1,241996461
CAGL0K03201g YHL018W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to mitochondria and is
induced in response to the DNA-damaging agent MMS -1,261816702
CAGL0I07315g YOR131C Putative protein of unknown function; non-essential gene; overexpression causes a cell cycle delay or arrest -1,346073704
CAGL0B02563g MSC1 Protein of unknown function; mutant is defective in directing meiotic recombination events to homologous chromatids; the
authentic, non-tagged protein is detected in highly purified mitochondria and is phosphorylated -1,387700851
CAGL0K09218g YCR061W Protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a punctate
pattern; induced by treatment with 8-methoxypsoralen and UVA irradiation -1,393351334
CAGL0M04763g YOR289W Putative protein of unknown function; transcription induced by the unfolded protein response; green fluorescent protein
(GFP)-fusion protein localizes to both the cytoplasm and the nucleus -1,418417415
CAGL0C02057g - - -1,390738703
CAGL0C04587g YJR098C Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-
throughput studies -1,406828864
CAGL0I05610g YNR014W Putative protein of unknown function; expression is cell-cycle regulated, Azf1p-dependent, and heat-inducible -1,42014997
CAGL0K04235g NQM1 Transaldolase of unknown function; transcription is repressed by Mot1p and induced by alpha-factor and during diauxic
shift -1,307961429
CAGL0G03531g SPR6 Protein of unknown function, expressed during sporulation; not required for sporulation, but gene exhibits genetic
interactions with other genes required for sporulation -1,392784819
96
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Unkow
n F
unctio
n
CAGL0G09086g - - -1,199597395
CAGL0C02739g FUN14 Mitochondrial protein of unknown function -1,516935281
CAGL0H09966g FMP23 Putative protein of unknown function; proposed to be involved in iron or copper homeostatis; the authentic, non-tagged
protein is detected in highly purified mitochondria in high-throughput studies -1,428817092
CAGL0K12958g YML131W Putative protein of unknown function with similarity to medium chain dehydrogenase/reductases; expression induced by
stresses including osmotic shock, DNA damaging agents, and other chemicals; GFP-fusion protein localizes to the cytoplasm
-1,396559313
CAGL0D00990g YDL057W Putative protein of unknown function; YDL057W is not an essential gene -1,522105169
CAGL0H02893g YJL070C Putative protein of unknown function with similarity to AMP deaminases; the authentic, non-tagged protein is detected in
highly purified mitochondria in high-throughput studies; YJL070C is a non-essential gene -1,467416397
CAGL0H03971g YCP4 Protein of unknown function, has sequence and structural similarity to flavodoxins; predicted to be palmitoylated; the
authentic, non-tagged protein is detected in highly purified mitochondria in high-throughput studies -1,580492108
CAGL0K00231g OXP1 Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm -1,621297451
CAGL0B01595g - - -1,550424989
CAGL0M12474g YIL055C Putative protein of unknown function -1,56049664
CAGL0K04631g YGR067C Putative protein of unknown function; contains a zinc finger motif similar to that of Adr1p -1,622524086
CAGL0L10582g YMR196W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm; YMR196W
is not an essential gene -1,689962775
CAGL0G06798g LSO1 Putative protein of unknown function, originally identified as a syntenic homolog of an <i>Ashbya gossypii</i> gene -1,728853425
CAGL0L06864g SIP5 Protein of unknown function; interacts with both the Reg1p/Glc7p phosphatase and the Snf1p kinase -1,672679457
CAGL0G05357g YNL200C Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-
throughput studies -1,757417025
CAGL0J04004g MCP1 Protein of unknown function, localized to the mitochondrial outer membrane -1,796084425
CAGL0B03817g MHO1 Putative protein of unknown function; expression repressed by inosine and choline in an Opi1p-dependent manner;
expression induced by mild heat-stress on a non-fermentable carbon source, -1,827401075
CAGL0I07865g PHM7 Protein of unknown function, expression is regulated by phosphate levels; green fluorescent protein (GFP)-fusion protein
localizes to the cell periphery and vacuole -1,48667234
CAGL0H02563g HOR7 Protein of unknown function; overexpression suppresses Ca2+ sensitivity of mutants lacking inositol phosphorylceramide
mannosyltransferases Csg1p and Csh1p; transcription is induced under hyperosmotic stress and repressed by alpha factor
-1,775861352
CAGL0F00605g EMI2 Non-essential protein of unknown function required for transcriptional induction of the early meiotic-specific transcription
factor IME1; required for sporulation; expression is regulated by glucose-repression transcription factors Mig1/2p -1,811890257
CAGL0M05401g YBR201C-A Putative protein of unknown function -1,831094083
97
Table S1 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Unkow
n F
unctio
n
CAGL0I01276g YHR112C Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm -1,837771112
CAGL0A02002g IGD1 Putative protein of unknown function; predicted to have thiol-disulfide oxidoreductase active site -2,044538323
CAGL0M12551g RGI2 Putative protein of unknown function; expression induced under carbon limitation and repressed under high glucose -2,057178228
CAGL0M11000g YCR075W-A Putative protein of unknown function; expression is regulated by Msn2p/Msn4p -2,039289411
CAGL0J11550g YNL195C Putative protein of unknown function; shares a promoter with YNL194C; the authentic, non-tagged protein is detected in
highly purified mitochondria in high-throughput studies -2,007756277
CAGL0J03080g RGI1 Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and
nucleus; YER067W is not an essential gene; protein abundance is increased upon intracellular iron depletion -2,26931154
CAGL0G05269g FMP16 Putative protein of unknown function; proposed to be involved in responding to conditions of stress; the authentic, non-
tagged protein is detected in highly purified mitochondria in high-throughput studies -2,207576794
CAGL0H02101g RTC3 Protein of unknown function involved in RNA metabolism; has structural similarity to SBDS, the human protein mutated in
Shwachman-Diamond Syndrome (the yeast SBDS ortholog = SDO1); null mutation suppresses cdc13-1 temperature sensitivity
-2,399157247
CAGL0F04631g MOH1 Protein of unknown function, has homology to kinase Snf7p; not required for growth on nonfermentable carbon sources;
essential for viability in stationary phase -2,348057295
CAGL0A01870g PEP1 Has domain(s) with predicted integral to membrane localization -2,583101734
CAGL0G05632g YDL218W Putative protein of unknown function; YDL218W transcription is regulated by Azf1p and induced by starvation and aerobic
conditions; expression also induced in cells treated with the mycotoxin patulin -3,432861725
98
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days.
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Energ
y a
nd C
arb
ohydra
te
me
tabolis
m
CAGL0H05137g ALD6 Cytosolic aldehyde dehydrogenase, activated by Mg2+ and utilizes NADP+ as the preferred coenzyme; required for conversion
of acetaldehyde to acetate; constitutively expressed; locates to the mitochondrial outer surface upon oxidative stress 1,407832548
CAGL0H07051g ASP1 Cytosolic L-asparaginase, involved in asparagine catabolism 0,997223907
CAGL0E01045g NBP2 Protein involved in the HOG (high osmolarity glycerol) pathway, negatively regulates Hog1p by recruitment of phosphatase
Ptc1p the Pbs2p-Hog1p complex, found in the nucleus and cytoplasm, contains an SH3 domain that binds Pbs2p 0,917183649
CAGL0J04840g AIM22 Putative lipoate-protein ligase, required along with Lip2 and Lip5 for lipoylation of Lat1p and Kgd2p; similar to E, coli LplA; null
mutant displays reduced frequency of mitochondrial genome loss 0,962624192
CAGL0E06028g ALG5 UDP-glucose:dolichyl-phosphate glucosyltransferase, involved in asparagine-linked glycosylation in the endoplasmic reticulum 0,850836139
CAGL0C02623g COX8 Subunit VIII of cytochrome c oxidase, which is the terminal member of the mitochondrial inner membrane electron transport
chain 0,769266395
Nitro
gen
Me
tabolis
m
CAGL0G07106g APT1 Adenine phosphoribosyltransferase, catalyzes the formation of AMP from adenine and 5-phosphoribosylpyrophosphate;
involved in the salvage pathway of purine nucleotide biosynthesis 1,677139094
CAGL0B01122g SAM1 S-adenosylmethionine synthetase, catalyzes transfer of the adenosyl group of ATP to the sulfur atom of methionine; one of two
differentially regulated isozymes (Sam1p and Sam2p) 1,259492834
CAGL0F00407g LIA1 Deoxyhypusine hydroxylase, a HEAT-repeat containing metalloenzyme that catalyzes hypusine formation; binds to and is
required for the modification of Hyp2p (eIF5A); complements S, pombe mmd1 mutants defective in mitochondrial positioning 0,967409069
CAGL0F04433g URA7 Major CTP synthase isozyme (see also URA8), catalyzes the ATP-dependent transfer of the amide nitrogen from glutamine to
UTP, forming CTP, the final step in de novo biosynthesis of pyrimidines; involved in phospholipid biosynthesis 0,877206176
Cell Wall
CAGL0C02211g UTR2 Chitin transglycosylase that functions in the transfer of chitin to beta(1-6) and beta(1-3) glucans in the cell wall; similar to and
functionally redundant with Crh1; glycosylphosphatidylinositol (GPI)-anchored protein localized to bud neck 1,096398259
CAGL0A01474g SCW11 Cell wall protein with similarity to glucanases; may play a role in conjugation during mating based on its regulation by Ste12p 0,870347078
Drug resistan
ce CAGL0K10208g PPH3
Catalytic subunit of an evolutionarily conserved protein phosphatase complex containing Psy2p and the regulatory subunit Psy4p; required for cisplatin resistance; involved in activation of Gln3p
0,861749117
Cell
Cycle
CAGL0M05599g TOS1 Covalently-bound cell wall protein of unknown function; identified as a cell cycle regulated SBF target gene; deletion mutants
are highly resistant to treatment with beta-1,3-glucanase; has sequence similarity to YJL171C 1,520740837
CAGL0L10648g CLN1 G1 cyclin involved in regulation of the cell cycle; activates Cdc28p kinase to promote the G1 to S phase transition; late G1
specific expression depends on transcription factor complexes, MBF (Swi6p-Mbp1p) and SBF (Swi6p-Swi4p) 1,351583177
CAGL0B02145g TOS2 Protein involved in localization of Cdc24p to the site of bud growth; may act as a membrane anchor; localizes to the bud neck
and bud tip; potentially phosphorylated by Cdc28p 1,244340585
CAGL0M11066g CLB6 B-type cyclin involved in DNA replication during S phase; activates Cdc28p to promote initiation of DNA synthesis; functions in
formation of mitotic spindles along with Clb3p and Clb4p; most abundant during late G1 1,184403068
CAGL0M11990g CLN3 G1 cyclin involved in cell cycle progression; activates Cdc28p kinase to promote the G1 to S phase transition; plays a role in
regulating transcription of the other G1 cyclins, CLN1 and CLN2; regulated by phosphorylation and proteolysis 1,255310772
CAGL0K12804g BUD20 Protein involved in bud-site selection; diploid mutants display a random budding pattern instead of the wild-type bipolar pattern 1,266936909
CAGL0I09350g REI1 Cytoplasmic pre-60S factor; required for the correct recycling of shuttling factors Alb1, Arx1 and Tif6 at the end of the
ribosomal large subunit biogenesis; involved in bud growth in the mitotic signaling network 1,075661574
99
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Cell
Cycle
CAGL0L12144g RAX2 N-glycosylated protein involved in the maintenance of bud site selection during bipolar budding; localization requires
Rax1p; RAX2 mRNA stability is regulated by Mpt5p 0,99182008
CAGL0E02233g PCL1 Cyclin, interacts with cyclin-dependent kinase Pho85p; member of the Pcl1,2-like subfamily, involved in the regulation of polarized growth and morphogenesis and progression through the cell cycle; localizes to sites of polarized cell growth
0,980571724
CAGL0A03828g RAX1 Protein involved in bud site selection during bipolar budding; localization requires Rax2p; has similarity to members of
the insulin-related peptide superfamily 0,977142317
CAGL0M07678g BUD22 Protein involved in bud-site selection; diploid mutants display a random budding pattern instead of the wild-type bipolar
pattern 0,857969062
CAGL0L08294g AXL2 Integral plasma membrane protein required for axial budding in haploid cells, localizes to the incipient bud site and bud
neck; glycosylated by Pmt4p; potential Cdc28p substrate 0,845295176
CAGL0M08888g SNM1 Subunit of RNase MRP, which cleaves pre-rRNA and has a role in cell cycle-regulated degradation of daughter cell-
specific mRNAs; binds to the NME1 RNA subunit of RNase MRP 0,809577106
Pro
tein
D
egra
datio
n CAGL0J00473g CIC1
Essential protein that interacts with proteasome components and has a potential role in proteasome substrate specificity; also copurifies with 66S pre-ribosomal particles
1,524957308
CAGL0J11352g UBP10 Ubiquitin-specific protease that deubiquitinates ubiquitin-protein moieties; may regulate silencing by acting on Sir4p; involved in posttranscriptionally regulating Gap1p and possibly other transporters; primarily located in the nucleus
1,223997548
CAGL0K09460g PNO1 Essential nucleolar protein required for pre-18S rRNA processing, interacts with Dim1p, an 18S rRNA
dimethyltransferase, and also with Nob1p, which is involved in proteasome biogenesis; contains a KH domain 1,225788356
Pro
tein
F
old
ing
CAGL0J06006g GIM3 Subunit of the heterohexameric cochaperone prefoldin complex which binds specifically to cytosolic chaperonin and
transfers target proteins to it 1,241579009
CAGL0G08272g CCT6 Subunit of the cytosolic chaperonin Cct ring complex, related to Tcp1p, essential protein that is required for the assembly
of actin and tubulins in vivo; contains an ATP-binding motif 0,881744473
CAGL0K12848g SEC53 Phosphomannomutase, involved in synthesis of GDP-mannose and dolichol-phosphate-mannose; required for folding
and glycosylation of secretory proteins in the ER lumen 0,815185296
Tra
nsport
CAGL0F04499g FUI1 High affinity uridine permease, localizes to the plasma membrane; also mediates low but significant transport of the
cytotoxic nucleoside analog 5-fluorouridine; not involved in uracil transport 1,691609322
CAGL0L02871g NOC2 Protein that forms a nucleolar complex with Mak21p that binds to 90S and 66S pre-ribosomes, as well as a nuclear complex with Noc3p that binds to 66S pre-ribosomes; both complexes mediate intranuclear transport of ribosomal
precursors 1,437073878
CAGL0I04730g HMT1 Nuclear SAM-dependent mono- and asymmetric arginine dimethylating methyltransferase that modifies hnRNPs,
including Npl3p and Hrp1p, thus facilitating nuclear export of these proteins; also methylates ribosomal protein Rps2p 1,396728443
CAGL0B04433g FUR4 Uracil permease, localized to the plasma membrane; expression is tightly regulated by uracil levels and environmental
cues 1,192903695
CAGL0D04834g TOM5 Component of the TOM (translocase of outer membrane) complex responsible for recognition and initial import of all mitochondrially directed proteins; involved in transfer of precursors from the Tom70p and Tom20p receptors to the
Tom40p pore 1,182139962
CAGL0E01617g ALR1 Plasma membrane Mg(2+) transporter, expression and turnover are regulated by Mg(2+) concentration; overexpression
confers increased tolerance to Al(3+) and Ga(3+) ions 1,207864792
100
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Tra
nsport
CAGL0L00671g FCY2 Purine-cytosine permease, mediates purine (adenine, guanine, and hypoxanthine) and cytosine accumulation 1,121859257
CAGL0F06693g TIM10 Essential protein of the mitochondrial intermembrane space, forms a complex with Tim9p (TIM10 complex) that delivers
hydrophobic proteins to the TIM22 complex for insertion into the inner membrane 0,996476694
CAGL0M11104g SSS1 Subunit of the Sec61p translocation complex (Sec61p-Sss1p-Sbh1p) that forms a channel for passage of secretory
proteins through the endoplasmic reticulum membrane, and of the Ssh1p complex (Ssh1p-Sbh2p-Sss1p); interacts with Ost4p and Wbp1p
0,86224518
CAGL0G04521g PAM16 Constituent of the import motor (PAM complex) component of the Translocase of the Inner Mitochondrial membrane
(TIM23 complex); forms a 1:1 subcomplex with Pam18p and inhibits its cochaperone activity; contains a J-like domain 0,889872977
CAGL0E01199g ENT5 Protein containing an N-terminal epsin-like domain involved in clathrin recruitment and traffic between the Golgi and
endosomes; associates with the clathrin adaptor Gga2p, clathrin adaptor complex AP-1, and clathrin 0,854721102
CAGL0K12034g ENA1 P-type ATPase sodium pump, involved in Na+ and Li+ efflux to allow salt tolerance 0,813481057
CAGL0A03212g ATO3 Plasma membrane protein, regulation pattern suggests a possible role in export of ammonia from the cell;
phosphorylated in mitochondria; member of the TC 9,B,33 YaaH family of putative transporters 0,825474447
CAGL0G07881g VMA21 Integral membrane protein that is required for vacuolar H+-ATPase (V-ATPase) function, although not an actual
component of the V-ATPase complex; functions in the assembly of the V-ATPase; localized to the yeast endoplasmic reticulum (ER)
0,801635405
CAGL0H00847g HUT1 Protein with a role in UDP-galactose transport to the Golgi lumen, has similarity to human UDP-galactose transporter
UGTrel1, exhibits a genetic interaction with S, cerevisiae ERO1 0,768048691
RN
A p
rocessin
g
CAGL0J09746g TRM8 Subunit of a tRNA methyltransferase complex composed of Trm8p and Trm82p that catalyzes 7-methylguanosine
modification of tRNA 1,38589261
CAGL0E00979g TRM82 Subunit of a tRNA methyltransferase complex composed of Trm8p and Trm82p that catalyzes 7-methylguanosine
modification of tRNA 1,432510621
CAGL0K01991g NCL1 S-adenosyl-L-methionine-dependent tRNA: m5C-methyltransferase, methylates cytosine to m5C at several positions in
tRNAs and intron-containing pre-tRNAs; similar to Nop2p and human proliferation associated nucleolar protein p120 1,336059225
CAGL0E06050g CTL1 RNA 5'-triphosphatase, localizes to both the nucleus and cytoplasm 1,211024649
CAGL0E05676g TYW1 Protein required for the synthesis of wybutosine, a modified guanosine found at the 3'-position adjacent to the anticodon
of phenylalanine tRNA which supports reading frame maintenance by stabilizing codon-anticodon interactions 1,128027621
CAGL0L04928g NUP100 Subunit of the nuclear pore complex (NPC) that is localized to both sides of the pore; contains a repetitive GLFG motif
that interacts with mRNA export factor Mex67p and with karyopherin Kap95p; homologous to Nup116p 1,197892391
CAGL0E05764g PUS1 tRNA:pseudouridine synthase, introduces pseudouridines at positions 26-28, 34-36, 65, and 67 of tRNA; nuclear protein
that appears to be involved in tRNA export; also acts on U2 snRNA 1,180097811
CAGL0J07458g CSL4 Exosome non-catalytic core component; involved in 3'-5' RNA processing and degradation in both the nucleus and the
cytoplasm; predicted to contain an S1 RNA binding domain; has similarity to human hCsl4p (EXOSC1) 1,145865315
CAGL0J09460g AIR1 Zinc knuckle protein, involved in nuclear RNA processing and degradation as a component of the TRAMP complex;
stimulates the poly(A) polymerase activity of Pap2p in vitro; functionally redundant with Air2p 1,104287056
CAGL0L05566g GCD14 Subunit of tRNA (1-methyladenosine) methyltransferase, with Gcd10p, required for the modification of the adenine at
position 58 in tRNAs, especially tRNAi-Met; first identified as a negative regulator of GCN4 expression 1,084337508
101
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
RN
A p
rocessin
g
CAGL0E02585g RRP6 Nuclear exosome exonuclease component; has 3'-5' exonuclease activity; involved in RNA processing, maturation,
surveillance, degradation, tethering, and export; has similarity to E, coli RNase D and to human PM-Sc1 100 (EXOSC10) 1,04822152
CAGL0I03234g SNU13 RNA binding protein, part of U3 snoRNP involved in rRNA processing, part of U4/U6-U5 tri-snRNP involved in mRNA
splicing, similar to human 15,5K protein 1,080591488
CAGL0H07183g TRM5 tRNA(m(1)G37)methyltransferase, methylates a tRNA base adjacent to the anticodon that has a role in prevention of
frameshifting; highly conserved across Archaea, Bacteria, and Eukarya 1,062618766
CAGL0J09614g NHP2 Nuclear protein related to mammalian high mobility group (HMG) proteins, essential for function of H/ACA-type
snoRNPs, which are involved in 18S rRNA processing 1,070620908
CAGL0F03289g LRP1 Nuclear exosome-associated nucleic acid binding protein; involved in RNA processing, surveillance, degradation, tethering, and export; homolog of mammalian nuclear matrix protein C1D involved in regulation of DNA repair and
recombination 1,064695306
CAGL0A03051g LSM6 Lsm (Like Sm) protein; part of heteroheptameric complexes (Lsm2p-7p and either Lsm1p or 8p): cytoplasmic Lsm1p
complex involved in mRNA decay; nuclear Lsm8p complex part of U6 snRNP and possibly involved in processing tRNA, snoRNA, and rRNA
0,95520959
CAGL0H07205g RRP4 Exosome non-catalytic core component; involved in 3'-5' RNA processing and degradation in both the nucleus and the
cytoplasm; predicted to contain RNA binding domains; has similarity to human hRrp4p (EXOSC2) 0,896232212
CAGL0H07865g MTO1 Mitochondrial protein, forms a heterodimer complex with Mss1p that performs the 5-carboxymethylaminomethyl
modification of the wobble uridine base in mitochondrial tRNAs; required for respiration in paromomycin-resistant 15S rRNA mutants
0,948101761
CAGL0K05049g POP1 Subunit of both RNase MRP, which cleaves pre-rRNA, and nuclear RNase P, which cleaves tRNA precursors to
generate mature 5' ends; binds to the RPR1 RNA subunit in RNase P 0,901139044
CAGL0L12386g SUV3 ATP-dependent RNA helicase, component of the mitochondrial degradosome along with the RNase Dss1p; the
degradosome associates with the ribosome and mediates turnover of aberrant or unprocessed RNAs 0,8786405
CAGL0M03619g PUS4 Pseudouridine synthase, catalyzes only the formation of pseudouridine-55 (Psi55), a highly conserved tRNA
modification, in mitochondrial and cytoplasmic tRNAs; PUS4 overexpression leads to translational derepression of GCN4 (Gcd- phenotype)
0,82120679
CAGL0F04961g SMD2 Core Sm protein Sm D2; part of heteroheptameric complex (with Smb1p, Smd1p, Smd3p, Sme1p, Smx3p, and Smx2p)
that is part of the spliceosomal U1, U2, U4, and U5 snRNPs; homolog of human Sm D2 0,818019011
CAGL0J00275g RRP45 Exosome non-catalytic core component; involved in 3'-5' RNA processing and degradation in both the nucleus and the
cytoplasm; has similarity to E, coli RNase PH and to human hRrp45p (PM/SCL-75, EXOSC9) 0,804689805
CAGL0L12408g TRM44 tRNA(Ser) Um(44) 2'-O-methyltransferase; involved in maintaining levels of the tRNA-Ser species tS(CGA) and tS(UGA); conserved among metazoans and fungi but there does not appear to be a homolog in plants; TRM44 is a non-essential
gene 0,789375404
Transcription
CAGL0L02849g RET1 Second-largest subunit of RNA polymerase III, which is responsible for the transcription of tRNA and 5S RNA genes, and
other low molecular weight RNAs 0,971492974
CAGL0L02799g RPB10 RNA polymerase subunit ABC10-beta, common to RNA polymerases I, II, and III 0,988112964
CAGL0L03025g RPC37 RNA polymerase III subunit C37 0,878271808
102
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Tra
nscriptio
n
CAGL0M11286g MTF1 Mitochondrial RNA polymerase specificity factor with structural similarity to S-adenosylmethionine-dependent
methyltransferases and functional similarity to bacterial sigma-factors, interacts with mitochondrial core polymerase Rpo41p
0,900773219
CAGL0L07062g ASM4 Nuclear pore complex subunit, part of a subcomplex also containing Nup53p, Nup170p, and Pse1p 0,856927172
CAGL0E05478g RPA43 RNA polymerase I subunit A43 1,956760834
CAGL0L03872g RPC19 RNA polymerase subunit, common to RNA polymerases I and III 1,747845929
CAGL0F00561g RPA12 RNA polymerase I subunit A12,2; contains two zinc binding domains, and the N terminal domain is responsible for
anchoring to the RNA pol I complex 1,735626955
CAGL0I07799g RPB5 RNA polymerase subunit ABC27, common to RNA polymerases I, II, and III; contacts DNA and affects transactivation 1,556256328
CAGL0E05500g RPA190 RNA polymerase I subunit; largest subunit of RNA polymerase I 1,415619937
CAGL0J04070g RPB8 RNA polymerase subunit ABC14,5, common to RNA polymerases I, II, and III 1,379698542
CAGL0G05874g RPC10 RNA polymerase subunit, found in RNA polymerase complexes I, II, and III 1,451076126
CAGL0G06974g RPC17 RNA polymerase III subunit C17; physically interacts with C31, C11, and TFIIIB70; may be involved in the recruitment of
pol III by the preinitiation complex 1,362665884
CAGL0G10043g RPO26 RNA polymerase subunit ABC23, common to RNA polymerases I, II, and III; part of central core; similar to bacterial
omega subunit 1,244008219
CAGL0B04125g RPC40 RNA polymerase subunit, common to RNA polymerase I and III 1,242482496
CAGL0I03630g RPC53 RNA polymerase III subunit C53 1,23084261
CAGL0J07766g RPA49 RNA polymerase I subunit A49 1,27804906
CAGL0J05698g RPC31 RNA polymerase III subunit C31; contains HMG-like C-terminal domain 1,106137928
CAGL0H08415g RPC11 RNA polymerase III subunit C11; mediates pol III RNA cleavage activity and is important for termination of transcription;
homologous to TFIIS 1,049049051
CAGL0G10109g RPC82 RNA polymerase III subunit C82 1,052636798
CAGL0E01155g RPA14 RNA polymerase I subunit A14 1,065605707
Ribosome Biogenesis
CAGL0M05775g NIP7 Nucleolar protein required for 60S ribosome subunit biogenesis, constituent of 66S pre-ribosomal particles; physically
interacts with Nop8p and the exosome subunit Rrp43p 1,65279119
CAGL0M03905g KRI1 Essential nucleolar protein required for 40S ribosome biogenesis; physically and functionally interacts with Krr1p 1,528747909
CAGL0L06886g RPL13A Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl13Bp; not essential for viability; has
similarity to rat L13 ribosomal protein 0,876290139
CAGL0G07535g RRS1 Essential protein that binds ribosomal protein L11 and is required for nuclear export of the 60S pre-ribosomal subunit
during ribosome biogenesis; mouse homolog shows altered expression in Huntington's disease model mice 1,649799151
103
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Rib
osom
e B
iogenesis
CAGL0D03124g DRS1 Nucleolar DEAD-box protein required for ribosome assembly and function, including synthesis of 60S ribosomal
subunits; constituent of 66S pre-ribosomal particles 1,606352441
CAGL0E02343g RCL1 Subunit of U3-containing 90S preribosome processome complex involved in 18S rRNA biogenesis and small ribosomal subunit assembly; stimulates Bms1p GTPase and U3 binding activity; similar to RNA cyclase-like proteins but no activity
detected 1,386813746
CAGL0E02673g UTP23 Essential nucleolar protein that is a component of the SSU (small subunit) processome involved in 40S ribosomal subunit biogenesis; has homology to PINc domain protein Fcf1p, although the PINc domain of Utp23p is not required for function
1,532045933
CAGL0E02013g RPL18A Protein component of the large (60S) ribosomal subunit, identical to Rpl18Bp and has similarity to rat L18 ribosomal
protein; intron of RPL18A pre-mRNA forms stem-loop structures that are a target for Rnt1p cleavage leading to degradation
0,887373575
CAGL0I03608g SAS10 Essential subunit of U3-containing Small Subunit (SSU) processome complex involved in production of 18S rRNA and
assembly of small ribosomal subunit; disrupts silencing when overproduced 1,605906139
CAGL0H06985g UTP14 Subunit of U3-containing Small Subunit (SSU) processome complex involved in production of 18S rRNA and assembly of
small ribosomal subunit 1,528122668
CAGL0G07843g NOP7 Component of several different pre-ribosomal particles; forms a complex with Ytm1p and Erb1p that is required for
maturation of the large ribosomal subunit; required for exit from G<sub>0</sub> and the initiation of cell proliferation 1,500314227
CAGL0K11748g RPS11A Protein component of the small (40S) ribosomal subunit; identical to Rps11Bp and has similarity to E, coli S17 and rat
S11 ribosomal proteins 0,829164953
CAGL0F04983g DBP9 ATP-dependent RNA helicase of the DEAD-box family involved in biogenesis of the 60S ribosomal subunit 1,386258147
CAGL0B00484g SPB1 AdoMet-dependent methyltransferase involved in rRNA processing and 60S ribosomal subunit maturation; methylates G2922 in the tRNA docking site of the large subunit rRNA and in the absence of snR52, U2921; suppressor of PAB1
mutants 1,517093812
CAGL0H02079g RPF1 Nucleolar protein involved in the assembly and export of the large ribosomal subunit; constituent of 66S pre-ribosomal
particles; contains a sigma(70)-like motif, which is thought to bind RNA 1,429325303
CAGL0G05027g RPS13 Protein component of the small (40S) ribosomal subunit; has similarity to E, coli S15 and rat S13 ribosomal proteins 0,807422056
CAGL0H03773g RLP7 Nucleolar protein with similarity to large ribosomal subunit L7 proteins; constituent of 66S pre-ribosomal particles; plays
an essential role in processing of precursors to the large ribosomal subunit RNAs 1,305088352
CAGL0G05742g NOP6 Putative RNA-binding protein implicated in ribosome biogenesis; contains an RNA recognition motif (RRM) and has
similarity to hydrophilins; NOP6 may be a fungal-specific gene as no homologs have been yet identified in higher eukaryotes
1,325497999
CAGL0L05500g ALB1 Shuttling pre-60S factor; involved in the biogenesis of ribosomal large subunit; interacts directly with Arx1p; responsible
for Tif6p recycling defects in absence of Rei1p 1,454288498
CAGL0L12672g NOP4 Nucleolar protein, essential for processing and maturation of 27S pre-rRNA and large ribosomal subunit biogenesis;
constituent of 66S pre-ribosomal particles; contains four RNA recognition motifs (RRMs) 1,429131629
CAGL0F09031g RPS4B Protein component of the small (40S) ribosomal subunit; identical to Rps4Ap and has similarity to rat S4 ribosomal
protein 0,947366463
CAGL0K02123g RPS26B Protein component of the small (40S) ribosomal subunit; nearly identical to Rps26Ap and has similarity to rat S26
ribosomal protein 0,893909459
104
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Rib
osom
e B
iogenesis
CAGL0L04950g ERB1 Constituent of 66S pre-ribosomal particles, forms a complex with Nop7p and Ytm1p that is required for maturation of the large ribosomal subunit; required for maturation of the 25S and 5,8S ribosomal RNAs; homologous to mammalian Bop1
1,44253037
CAGL0K04587g RPS22B Protein component of the small (40S) ribosomal subunit; nearly identical to Rps22Ap and has similarity to E, coli S8 and
rat S15a ribosomal proteins 0,873322304
CAGL0J00165g RPS25A Protein component of the small (40S) ribosomal subunit; nearly identical to Rps25Bp and has similarity to rat S25
ribosomal protein 0,892672402
CAGL0M11154g MAK21 Constituent of 66S pre-ribosomal particles, required for large (60S) ribosomal subunit biogenesis; involved in nuclear
export of pre-ribosomes; required for maintenance of dsRNA virus; homolog of human CAATT-binding protein 1,420534015
CAGL0C01639g ENP1 Protein associated with U3 and U14 snoRNAs, required for pre-rRNA processing and 40S ribosomal subunit synthesis;
localized in the nucleus and concentrated in the nucleolus 1,376796188
CAGL0I07931g REX4 Putative RNA exonuclease possibly involved in pre-rRNA processing and ribosome assembly 1,365832263
CAGL0J02222g NOP16 Constituent of 66S pre-ribosomal particles, involved in 60S ribosomal subunit biogenesis 1,377837521
CAGL0G02475g RPL40B Fusion protein, identical to Rpl40Ap, that is cleaved to yield ubiquitin and a ribosomal protein of the large (60S) ribosomal
subunit with similarity to rat L40; ubiquitin may facilitate assembly of the ribosomal protein into ribosomes 0,907120906
CAGL0G00264g PXR1 Essential protein involved in rRNA and snoRNA maturation; competes with TLC1 RNA for binding to Est2p, suggesting a
role in negative regulation of telomerase; human homolog inhibits telomerase; contains a G-patch RNA interacting domain
1,323200966
CAGL0B01203g RPL37A Protein component of the large (60S) ribosomal subunit, has similarity to Rpl37Bp and to rat L37 ribosomal protein 0,918086388
CAGL0M03861g RPL25 Primary rRNA-binding ribosomal protein component of the large (60S) ribosomal subunit, has similarity to E, coli L23 and
rat L23a ribosomal proteins; binds to 26S rRNA via a conserved C-terminal motif 0,951856432
CAGL0K02211g LCP5 Essential protein involved in maturation of 18S rRNA; depletion leads to inhibited pre-rRNA processing and reduced
polysome levels; localizes primarily to the nucleolus 1,166545562
CAGL0G02409g SRP40 Nucleolar, serine-rich protein with a role in preribosome assembly or transport; may function as a chaperone of small
nucleolar ribonucleoprotein particles (snoRNPs); immunologically and structurally to rat Nopp140 1,333821351
CAGL0J00957g RLP24 Essential protein with similarity to Rpl24Ap and Rpl24Bp, associated with pre-60S ribosomal subunits and required for
ribosomal large subunit biogenesis 1,324821023
CAGL0J10164g RPL16B N-terminally acetylated protein component of the large (60S) ribosomal subunit, binds to 5,8 S rRNA; has similarity to
Rpl16Ap, E, coli L13 and rat L13a ribosomal proteins; transcriptionally regulated by Rap1p 0,993861921
CAGL0I02398g NMD3 Protein involved in nuclear export of the large ribosomal subunit; acts as a Crm1p-dependent adapter protein for export
of nascent ribosomal subunits through the nuclear pore complex 1,305949855
CAGL0K02497g TIF6 Constituent of 66S pre-ribosomal particles, has similarity to human translation initiation factor 6 (eIF6); may be involved
in the biogenesis and or stability of 60S ribosomal subunits 1,311331562
CAGL0M02849g RPS0B Protein component of the small (40S) ribosomal subunit, nearly identical to Rps0Ap; required for maturation of 18S rRNA
along with Rps0Ap; deletion of either RPS0 gene reduces growth rate, deletion of both genes is lethal 1,19190498
CAGL0M01056g FCF1 Putative PINc domain nuclease required for early cleavages of 35S pre-rRNA and maturation of 18S rRNA; component
of the SSU (small subunit) processome involved in 40S ribosomal subunit biogenesis; copurifies with Faf1p 1,196104378
CAGL0F07645g UTP11 Subunit of U3-containing Small Subunit (SSU) processome complex involved in production of 18S rRNA and assembly of
small ribosomal subunit 1,072059755
105
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Rib
osom
e B
iogenesis
CAGL0F06853g MAK11 Protein involved in an early, nucleolar step of 60S ribosomal subunit biogenesis; essential for cell growth and replication
of killer M1 dsRNA virus; contains four beta-transducin repeats 1,222273016
CAGL0K05555g BUD21 Component of small ribosomal subunit (SSU) processosome that contains U3 snoRNA; originally isolated as bud-site
selection mutant that displays a random budding pattern 1,147226001
CAGL0D05588g SOF1 Essential protein required for biogenesis of 40S (small) ribosomal subunit; has similarity to the beta subunit of trimeric G-
proteins and the splicing factor Prp4p 1,107757775
CAGL0G06248g MAK16 Essential nuclear protein, constituent of 66S pre-ribosomal particles; required for maturation of 25S and 5,8S rRNAs;
required for maintenance of M1 satellite double-stranded RNA of the L-A virus 1,200788782
CAGL0C00715g RSA3 Protein with a likely role in ribosomal maturation, required for accumulation of wild-type levels of large (60S) ribosomal
subunits; binds to the helicase Dbp6p in pre-60S ribosomal particles in the nucleolus 1,191353315
CAGL0L05170g RRP14 Essential protein, constituent of 66S pre-ribosomal particles; interacts with proteins involved in ribosomal biogenesis and
cell polarity; member of the SURF-6 family 1,189450103
CAGL0M06303g RPS6B Protein component of the small (40S) ribosomal subunit; identical to Rps6Ap and has similarity to rat S6 ribosomal
protein 1,242809309
CAGL0B01397g NOP8 Nucleolar protein required for 60S ribosomal subunit biogenesis 1,167138465
CAGL0H05643g RPS6A Protein component of the small (40S) ribosomal subunit; identical to Rps6Bp and has similarity to rat S6 ribosomal
protein 1,136029373
CAGL0M01210g IPI1 Essential component of the Rix1 complex (with Rix1p and Ipi3p) that is required for processing of ITS2 sequences from
35S pre-rRNA; Rix1 complex associates with Mdn1p in pre-60S ribosomal particles 1,205763661
CAGL0E03245g NSR1 Nucleolar protein that binds nuclear localization sequences, required for pre-rRNA processing and ribosome biogenesis 1,184005205
CAGL0G07975g DBP6 Essential protein involved in ribosome biogenesis; putative ATP-dependent RNA helicase of the DEAD-box protein family 1,162658672
CAGL0H05709g NOG1 Putative GTPase that associates with free 60S ribosomal subunits in the nucleolus and is required for 60S ribosomal
subunit biogenesis; constituent of 66S pre-ribosomal particles; member of the ODN family of nucleolar G-proteins 1,185770803
CAGL0M02409g NOP53 Nucleolar protein; involved in biogenesis of the 60S subunit of the ribosome; interacts with rRNA processing factors
Cbf5p and Nop2p; null mutant is viable but growth is severely impaired 1,018716729
CAGL0M00814g RPS1A Ribosomal protein 10 (rp10) of the small (40S) subunit; nearly identical to Rps1Bp and has similarity to rat S3a ribosomal
protein 0,988199462
CAGL0K06149g RPS17B Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Ap and has similarity to rat S17
ribosomal protein 1,040818193
CAGL0L06314g ARX1 Shuttling pre-60S factor; involved in the biogenesis of ribosomal large subunit biogenesis; interacts directly with Alb1;
responsible for Tif6 recycling defects in absence of Rei1; associated with the ribosomal export complex 1,117431068
CAGL0A03278g RPL19A Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl19Bp and has similarity to rat L19
ribosomal protein; rpl19a and rpl19b single null mutations result in slow growth, while the double null mutation is lethal 1,108725465
CAGL0L04510g RPS28A Protein component of the small (40S) ribosomal subunit; nearly identical to Rps28Bp and has similarity to rat S28
ribosomal protein 1,04976894
CAGL0I10670g NOC4 Nucleolar protein, forms a complex with Nop14p that mediates maturation and nuclear export of 40S ribosomal subunits 1,060713793
CAGL0F07403g NSA1 Constituent of 66S pre-ribosomal particles, involved in 60S ribosomal subunit biogenesis 0,957006678
106
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Rib
osom
e B
iogenesis
CAGL0L08110g RPL39 Protein component of the large (60S) ribosomal subunit, has similarity to rat L39 ribosomal protein; required for ribosome
biogenesis; loss of both Rpl31p and Rpl39p confers lethality; also exhibits genetic interactions with SIS1 and PAB1 1,032210909
CAGL0I01826g IMP3 Component of the SSU processome, which is required for pre-18S rRNA processing, essential protein that interacts with
Mpp10p and mediates interactions of Imp4p and Mpp10p with U3 snoRNA 0,9755517
CAGL0J11066g NOC3 Protein that forms a nuclear complex with Noc2p that binds to 66S ribosomal precursors to mediate their intranuclear
transport; also binds to chromatin to promote the association of DNA replication factors and replication initiation 1,0656121
CAGL0K01089g SLX9 Protein required for pre-rRNA processing; associated with the 90S pre-ribosome and 43S small ribosomal subunit
precursor; interacts with U3 snoRNA; deletion mutant has synthetic fitness defect with an sgs1 deletion mutant 0,962329109
CAGL0B00880g RRP7 Essential protein involved in rRNA processing and ribosome biogenesis 1,033575135
CAGL0F06523g DHR2 Predominantly nucleolar DEAH-box ATP-dependent RNA helicase, required for 18S rRNA synthesis 0,995216459
CAGL0A03652g MAK5 Essential nucleolar protein, putative DEAD-box RNA helicase required for maintenance of M1 dsRNA virus; involved in
biogenesis of large (60S) ribosomal subunits 0,950837438
CAGL0J11154g NOP13 Nucleolar protein found in preribosomal complexes; contains an RNA recognition motif (RRM) 0,96695343
CAGL0M01430g UTP4 Subunit of U3-containing 90S preribosome and Small Subunit (SSU) processome complexes involved in production of 18S rRNA and assembly of small ribosomal subunit; member of t-Utp subcomplex involved with transcription of 35S
rRNA transcript 0,927753897
CAGL0K02387g ROK1 ATP-dependent RNA helicase of the DEAD box family; required for 18S rRNA synthesis 0,889337708
CAGL0H03377g DBP3 Putative ATP-dependent RNA helicase of the DEAD-box family involved in ribosomal biogenesis 0,917102851
CAGL0L09669g URB1 Nucleolar protein required for the normal accumulation of 25S and 5,8S rRNAs, associated with the 27SA2 pre-ribosomal
particle; proposed to be involved in the biogenesis of the 60S ribosomal subunit 0,842331775
CAGL0I02354g DBP8 ATPase, putative RNA helicase of the DEAD-box family; component of 90S preribosome complex involved in production
of 18S rRNA and assembly of 40S small ribosomal subunit; ATPase activity stimulated by association with Esp2p 0,810511634
CAGL0A04521g RPS8A Protein component of the small (40S) ribosomal subunit; identical to Rps8Bp and has similarity to rat S8 ribosomal
protein 0,982677978
CAGL0G06490g RPS7B Protein component of the small (40S) ribosomal subunit, nearly identical to Rps7Ap; interacts with Kti11p; deletion
causes hypersensitivity to zymocin; has similarity to rat S7 and Xenopus S8 ribosomal proteins 0,803323341
CAGL0J09086g RPL35B Protein component of the large (60S) ribosomal subunit, identical to Rpl35Ap and has similarity to rat L35 ribosomal
protein 1,207147164
CAGL0M04873g RPS10A Protein component of the small (40S) ribosomal subunit; nearly identical to Rps10Bp and has similarity to rat ribosomal
protein S10 1,439383799
CAGL0J11220g RPS3 Protein component of the small (40S) ribosomal subunit, has apurinic/apyrimidinic (AP) endonuclease activity; essential
for viability; has similarity to E, coli S3 and rat S3 ribosomal proteins 1,346979649
CAGL0E04994g RPL9A Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl9Bp and has similarity to E, coli L6 and rat
L9 ribosomal proteins 1,230529024
CAGL0I07975g BRX1 Nucleolar protein, constituent of 66S pre-ribosomal particles; depletion leads to defects in rRNA processing and a block
in the assembly of large ribosomal subunits; possesses a sigma(70)-like RNA-binding motif 1,96454863
107
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Rib
osom
e B
iogenesis
CAGL0I09790g NOP58 Protein involved in pre-rRNA processing, 18S rRNA synthesis, and snoRNA synthesis; component of the small subunit
processome complex, which is required for processing of pre-18S rRNA 1,886385074
CAGL0B00352g KRR1 Essential nucleolar protein required for the synthesis of 18S rRNA and for the assembly of 40S ribosomal subunit 1,729504437
CAGL0K09284g PWP2 Conserved 90S pre-ribosomal component essential for proper endonucleolytic cleavage of the 35 S rRNA precursor at A0, A1, and A2 sites; contains eight WD-repeats; PWP2 deletion leads to defects in cell cycle and bud morphogenesis
1,767916309
CAGL0H02937g UTP18 Possible U3 snoRNP protein involved in maturation of pre-18S rRNA, based on computational analysis of large-scale
protein-protein interaction data 1,66881244
CAGL0D00880g TSR1 Protein required for processing of 20S pre-rRNA in the cytoplasm, associates with pre-40S ribosomal particles 1,664363219
CAGL0K06215g UTP6 Nucleolar protein, component of the small subunit (SSU) processome containing the U3 snoRNA that is involved in
processing of pre-18S rRNA 1,683715237
CAGL0L00341g EBP2 Essential protein required for the maturation of 25S rRNA and 60S ribosomal subunit assembly, localizes to the
nucleolus; constituent of 66S pre-ribosomal particles 1,700612779
CAGL0L10846g BUD23 Methyltransferase, methylates residue G1575 of 18S rRNA; required for rRNA processing and nuclear export of 40S
ribosomal subunits independently of methylation activity; diploid mutant displays random budding pattern 1,618175251
CAGL0H01419g BFR2 Essential protein that is a component of 90S preribosomes; may be involved in rRNA processing; multicopy suppressor
of sensitivity to Brefeldin A; expression is induced during lag phase and also by cold shock 1,56503833
CAGL0D04884g RRP9 Protein involved in pre-rRNA processing, associated with U3 snRNP; component of small ribosomal subunit (SSU)
processosome; ortholog of the human U3-55k protein 1,557735511
CAGL0L07678g DIM1 Essential 18S rRNA dimethylase (dimethyladenosine transferase), responsible for conserved m6(2)Am6(2)A
dimethylation in 3'-terminal loop of 18S rRNA, part of 90S and 40S pre-particles in nucleolus, involved in pre-ribosomal RNA processing
1,520948576
CAGL0J10890g SSF2 Protein required for ribosomal large subunit maturation, functionally redundant with Ssf1p; member of the Brix family 1,495033991
CAGL0H03685g CBF5 Pseudouridine synthase catalytic subunit of box H/ACA small nucleolar ribonucleoprotein particles (snoRNPs), acts on both large and small rRNAs and on snRNA U2; mutations in human ortholog dyskerin cause the disorder dyskeratosis
congenita 1,604761217
CAGL0A04015g NOP56 Essential evolutionarily-conserved nucleolar protein component of the box C/D snoRNP complexes that direct 2'-O-
methylation of pre-rRNA during its maturation; overexpression causes spindle orientation defects 1,427297852
CAGL0I10560g UTP8 Nucleolar protein required for export of tRNAs from the nucleus; also copurifies with the small subunit (SSU) processome
containing the U3 snoRNA that is involved in processing of pre-18S rRNA 1,398051989
CAGL0F02299g LOC1 Nuclear protein involved in asymmetric localization of ASH1 mRNA; binds double-stranded RNA in vitro; constituent of
66S pre-ribosomal particles 1,24641284
CAGL0L04114g NAF1 RNA-binding protein required for the assembly of box H/ACA snoRNPs and thus for pre-rRNA processing, forms a
complex with Shq1p and interacts with H/ACA snoRNP components Nhp2p and Cbf5p; similar to Gar1p 1,02586218
CAGL0J10912g RRP3 Protein involved in rRNA processing; required for maturation of the 35S primary transcript of pre-rRNA and for cleavage leading to mature 18S rRNA; homologous to eIF-4a, which is a DEAD box RNA-dependent ATPase with helicase activity
0,893315467
CAGL0F01023g NOP12 Nucleolar protein involved in pre-25S rRNA processing and biogenesis of large 60S ribosomal subunit; contains an RNA
recognition motif (RRM); binds to Ebp2; similar to Nop13p and Nsr1p 1,687009407
108
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Rib
osom
e B
iogenesis
CAGL0E02937g CGR1 Protein involved in nucleolar integrity and processing of the pre-rRNA for the 60S ribosome subunit; transcript is induced
in response to cytotoxic stress but not genotoxic stress 1,544021143
CAGL0K02233g NSA2 Protein constituent of 66S pre-ribosomal particles, contributes to processing of the 27S pre-rRNA 1,483759825
CAGL0H08019g RIO2 Essential serine kinase involved in the processing of the 20S pre-rRNA into mature 18S rRNA; has similarity to Rio1p 1,223696815
CAGL0D05874g MPP10 Component of the SSU processome and 90S preribosome, required for pre-18S rRNA processing, interacts with and
controls the stability of Imp3p and Imp4p, essential for viability; similar to human Mpp10p 1,371349652
CAGL0M07227g UTP9 Nucleolar protein, component of the small subunit (SSU) processome containing the U3 snoRNA that is involved in
processing of pre-18S rRNA 1,225762307
Tra
nsla
tio
n
CAGL0H04675g TIF35 eIF3g subunit of the core complex of translation initiation factor 3 (eIF3), which is essential for translation 1,152656474
CAGL0M10197g MRT4 Protein involved in mRNA turnover and ribosome assembly, localizes to the nucleolus 1,100196441
CAGL0M12122g RBG1 Member of the DRG family of GTP-binding proteins; associates with translating ribosomes; interacts with Tma46p,
Ygr250cp, Gir2p and Yap1p via two-hybrid 1,089252304
CAGL0F07073g RPS2 Protein component of the small (40S) subunit, essential for control of translational accuracy; phosphorylation by C-
terminal domain kinase I (CTDK-I) enhances translational accuracy; methylated on one or more arginine residues by Hmt1p
0,944959278
CAGL0F02937g RPL12B Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl12Ap; rpl12a rpl12b double mutant
exhibits slow growth and slow translation; has similarity to E, coli L11 and rat L12 ribosomal proteins 0,940507102
CAGL0C01419g MRN1 RNA-binding protein proposed to be involved in translational regulation; binds specific categories of mRNAs, including
those that contain upstream open reading frames (uORFs) and internal ribosome entry sites (IRES) 1,02276968
CAGL0E00781g SUP35 Translation termination factor eRF3; altered protein conformation creates the [PSI(+)] prion, a dominant cytoplasmically
inherited protein aggregate that alters translational fidelity and creates a nonsense suppressor phenotype 1,004977834
CAGL0H04691g MRPL39 Mitochondrial ribosomal protein of the large subunit 0,973469571
CAGL0L10978g CAF20 Phosphoprotein of the mRNA cap-binding complex involved in translational control, repressor of cap-dependent
translation initiation, competes with eIF4G for binding to eIF4E 0,895791751
CAGL0K08888g GCD1 Gamma subunit of the translation initiation factor eIF2B, the guanine-nucleotide exchange factor for eIF2; activity
subsequently regulated by phosphorylated eIF2; first identified as a negative regulator of GCN4 expression 0,966003035
CAGL0I02926g PUF6 Pumilio-homology domain protein that binds ASH1 mRNA at PUF consensus sequences in the 3' UTR and represses its
translation, resulting in proper asymmetric localization of ASH1 mRNA 0,945521308
CAGL0K01375g MRP10 Mitochondrial ribosomal protein of the small subunit; contains twin cysteine-x9-cysteine motifs 0,934892055
CAGL0J11330g MRPL19 Mitochondrial ribosomal protein of the large subunit 0,871497908
CAGL0L03003g GCN3 Alpha subunit of the translation initiation factor eIF2B, the guanine-nucleotide exchange factor for eIF2; activity
subsequently regulated by phosphorylated eIF2; first identified as a positive regulator of GCN4 expression 0,824475461
CAGL0B01793g YDR115W
Putative mitochondrial ribosomal protein of the large subunit, has similarity to E, coli L34 ribosomal protein; required for respiratory growth, as are most mitochondrial ribosomal proteins
0,82323373
CAGL0I02706g MRPL33 Mitochondrial ribosomal protein of the large subunit 0,835061048
109
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID Sc
Homologous Description
Posaconazole Resistance vs Susceptible
(log2 change)
Tra
nsla
tio
n
CAGL0M11236g MRPL44 Mitochondrial ribosomal protein of the large subunit 0,752330387
CAGL0J11220g RPS3 Protein component of the small (40S) ribosomal subunit, has apurinic/apyrimidinic (AP) endonuclease activity; essential
for viability; has similarity to E, coli S3 and rat S3 ribosomal proteins 1,346979649
CAGL0D02090g ASC1 G-protein beta subunit and guanine nucleotide dissociation inhibitor for Gpa2p; ortholog of RACK1 that inhibits
translation; core component of the small (40S) ribosomal subunit; represses Gcn4p in the absence of amino acid starvation
1,317767112
CAGL0E04994g RPL9A Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl9Bp and has similarity to E, coli L6 and rat
L9 ribosomal proteins 1,230529024
CAGL0L06754g SUP45 Polypeptide release factor (eRF1) in translation termination; mutant form acts as a recessive omnipotent suppressor;
methylated by Mtq2p-Trm112p in ternary complex eRF1-eRF3-GTP; mutation of methylation site confers resistance to zymocin
1,736625316
CAGL0B00792g SRO9 Cytoplasmic RNA-binding protein that associates with translating ribosomes; involved in heme regulation of Hap1p as a
component of the HMC complex, also involved in the organization of actin filaments; contains a La motif 1,478968168
Sig
nalin
g P
ath
way CAGL0I10010g BTN2
v-SNARE binding protein that facilitates specific protein retrieval from a late endosome to the Golgi; modulates arginine uptake, possible role in mediating pH homeostasis between the vacuole and plasma membrane H(+)-ATPase
1,234653335
CAGL0K00429g NPA3 Essential, conserved, cytoplasmic ATPase; phosphorylated by the Pcl1p-Pho85p kinase complex 1,055030321
CAGL0I05390g SKS1 Putative serine/threonine protein kinase; involved in the adaptation to low concentrations of glucose independent of the
SNF3 regulated pathway 1,075194845
CAGL0E05742g SRP72 Core component of the signal recognition particle (SRP) ribonucleoprotein (RNP) complex that functions in targeting
nascent secretory proteins to the endoplasmic reticulum (ER) membrane 0,947088945
CAGL0F08833g MSB2 Mucin family member involved in the Cdc42p- and MAP kinase-dependent filamentous growth signaling pathway; also
functions as an osmosensor in parallel to the Sho1p-mediated pathway; potential Cdc28p substrate 1,00097642
DN
A p
rocessin
g
CAGL0K11462g HTB1 Histone H2B, core histone protein required for chromatin assembly and chromosome function; nearly identical to HTB2;
Rad6p-Bre1p-Lge1p mediated ubiquitination regulates transcriptional activation, meiotic DSB formation and H3 methylation
2,301463423
CAGL0C04411g HTA2 Histone H2A, core histone protein required for chromatin assembly and chromosome function; one of two nearly identical
(see also HTA1) subtypes; DNA damage-dependent phosphorylation by Mec1p facilitates DNA repair; acetylated by Nat4p
2,131468761
CAGL0K11440g HTA1 Histone H2A, core histone protein required for chromatin assembly and chromosome function; one of two nearly identical
subtypes (see also HTA2); DNA damage-dependent phosphorylation by Mec1p facilitates DNA repair; acetylated by Nat4p
2,057704928
CAGL0H09834g HHF1 Histone H4, core histone protein required for chromatin assembly and chromosome function; one of two identical histone proteins (see also HHF2); contributes to telomeric silencing; N-terminal domain involved in maintaining genomic integrity
1,744647588
CAGL0M06677g HHF2 Histone H4, core histone protein required for chromatin assembly and chromosome function; one of two identical histone proteins (see also HHF1); contributes to telomeric silencing; N-terminal domain involved in maintaining genomic integrity
1,6747799
CAGL0M06655g HHT2 Histone H3, core histone protein required for chromatin assembly, part of heterochromatin-mediated telomeric and HM
silencing; one of two identical histone H3 proteins (see HHT1); regulated by acetylation, methylation, and phosphorylation
1,524169284
110
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
DN
A p
rocessin
g
CAGL0C04136g HHF1 Histone H4, core histone protein required for chromatin assembly and chromosome function; one of two identical histone proteins (see also HHF2); contributes to telomeric silencing; N-terminal domain involved in maintaining genomic integrity
1,524737938
CAGL0D01716g POL30 Proliferating cell nuclear antigen (PCNA), functions as the sliding clamp for DNA polymerase delta; may function as a
docking site for other proteins required for mitotic and meiotic chromosomal DNA replication and for DNA repair 1,453169286
CAGL0L09581g DUT1 dUTPase, catalyzes hydrolysis of dUTP to dUMP and PPi, thereby preventing incorporation of uracil into DNA during
replication; critical for the maintenance of genetic stability 1,393690548
CAGL0E01925g TRM11 Catalytic subunit of an adoMet-dependent tRNA methyltransferase complex (Trm11p-Trm112p), required for the
methylation of the guanosine nucleotide at position 10 (m2G10) in tRNAs; contains a THUMP domain and a methyltransferase domain
1,299546284
CAGL0C04114g HHT1 Histone H3, core histone protein required for chromatin assembly, part of heterochromatin-mediated telomeric and HM
silencing; one of two identical histone H3 proteins (see HHT2); regulated by acetylation, methylation, and phosphorylation
1,260617868
CAGL0F03927g GUA1 GMP synthase, an enzyme that catalyzes the second step in the biosynthesis of GMP from inosine 5'-phosphate (IMP);
transcription is not subject to regulation by guanine but is negatively regulated by nutrient starvation 1,259930492
CAGL0D00550g PRS1 5-phospho-ribosyl-1(alpha)-pyrophosphate synthetase, synthesizes PRPP, which is required for nucleotide, histidine,
and tryptophan biosynthesis; one of five related enzymes, which are active as heteromultimeric complexes 1,103323405
CAGL0C00759g IFH1 Essential protein with a highly acidic N-terminal domain; IFH1 exhibits genetic interactions with FHL1, overexpression
interferes with silencing at telomeres and HM loci; potential Cdc28p substrate 1,147960859
CAGL0H09856g HHT1 Histone H3, core histone protein required for chromatin assembly, part of heterochromatin-mediated telomeric and HM
silencing; one of two identical histone H3 proteins (see HHT2); regulated by acetylation, methylation, and phosphorylation
1,095009054
CAGL0F02563g HPT1 Dimeric hypoxanthine-guanine phosphoribosyltransferase, catalyzes the formation of both inosine monophosphate and guanosine monophosphate; mutations in the human homolog HPRT1 can cause Lesch-Nyhan syndrome and Kelley-
Seegmiller syndrome 1,060731105
CAGL0K00605g CDC6 Essential ATP-binding protein required for DNA replication, component of the pre-replicative complex (pre-RC) which
requires ORC to associate with chromatin and is in turn required for Mcm2-7p DNA association; homologous to S, pombe Cdc18p
1,09111302
CAGL0J01243g CTF13 Subunit of the CBF3 complex, which binds to the CDE III element of centromeres, bending the DNA upon binding, and
may be involved in sister chromatid cohesion during mitosis 0,93036433
CAGL0F01551g FYV7 Essential protein required for maturation of 18S rRNA; required for survival upon exposure to K1 killer toxin 1,088461998
CAGL0I00792g RPS16A Protein component of the small (40S) ribosomal subunit; identical to Rps16Bp and has similarity to E, coli S9 and rat S16
ribosomal proteins 1,076038638
CAGL0M11550g CDC45 DNA replication initiation factor; recruited to MCM pre-RC complexes at replication origins; promotes release of MCM from Mcm10p, recruits elongation machinery; mutants in human homolog may cause velocardiofacial and DiGeorge
syndromes 0,996558496
CAGL0K09746g EAF7 Subunit of the NuA4 histone acetyltransferase complex, which acetylates the N-terminal tails of histones H4 and H2A 1,022678331
CAGL0D05258g SMC2 Subunit of the condensin complex; essential SMC chromosomal ATPase family member that forms a complex with Smc4p to form the active ATPase; Smc2p/Smc4p complex binds DNA; required for clustering of tRNA genes at the
nucleolus 1,043395903
111
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
DN
A p
rocessin
g
CAGL0M09801g NNT1 Putative nicotinamide N-methyltransferase, has a role in rDNA silencing and in lifespan determination 0,902538125
CAGL0B01771g FOB1 Nucleolar protein that binds the rDNA replication fork barrier (RFB) site; required for replication fork blocking,
recombinational hotspot activity, condensin recruitment to RFB and rDNA repeat segregation; related to retroviral integrases
0,921118546
CAGL0J05984g AAH1 Adenine deaminase (adenine aminohydrolase), converts adenine to hypoxanthine; involved in purine salvage;
transcriptionally regulated by nutrient levels and growth phase; Aah1p degraded upon entry into quiescence via SCF and the proteasome
0,95343816
CAGL0J02640g RSC8 Component of the RSC chromatin remodeling complex; essential for viability and mitotic growth; homolog of SWI/SNF
subunit Swi3p, but unlike Swi3p, does not activate transcription of reporters 0,854571205
CAGL0E04576g DBF4 Regulatory subunit of Cdc7p-Dbf4p kinase complex, required for Cdc7p kinase activity and initiation of DNA replication;
phosphorylates the Mcm2-7 family of proteins; cell cycle regulated 0,892075938
CAGL0J06424g MCM6 Protein involved in DNA replication; component of the Mcm2-7 hexameric complex that binds chromatin as a part of the
pre-replicative complex 0,818517019
CAGL0M00638g FPR4 Peptidyl-prolyl cis-trans isomerase (PPIase) (proline isomerase) localized to the nucleus; catalyzes isomerization of
proline residues in histones H3 and H4, which affects lysine methylation of those histones 0,791735021
Tra
nscriptio
nal R
egula
tio
n
CAGL0I05764g NRM1 Transcriptional co-repressor of MBF (MCB binding factor)-regulated gene expression; Nrm1p associates stably with
promoters via MBF to repress transcription upon exit from G1 phase 1,556616724
CAGL0E05434g TEA1 Ty1 enhancer activator required for full levels of Ty enhancer-mediated transcription; C6 zinc cluster DNA-binding protein 1,300061004
CAGL0G10021g PZF1 Transcription factor IIIA (TFIIIA), essential protein with nine C2H2 Zn-fingers, binds the 5S rRNA gene through the zinc
finger domain and directs assembly of a multiprotein initiation complex for RNA polymerase III; also binds DNA 1,004455662
CAGL0D02002g CTK1 Catalytic (alpha) subunit of C-terminal domain kinase I (CTDK-I), which phosphorylates both RNA pol II subunit Rpo21p
to affect transcription and pre-mRNA 3' end processing, and ribosomal protein Rps2p to increase translational fidelity 1,017023368
CAGL0D00682g SFP1 Transcription factor that controls expression of ribosome biogenesis genes in response to nutrients and stress, regulates
G2/M transitions during mitotic cell cycle and DNA-damage response, modulates cell size; regulated by TORC1 and Mrs6p
0,955874247
CAGL0A01628g MIG1 Transcription factor involved in glucose repression; sequence specific DNA binding protein containing two Cys2His2 zinc
finger motifs; regulated by the SNF1 kinase and the GLC7 phosphatase 0,826608864
CAGL0G05379g GCR2 Transcriptional activator of genes involved in glycolysis; interacts and functions with the DNA-binding protein Gcr1p 0,811696633
CAGL0I10769g MCM1 Transcription factor involved in cell-type-specific transcription and pheromone response; plays a central role in the
formation of both repressor and activator complexes 0,828768635
CAGL0E03289g TIF4631 Translation initiation factor eIF4G, subunit of the mRNA cap-binding protein complex (eIF4F) that also contains eIF4E
(Cdc33p); associates with the poly(A)-binding protein Pab1p, also interacts with eIF4A (Tif1p); homologous to Tif4632p 0,800909998
Stress Adaptation
CAGL0F05709g ATC1 Nuclear protein, possibly involved in regulation of cation stress responses and/or in the establishment of bipolar budding
pattern 1,559873496
CAGL0M03949g ZIM17 Heat shock protein with a zinc finger motif; essential for protein import into mitochondria; may act with Pam18p to
facilitate recognition and folding of imported proteins by Ssc1p (mtHSP70) in the mitochondrial matrix 1,141212484
112
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Establisment of Cell Polarity
CAGL0G02387g PXL1 LIM domain-containing protein that localizes to sites of polarized growth, required for selection and/or maintenance of
polarized growth sites, may modulate signaling by the GTPases Cdc42p and Rho1p; has similarity to metazoan paxillin 0,989535285
Organelle Inheritance
CAGL0H04455g INP2 Peroxisome-specific receptor important for peroxisome inheritance; co-fractionates with peroxisome membranes and co-
localizes with peroxisomes in vivo; physically interacts with the myosin V motor Myo2p; INP2 is not an essential gene 1,075409479
CAGL0A04169g MMR1 Phosphorylated protein of the mitochondrial outer membrane, localizes only to mitochondria of the bud; interacts with Myo2p to mediate mitochondrial distribution to buds; mRNA is targeted to the bud via the transport system involving
She2p 0,915248854
Unkow
n F
unctio
n
CAGL0E03069g ENP2 Essential nucleolar protein of unknown function; contains WD repeats, interacts with Mpp10p and Bfr2p, and has
homology to Spb1p 1,725763179
CAGL0D05500g HGH1 Nonessential protein of unknown function; predicted to be involved in ribosome biogenesis; green fluorescent protein
(GFP)-fusion protein localizes to the cytoplasm; similar to mammalian BRP16 (Brain protein 16) 1,511263066
CAGL0D00220g ECM1 Protein of unknown function, localized in the nucleoplasm and the nucleolus, genetically interacts with MTR2 in 60S
ribosomal protein subunit export 1,560326978
CAGL0G04983g YLR363W-A Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the nucleus 1,437317084
CAGL0G00484g EFG1 - 1,330988507
CAGL0G01276g YNL050C Putative protein of unknown function; YNL050c is not an essential gene 1,308826654
CAGL0I06490g JIP5 Essential protein of unknown function; interacts with proteins involved in RNA processing, ribosome biogenesis,
ubiquitination and demethylation; tagged protein localizes to nucleus and nucleolus; similar to WDR55, a human WD repeat protein
1,385890358
CAGL0J00385g FSH1 Putative serine hydrolase that localizes to both the nucleus and cytoplasm; sequence is similar to S, cerevisiae Fsh2p
and Fsh3p and the human candidate tumor suppressor OVCA2 1,284312828
CAGL0G08778g RRT14 Putative protein of unknown function; identified in a screen for mutants with decreased levels of rDNA transcription;
green fluorescent protein (GFP)-fusion protein localizes to the nucleolus; predicted to be involved in ribosome biogenesis 1,287967508
CAGL0M13915g YMR310C
Putative protein of unknown function; predicted to be involved in ribosome biogenesis; green fluorescent protein (GFP)-fusion protein localizes to the nucleus; YMR310C is not an essential gene
1,206006094
CAGL0G04499g SET3 Protein of unknown function, contains a SET domain 1,252873255
Cgla_YGOB_Anc_7,246
- - 1,23272064
CAGL0H05973g YPL108W
Cytoplasmic protein of unknown function; non-essential gene that is induced in a GDH1 deleted strain with altered redox metabolism; GFP-fusion protein is induced in response to the DNA-damaging agent MMS
1,011904429
CAGL0G07018g YML018C
Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the membrane of the vacuole; physical interaction with Atg27p suggests a possible role in autophagy; YML018C is not an essential gene
1,045218511
CAGL0J11682g MIC17 Mitochondrial intermembrane space protein; contains twin cysteine-x9-cysteine motifs; MIC17 is not an essential gene 1,153041787
CAGL0G07667g PRY1 Protein of unknown function 1,105646778
113
Table S2 - Gene ID, S. cerevisiae homologous, description and posaconazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 21 days (continued).
Gene ID
Sc Homologous
Description
Posaconazole Resistance vs Susceptible
(log2 change)
Unkow
n F
unctio
n
CAGL0D02816g GRC3 Protein of unknown function, required for cell growth and possibly involved in rRNA processing; mRNA is cell cycle
regulated 0,954950222
CAGL0E02409g CSI2 Protein of unknown function; green fluorescent protein (GFP)- fusion protein localizes to the mother side of the bud neck
and the vacuole; YOL007C is not an essential gene 0,938865156
CAGL0M04719g RRP36 Putative protein of unknown function; may play a role in the ribosome and rRNA biosynthesis based on expression
profiles and mutant phenotype 0,931432617
CAGL0G05808g TDA7 Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the vacuole 1,000035642
Cgla_YGOB_K07414
- - 0,894225405
Cgla_YGOB_YDR374W-A
- Putative protein of unknown function 0,997597779
CAGL0L06424g CCW12 - 0,934352303
CAGL0I04328g YJL133C-A
Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in high-throughput studies
0,926271816
CAGL0E01221g GIR2 Highly-acidic cytoplasmic RWD domain-containing protein of unknown function; interacts with Rbg1p and Gcn1p;
associates with translating ribosomes; putative intrinsically unstructured protein 0,940765984
CAGL0F05115g INA1 Putative protein of unknown function; YLR413W is not an essential gene 0,882177103
Cgla_YGOB_YIL102C-A
- Putative protein of unknown function, identified based on comparisons of the genome sequences of six Saccharomyces
species 0,848747585
CAGL0E06644g FLO1 - 0,903604553
CAGL0K03751g DLT1 Protein of unknown function, mutant sensitive to 6-azauracil (6AU) and mycophenolic acid (MPA) 0,837189853
CAGL0G03069g DRN1 Putative protein of unconfirmed function; green fluorescent protein (GFP)-fusion protein localizes to the nucleus 0,839471393
114
Table S3 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 31 days.
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Energ
y a
nd C
arb
ohydra
te m
eta
bolis
m
CAGL0D00198g BDH1 NAD-dependent (R,R)-butanediol dehydrogenase, catalyzes oxidation of (R,R)-2,3-butanediol to (3R)-acetoin,
oxidation of meso-butanediol to (3S)-acetoin, and reduction of acetoin; enhances use of 2,3-butanediol as an aerobic carbon source
-0,91971811
CAGL0G02189g MTD1 NAD-dependent 5,10-methylenetetrahydrafolate dehydrogenase, plays a catalytic role in oxidation of cytoplasmic one-carbon units; expression is regulated by Bas1p and Bas2p, repressed by adenine, and may be induced by
inositol and choline -0,969573117
CAGL0H02695g GLG1 Self-glucosylating initiator of glycogen synthesis, also glucosylates n-dodecyl-beta-D-maltoside; similar to mammalian
glycogenin -0,943071118
CAGL0H06699g GUT2 Mitochondrial glycerol-3-phosphate dehydrogenase; expression is repressed by both glucose and cAMP and derepressed by non-fermentable carbon sources in a Snf1p, Rsf1p, Hap2/3/4/5 complex dependent manner
-1,069582515
CAGL0I07969g ATP19 Subunit k of the mitochondrial F1F0 ATP synthase, which is a large enzyme complex required for ATP synthesis;
associated only with the dimeric form of ATP synthase -1,005623683
CAGL0I01100g GCY1 Putative NADP(+) coupled glycerol dehydrogenase, proposed to be involved in an alternative pathway for glycerol
catabolism; member of the aldo-keto reductase (AKR) family -1,171631605
CAGL0K10736g CYB2 Cytochrome b2 (L-lactate cytochrome-c oxidoreductase), component of the mitochondrial intermembrane space,
required for lactate utilization; expression is repressed by glucose and anaerobic conditions -1,185050505
CAGL0F08261g ENO1 Enolase I, a phosphopyruvate hydratase that catalyzes the conversion of 2-phosphoglycerate to
phosphoenolpyruvate during glycolysis and the reverse reaction during gluconeogenesis; expression is repressed in response to glucose
-1,319435698
CAGL0K03421g PGM2 Phosphoglucomutase, catalyzes the conversion from glucose-1-phosphate to glucose-6-phosphate, which is a key
step in hexose metabolism; functions as the acceptor for a Glc-phosphotransferase -1,237437743
CAGL0H08327g TPI1 Triose phosphate isomerase, abundant glycolytic enzyme; mRNA half-life is regulated by iron availability;
transcription is controlled by activators Reb1p, Gcr1p, and Rap1p through binding sites in the 5' non-coding region -1,314417738
CAGL0H02491g COX7 Subunit VII of cytochrome c oxidase, which is the terminal member of the mitochondrial inner membrane electron
transport chain -1,520426202
CAGL0F08745g STF2 Protein involved in regulation of the mitochondrial F1F0-ATP synthase; Stf1p and Stf2p may act as stabilizing factors
that enhance inhibitory action of the Inh1p protein -2,054981536
Nitrogen Metabolism
CAGL0G09691g SER1 3-phosphoserine aminotransferase, catalyzes the formation of phosphoserine from 3-phosphohydroxypyruvate,
required for serine and glycine biosynthesis; regulated by the general control of amino acid biosynthesis mediated by Gcn4p
-1,163918685
CAGL0C01243g HIS5 Histidinol-phosphate aminotransferase, catalyzes the seventh step in histidine biosynthesis; responsive to general
control of amino acid biosynthesis; mutations cause histidine auxotrophy and sensitivity to Cu, Co, and Ni salts -1,331573672
Lipid Metabolism CAGL0I04620g CST26 Protein required for incorporation of stearic acid into phosphatidylinositol; affects chromosome stability when
overexpressed -1,035752709
Cytoskeleton CAGL0E04048g COF1 Cofilin, promotes actin filament depolarization in a pH-dependent manner; binds both actin monomers and filaments and severs filaments; thought to be regulated by phosphorylation at SER4; ubiquitous and essential in eukaryotes
-1,174376703
Cell Wall
CAGL0F01463g TIR2 Putative cell wall mannoprotein of the Srp1p/Tip1p family of serine-alanine-rich proteins; transcription is induced by
cold shock and anaerobiosis -0,995890426
CAGL0M11726g CCW12 Cell wall mannoprotein, mutants are defective in mating and agglutination, expression is downregulated by alpha-
factor -1,864151555
115
Table S3 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Cell Wall CAGL0E02255g ZEO1 Peripheral membrane protein of the plasma membrane that interacts with Mid2p; regulates the cell integrity pathway
mediated by Pkc1p and Slt2p; the authentic protein is detected in a phosphorylated state in highly purified mitochondria
-1,770223214
Drug resistance CAGL0M07293g PDR12 Plasma membrane ATP-binding cassette (ABC) transporter, weak-acid-inducible multidrug transporter required for weak organic acid resistance; induced by sorbate and benzoate and regulated by War1p; mutants exhibit sorbate
hypersensitivity -1,607507519
Cell Cycle CAGL0K05797g EMI1 Non-essential protein required for transcriptional induction of the early meiotic-specific transcription factor IME1, also
required for sporulation; contains twin cysteine-x9-cysteine motifs -0,970297466
Pro
tein
Degra
datio
n CAGL0L07128g UBX3
UBX (ubiquitin regulatory X) domain-containing protein that interacts with Cdc48p, green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a punctate pattern
-1,000093157
CAGL0G02849g UIP4 Protein that interacts with Ulp1p, a Ubl (ubiquitin-like protein)-specific protease for Smt3p protein conjugates;
detected in a phosphorylated state in the mitochondrial outer membrane; also detected in ER and nuclear envelope -1,23157514
CAGL0C00275g HSP31 Putative cysteine protease; protein differentially expressed in azole resistant strain; gene is upregulated in azole-
resistant strain -1,498131134
Protein Folding
CAGL0L02365g WBP1 Beta subunit of the oligosaccharyl transferase (OST) glycoprotein complex; required for N-linked glycosylation of
proteins in the endoplasmic reticulum -1,094908019
CAGL0D05742g OST1 Alpha subunit of the oligosaccharyltransferase complex of the ER lumen, which catalyzes asparagine-linked
glycosylation of newly synthesized proteins -1,122123192
Pos-translational modifications
CAGL0I08217g STE24 Highly conserved zinc metalloprotease that functions in two steps of a-factor maturation, C-terminal CAAX proteolysis
and the first step of N-terminal proteolytic processing; contains multiple transmembrane spans -1,374233754
CAGL0M02211g PEP4 Vacuolar aspartyl protease (proteinase A), required for the posttranslational precursor maturation of vacuolar proteinases; important for protein turnover after oxidative damage; synthesized as a zymogen, self-activates
-1,396803877
Tra
nsport
CAGL0J07980g ATX1 Cytosolic copper metallochaperone that transports copper to the secretory vesicle copper transporter Ccc2p for
eventual insertion into Fet3p, which is a multicopper oxidase required for high-affinity iron uptake -0,940829887
CAGL0G05786g SHR3 Endoplasmic reticulum packaging chaperone, required for incorporation of amino acid permeases into COPII coated
vesicles for transport to the cell surface -1,273675719
CAGL0H09658g NTF2 Nuclear envelope protein, interacts with GDP-bound Gsp1p and with proteins of the nuclear pore to transport Gsp1p
into the nucleus where it is an essential player in nucleocytoplasmic transport -1,630756506
CAGL0M11104g SSS1 Subunit of the Sec61p translocation complex (Sec61p-Sss1p-Sbh1p) that forms a channel for passage of secretory proteins through the endoplasmic reticulum membrane, and of the Ssh1p complex (Ssh1p-Sbh2p-Sss1p); interacts
with Ost4p and Wbp1p -1,649312746
Sorting CAGL0F04455g ERD2 HDEL receptor, an integral membrane protein that binds to the HDEL motif in proteins destined for retention in the
endoplasmic reticulum; has a role in maintenance of normal levels of ER-resident proteins -1,084295552
Rib
osom
e
bio
genesis
CAGL0K08382g RPS21A Protein component of the small (40S) ribosomal subunit; nearly identical to Rps21Bp and has similarity to rat S21
ribosomal protein -1,280583527
CAGL0M06303g RPS6B Protein component of the small (40S) ribosomal subunit; identical to Rps6Ap and has similarity to rat S6 ribosomal
protein -1,29333645
CAGL0J00165g RPS25A Protein component of the small (40S) ribosomal subunit; nearly identical to Rps25Bp and has similarity to rat S25
ribosomal protein -1,914042143
116
Table S3 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 31 days (continued).
Gene ID Sc
Homologous Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Rib
osom
e b
iogenesis
CAGL0G08173g RPS31 Fusion protein that is cleaved to yield a ribosomal protein of the small (40S) subunit and ubiquitin; ubiquitin may
facilitate assembly of the ribosomal protein into ribosomes; interacts genetically with translation factor eIF2B -1,732645738
CAGL0K06567g RPL27B Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl27Ap and has similarity to rat L27
ribosomal protein -1,700723722
CAGL0G06490g RPS7B Protein component of the small (40S) ribosomal subunit, nearly identical to Rps7Ap; interacts with Kti11p; deletion
causes hypersensitivity to zymocin; has similarity to rat S7 and Xenopus S8 ribosomal proteins -2,068108648
CAGL0A01562g RPL24A Ribosomal protein L30 of the large (60S) ribosomal subunit, nearly identical to Rpl24Bp and has similarity to rat L24
ribosomal protein; not essential for translation but may be required for normal translation rate -2,098417544
CAGL0A01540g RPL30 Protein component of the large (60S) ribosomal subunit, has similarity to rat L30 ribosomal protein; involved in pre-
rRNA processing in the nucleolus; autoregulates splicing of its transcript -2,198802105
CAGL0K06149g RPS17B Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Ap and has similarity to rat S17
ribosomal protein -1,923578561
CAGL0K03135g RPS20 Protein component of the small (40S) ribosomal subunit; overproduction suppresses mutations affecting RNA
polymerase III-dependent transcription; has similarity to E, coli S10 and rat S20 ribosomal proteins -2,061573803
CAGL0M04873g RPS10A Protein component of the small (40S) ribosomal subunit; nearly identical to Rps10Bp and has similarity to rat
ribosomal protein S10 -2,888580006
RNA processing CAGL0L12870g TMA19 Protein that associates with ribosomes; homolog of translationally controlled tumor protein; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and relocates to the mitochondrial outer surface upon oxidative stress
-1,804919552
Signal Transduction
CAGL0C02893g HRK1 Protein kinase implicated in activation of the plasma membrane H(+)-ATPase Pma1p in response to glucose
metabolism; plays a role in ion homeostasis -1,372092605
Oxidation reduction CAGL0M14025g YMR315W Protein with NADP(H) oxidoreductase activity; transcription is regulated by Stb5p in response to NADPH depletion
induced by diamide; promoter contains a putative Stb5p binding site -1,848937684
Str
ess
Adapta
tio
n
CAGL0L11990g GRX4 Hydroperoxide and superoxide-radical responsive glutathione-dependent oxidoreductase; monothiol glutaredoxin
subfamily member along with Grx3p and Grx5p; protects cells from oxidative damage -1,197435797
CAGL0J04202g HSP12 Plasma membrane localized protein that protects membranes from desiccation; induced by heat shock, oxidative stress, osmostress, stationary phase entry, glucose depletion, oleate and alcohol; regulated by the HOG and Ras-
Pka pathways -1,98076876
CAGL0K05813g GRX2 Cytoplasmic glutaredoxin, thioltransferase, glutathione-dependent disulfide oxidoreductase involved in maintaining
redox state of target proteins, also exhibits glutathione peroxidase activity, expression induced in response to stress -2,005237698
Mitochondrial Organization
CAGL0L08068g RIM1 Single-stranded DNA-binding protein essential for mitochondrial genome maintenance; involved in mitochondrial DNA
replication -0,990681341
Apoptose CAGL0M01386g YSP2 Protein involved in programmed cell death; mutant shows resistance to cell death induced by amiodarone or
intracellular acidification -1,259063597
Unkow
n
Fu
nctio
n CAGL0K07205g YGL117W Putative protein of unknown function -0,825943348
CAGL0B01875g COX26 Putative protein of unknown function; may interact with respiratory chain complexes III (ubiquinol-cytochrome c
reductase) or IV (cytochrome c oxidase) -0,849485191
CAGL0K02145g COM2 Protein of unknown function -0,892195731
117
Table S3 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each down regulated gene at the fluconazole
induction time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Unkow
n F
unctio
n
CAGL0K03927g ERG29 Protein of unknown function that may be involved in iron metabolism; mutant bm-8 has a growth defect on iron-limited
medium that is complemented by overexpression of Yfh1p; shows localization to the ER; highly conserved in ascomycetes
-1,053634147
CAGL0K12760g YFL042C Putative protein of unknown function; YFL042C is not an essential gene -1,036214333
Cgla_YGOB_Anc_7,478
- - -1,020092458
Cgla_YGOB_YER053C-A
- Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the endoplasmic
reticulum -1,131049986
CAGL0M13255g YET1 Endoplasmic reticulum transmembrane protein; may interact with ribosomes, based on co-purification experiments;
homolog of human BAP31 protein -1,106867113
CAGL0C00451g YBR137W Protein of unknown function; localized to the cytoplasm; binds to Replication Protein A (RPA); YBR137W is not an
essential gene -1,089086046
CAGL0H00418g TMT1 - -1,099040329
CAGL0K04301g FMP48 Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in
high-throughput studies; induced by treatment with 8-methoxypsoralen and UVA irradiation -1,174914364
CAGL0A02882g - - -1,220744865
CAGL0I00462g HRI1 Protein of unknown function that interacts with Sec72p -1,28345206
CAGL0F04807g OM45 Protein of unknown function, major constituent of the mitochondrial outer membrane; located on the outer (cytosolic)
face of the outer membrane -1,239505127
CAGL0G05357g YNL200C Putative protein of unknown function; the authentic, non-tagged protein is detected in highly purified mitochondria in
high-throughput studies -1,44388801
CAGL0A02002g IGD1 Putative protein of unknown function; predicted to have thiol-disulfide oxidoreductase active site -1,538307228
CAGL0I00550g YLR297W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the vacuole;
YLR297W is not an essential gene; induced by treatment with 8-methoxypsoralen and UVA irradiation -1,868358505
Cgla_YGOB_Anc_7,299
- - -1,928723071
CAGL0H02101g RTC3 Protein of unknown function involved in RNA metabolism; has structural similarity to SBDS, the human protein
mutated in Shwachman-Diamond Syndrome (the yeast SBDS ortholog = SDO1); null mutation suppresses cdc13-1 temperature sensitivity
-1,988872692
CAGL0H02563g HOR7 Protein of unknown function; overexpression suppresses Ca2+ sensitivity of mutants lacking inositol
phosphorylceramide mannosyltransferases Csg1p and Csh1p; transcription is induced under hyperosmotic stress and repressed by alpha factor
-1,966220717
CAGL0G05632g YDL218W Putative protein of unknown function; YDL218W transcription is regulated by Azf1p and induced by starvation and
aerobic conditions; expression also induced in cells treated with the mycotoxin patulin -2,215931821
118
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Energ
y a
nd C
arb
ohydra
te m
eta
bolis
m
CaglfMp04_COX1 COX1 cytochrome-c oxidase subunit I 3,652636088
CaglfMp09_ATP6 ATP6 ATP synthase subunit 6 3,671833678
CaglfMp10_ATP9 ATP9 ATP synthase protein 9 3,662393397
CaglfMp08_ATP8 ATP8 ATP synthase subunit 8 3,30371967
CAGL0D05918g ATF2 Alcohol acetyltransferase, may play a role in steroid detoxification; forms volatile esters during fermentation, which is
important in brewing 1,826581277
CAGL0G01562g GPI15 Protein involved in the synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI), the first intermediate in the
synthesis of glycosylphosphatidylinositol (GPI) anchors; homologous to the human PIG-H protein 1,465822719
CAGL0B03663g CIT2 Citrate synthase, catalyzes the condensation of acetyl coenzyme A and oxaloacetate to form citrate, peroxisomal isozyme
involved in glyoxylate cycle; expression is controlled by Rtg1p and Rtg2p transcription factors 1,313024867
CAGL0E01529g PFK27 6-phosphofructo-2-kinase, catalyzes synthesis of fructose-2,6-bisphosphate; inhibited by phosphoenolpyruvate and sn-glycerol 3-phosphate, expression induced by glucose and sucrose, transcriptional regulation involves protein kinase A
1,100466161
CAGL0J03212g ALD5 Mitochondrial aldehyde dehydrogenase, involved in regulation or biosynthesis of electron transport chain components and
acetate formation; activated by K+; utilizes NADP+ as the preferred coenzyme; constitutively expressed 1,111135409
CAGL0E05170g ARI1 NADPH-dependent aldehyde reductase, utilizes aromatic and alophatic aldehyde substrates; member of the short-chain
dehydrogenase/reductase superfamily 0,964711198
Nitro
gen
Me
tabolis
m
CAGL0E01133g HOM2 Aspartic beta semi-aldehyde dehydrogenase, catalyzes the second step in the common pathway for methionine and
threonine biosynthesis; expression regulated by Gcn4p and the general control of amino acid synthesis 1,854330213
CAGL0E05126g CDC43 Beta subunit of geranylgeranyltransferase type I, catalyzes geranylgeranylation to the cysteine residue in proteins
containing a C-terminal CaaX sequence ending in Leu or Phe; has substrates important for morphogenesis 1,748840615
CAGL0E05016g ARO2 Bifunctional chorismate synthase and flavin reductase, catalyzes the conversion of 5-enolpyruvylshikimate 3-phosphate
(EPSP) to form chorismate, which is a precursor to aromatic amino acids 1,344915841
CAGL0E00759g ARG82 Inositol polyphosphate multikinase (IPMK), sequentially phosphorylates Ins(1,4,5)P3 to form Ins(1,3,4,5,6)P5; also has
diphosphoinositol polyphosphate synthase activity; regulates arginine-, phosphate-, and nitrogen-responsive genes 1,180498601
Lip
id M
eta
bolis
m
CAGL0E04334g ERG11 Lanosterol 14-alpha-demethylase, catalyzes the C-14 demethylation of lanosterol to form 4,4''-dimethyl cholesta-8,14,24-
triene-3-beta-ol in the ergosterol biosynthesis pathway; member of the cytochrome P450 family 1,490814419
CAGL0J10868g HTD2 Mitochondrial 3-hydroxyacyl-thioester dehydratase involved in fatty acid biosynthesis, required for respiratory growth and
for normal mitochondrial morphology 1,138492798
CAGL0C02717g SPO7 Putative regulatory subunit of Nem1p-Spo7p phosphatase holoenzyme, regulates nuclear growth by controlling
phospholipid biosynthesis, required for normal nuclear envelope morphology, premeiotic replication, and sporulation 1,164556492
CAGL0F07535g YJU3 Serine hydrolase with sequence similarity to monoglyceride lipase (MGL), localizes to lipid particles 1,198973428
CAGL0H10340g ROG1 Putative lipase; involved in lipid metabolism; YDL109C is not an essential gene 1,102011862
CAGL0K10846g PCD1 Peroxisomal nudix pyrophosphatase with specificity for coenzyme A and CoA derivatives, may function to remove potentially toxic oxidized CoA disulfide from peroxisomes to maintain the capacity for beta-oxidation of fatty acids
1,094968089
119
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Lipid Metabolism
CAGL0E02189g SHR5 Subunit of a palmitoyltransferase, composed of Shr5p and Erf2p, that adds a palmitoyl lipid moiety to heterolipidated
substrates such as Ras1p and Ras2p through a thioester linkage; palmitoylation is required for Ras2p membrane localization
0,936637479
CAGL0I10450g PEX4 Peroxisomal ubiquitin conjugating enzyme required for peroxisomal matrix protein import and peroxisome biogenesis 0,898611735
Cyto
skele
ton CAGL0E05302g SCD5
Protein required for normal actin organization and endocytosis; targeting subunit for protein phosphatase type 1; undergoes Crm1p-dependent nuclear-cytoplasmic shuttling; multicopy suppressor of clathrin deficiency
1,205531914
CAGL0H00913g CIN2 GTPase-activating protein (GAP) for Cin4p; tubulin folding factor C involved in beta-tubulin (Tub2p) folding; mutants display
increased chromosome loss and benomyl sensitivity; deletion complemented by human GAP, retinitis pigmentosa 2 1,298850307
CAGL0I02464g SPC97 Component of the microtubule-nucleating Tub4p (gamma-tubulin) complex; interacts with Spc110p at the spindle pole body
(SPB) inner plaque and with Spc72p at the SPB outer plaque 1,089084544
Cell
Wall
CAGL0G10219g FLO5 Adhesin-like protein with 5 tandem repeats; predicted GPI-anchor; similarity to S. cerevisiae flocculins, cell wall proteins
that mediate adhesion 3,770534825
CAGL0I10200g FLO1 (PWP3) Protein with tandem repeats; putative adhesin-like protein 3,777703874
CAGL0E06688g FLO10 (EPA3) Epithelial adhesion protein 2,244025427
CAGL0C00968g YOL155C Adhesin-like protein with a predicted role in cell adhesion; predicted GPI-anchor 2,575973047
CAGL0J09702g ACK1 Protein that functions upstream of Pkc1p in the cell wall integrity pathway; GFP-fusion protein expression is induced in
response to the DNA-damaging agent MMS; non-tagged Ack1p is detected in purified mitochondria 2,064988338
CAGL0E05940g FLC1 Putative FAD transporter; required for uptake of FAD into endoplasmic reticulum; involved in cell wall maintenance 1,373034631
CAGL0E06644g FLO1 (EPA1) Sub-telomerically encoded adhesin with a role in cell adhesion; glycosylphosphatidylinositol-anchored cell wall protein
(GPI-CWP); N-terminal ligand binding domain binds to ligands containing a terminal galactose residue 1,233966604
CAGL0C03575g AGA1 Anchorage subunit of a-agglutinin of a-cells, highly O-glycosylated protein with N-terminal secretion signal and C-terminal
signal for addition of GPI anchor to cell wall, linked to adhesion subunit Aga2p via two disulfide bonds 1,233363377
Cell
Cycle
CAGL0E06182g NSL1 Essential component of the MIND kinetochore complex (Mtw1p Including Nnf1p-Nsl1p-Dsn1p) which joins kinetochore
subunits contacting DNA to those contacting microtubules; required for accurate chromosome segregation 1,744713634
CAGL0M13079g ASK1 Essential subunit of the Dam1 complex (aka DASH complex), couples kinetochores to the force produced by MT
depolymerization thereby aiding in chromosome segregation; phosphorylated during the cell cycle by cyclin-dependent kinases
1,239682871
CAGL0J10318g NIS1 Protein localized in the bud neck at G2/M phase; physically interacts with septins; possibly involved in a mitotic signaling
network 1,129223118
CAGL0M02189g KIP2 Kinesin-related motor protein involved in mitotic spindle positioning, stabilizes microtubules by targeting Bik1p to the plus
end; Kip2p levels are controlled during the cell cycle 1,041235391
CAGL0B02145g TOS2 Protein involved in localization of Cdc24p to the site of bud growth; may act as a membrane anchor; localizes to the bud
neck and bud tip; potentially phosphorylated by Cdc28p 1,104892998
CAGL0E04444g ARD1 Subunit of N-terminal acetyltransferase NatA (Nat1p, Ard1p, Nat5p); acetylates many proteins and thus affects telomeric
silencing, cell cycle, heat-shock resistance, mating, and sporulation; human Ard1p levels are elevated in cancer cells 1,062285504
CAGL0L10626g CIK1 Kinesin-associated protein required for both karyogamy and mitotic spindle organization, interacts stably and specifically
with Kar3p and may function to target this kinesin to a specific cellular role; has similarity to Vik1p 0,863828987
120
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Pro
tein
Degra
datio
n
CAGL0E00671g UBC1 Ubiquitin-conjugating enzyme that mediates selective degradation of short-lived and abnormal proteins; plays a role in
vesicle biogenesis and ER-associated protein degradation (ERAD); component of the cellular stress response 1,375225959
CAGL0J11484g DUG3 Probable glutamine amidotransferase, forms a complex with Dug1p and Dug2p to degrade glutathione (GSH) and other
peptides containing a gamma-glu-X bond in an alternative pathway to GSH degradation by gamma-glutamyl transpeptidase (Ecm38p)
1,140610456
CAGL0K04653g ART5 Protein proposed to regulate the endocytosis of plasma membrane proteins by recruiting the ubiquitin ligase Rsp5p to its
target in the plasma membrane 1,112670866
CAGL0H00803g RBD2 Possible rhomboid protease, has similarity to eukaryotic rhomboid proteases including Pcp1p 0,713857291
CAGL0I06116g SSY5 Serine protease of SPS plasma membrane amino acid sensor system (Ssy1p-Ptr3p-Ssy5p); contains an inhibitory domain that dissociates in response to extracellular amino acids, freeing a catalytic domain to activate transcription factor Stp1p
1,074952627
CAGL0J07414g ELA1 Elongin A, F-box protein that forms a heterodimer with Elc1p and is required for ubiquitin-dependent degredation of the
RNA Polymerase II subunit RPO21; subunit of the Elongin-Cullin-Socs (ECS) ligase complex 0,975634396
CAGL0E01441g SAN1 Ubiquitin-protein ligase, involved in the proteasome-dependent degradation of aberrant nuclear proteins 0,931322191
Pro
tein
Fo
ldin
g
CAGL0I10472g PHB1 Subunit of the prohibitin complex (Phb1p-Phb2p), a 1,2 MDa ring-shaped inner mitochondrial membrane chaperone that
stabilizes newly synthesized proteins; determinant of replicative life span; involved in mitochondrial segregation 2,163438107
CAGL0J07590g NAR1 Component of the cytosolic iron-sulfur (FeS) protein assembly machinery, required for maturation of cytosolic and nuclear
FeS proteins and for normal resistance to oxidative stress; homologous to human Narf 1,979659904
CAGL0E04906g AHA1 Co-chaperone that binds to Hsp82p and activates its ATPase activity; similar to Hch1p; expression is regulated by stresses
such as heat shock 1,986333439
CAGL0E00913g CDC37 Essential Hsp90p co-chaperone; necessary for passage through the START phase of the cell cycle; stabilizes protein
kinase nascent chains and participates along with Hsp90p in their folding 1,440782245
CAGL0E04796g GTB1 Glucosidase II beta subunit, forms a complex with alpha subunit Rot2p, involved in removal of two glucose residues from
N-linked glycans during glycoprotein biogenesis in the ER 1,528933887
Tra
nsport
CAGL0H01837g PTK2 Putative serine/threonine protein kinase involved in regulation of ion transport across plasma membrane; enhances
spermine uptake 1,375554357
CAGL0E06006g MMT2 Putative metal transporter involved in mitochondrial iron accumulation; closely related to Mmt1p 1,109437242
CAGL0I09746g SLY41 Protein involved in ER-to-Golgi transport 1,297719215
CAGL0E01353g ZRT2 Low-affinity zinc transporter of the plasma membrane; transcription is induced under low-zinc conditions by the Zap1p
transcription factor 1,125042097
CAGL0F04499g FUI1 High affinity uridine permease, localizes to the plasma membrane; also mediates low but significant transport of the
cytotoxic nucleoside analog 5-fluorouridine; not involved in uracil transport 1,099488036
CAGL0E01617g ALR1 Plasma membrane Mg(2+) transporter, expression and turnover are regulated by Mg(2+) concentration; overexpression
confers increased tolerance to Al(3+) and Ga(3+) ions 1,039351433
CAGL0L12694g VPS16 Subunit of the vacuole fusion and protein sorting HOPS complex and the CORVET tethering complex; part of the Class C
Vps complex essential for membrane docking and fusion at Golgi-to-endosome and endosome-to-vacuole protein transport stages
0,907828839
CAGL0I09724g MCH5 Has domain(s) with predicted role in transmembrane transport and integral to membrane localization 0,926175793
121
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Sort
ing
CAGL0E06160g SSO2 Plasma membrane t-SNARE involved in fusion of secretory vesicles at the plasma membrane; syntaxin homolog that is
functionally redundant with Sso1p 1,500515197
CAGL0E05258g SNC2 Vesicle membrane receptor protein (v-SNARE) involved in the fusion between Golgi-derived secretory vesicles with the
plasma membrane; member of the synaptobrevin/VAMP family of R-type v-SNARE proteins 1,574907183
CAGL0E01199g ENT5 Protein containing an N-terminal epsin-like domain involved in clathrin recruitment and traffic between the Golgi and
endosomes; associates with the clathrin adaptor Gga2p, clathrin adaptor complex AP-1, and clathrin 1,121963263
CAGL0E01001g SEC1 Sm-like protein involved in docking and fusion of exocytic vesicles through binding to assembled SNARE complexes at the
membrane; localization to sites of secretion (bud neck and bud tip) is dependent on SNARE function 1,098567752
Rib
osom
e b
iogenesis
CAGL0C03355g ESF2 Essential nucleolar protein involved in pre-18S rRNA processing; binds to RNA and stimulates ATPase activity of Dbp8;
involved in assembly of the small subunit (SSU) processome 1,731829731
CAGL0K02211g LCP5 Essential protein involved in maturation of 18S rRNA; depletion leads to inhibited pre-rRNA processing and reduced
polysome levels; localizes primarily to the nucleolus 1,449813865
CAGL0G06248g MAK16 Essential nuclear protein, constituent of 66S pre-ribosomal particles; required for maturation of 25S and 5,8S rRNAs;
required for maintenance of M1 satellite double-stranded RNA of the L-A virus 1,190652666
CAGL0A04037g PWP1 Protein with WD-40 repeats involved in rRNA processing; associates with trans-acting ribosome biogenesis factors; similar
to beta-transducin superfamily 1,289051553
CAGL0J01265g UTP15 Nucleolar protein, component of the small subunit (SSU) processome containing the U3 snoRNA that is involved in
processing of pre-18S rRNA 1,184412605
CAGL0B01397g NOP8 Nucleolar protein required for 60S ribosomal subunit biogenesis 1,150401912
CAGL0J10252g IMP4 Component of the SSU processome, which is required for pre-18S rRNA processing; interacts with Mpp10p; member of a
superfamily of proteins that contain a sigma(70)-like motif and associate with RNAs 1,023722263
CAGL0J02376g FAF1 Protein required for pre-rRNA processing and 40S ribosomal subunit assembly 1,17489655
CAGL0H02717g PUS5 Pseudouridine synthase, catalyzes only the formation of pseudouridine (Psi)-2819 in mitochondrial 21S rRNA; not essential
for viability 1,106782722
CAGL0D04884g RRP9 Protein involved in pre-rRNA processing, associated with U3 snRNP; component of small ribosomal subunit (SSU)
processosome; ortholog of the human U3-55k protein 1,04751086
CAGL0H02057g GAR1 Protein component of the H/ACA snoRNP pseudouridylase complex, involved in the modification and cleavage of the 18S
pre-rRNA 1,026171278
CAGL0J01045g HCA4 Putative nucleolar DEAD box RNA helicase; high-copy number suppression of a U14 snoRNA processing mutant suggests
an involvement in 18S rRNA synthesis 1,008405593
CAGL0I02376g NOP19 Essential protein required for maturation of 18S rRNA; green fluorescent protein (GFP)-fusion protein localizes to both the
nucleus and the nucleolus 1,01212841
CAGL0D05874g MPP10 Component of the SSU processome and 90S preribosome, required for pre-18S rRNA processing, interacts with and
controls the stability of Imp3p and Imp4p, essential for viability; similar to human Mpp10p 0,960497329
DNA processing
CAGL0E04488g AHC1 Subunit of the Ada histone acetyltransferase complex, required for structural integrity of the complex 1,550685664
CAGL0J01980g MPH1 Member of the DEAH family of helicases, functions in an error-free DNA damage bypass pathway that involves
homologous recombination, binds to flap DNA and stimulates activity of Rad27p and Dna2p; mutations confer a mutator phenotype
1,589635681
122
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID Sc
Homologous Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
DN
A p
rocessin
g
CAGL0D03960g BRL1 Essential nuclear envelope integral membrane protein identified as a suppressor of a conditional mutation in the major
karyopherin, CRM1; homologous to and interacts with Brr6p, a nuclear envelope protein involved in nuclear export 1,554374023
CAGL0E05720g IPL1 Aurora kinase subunit of the conserved chromosomal passenger complex (CPC; Ipl1p-Sli15p-Bir1p-Nbl1p), involved in regulating kinetochore-microtubule attachments; helps maintain condensed chromosomes during anaphase and early
telophase 1,263752715
CAGL0E00473g MSH3 Mismatch repair protein, forms dimers with Msh2p that mediate repair of insertion or deletion mutations and removal of
nonhomologous DNA ends, contains a PCNA (Pol30p) binding motif required for genome stability 1,310491897
CAGL0A02706g ESC2 Protein involved in silencing; may recruit or stabilize Sir proteins; role in Rad51-dependent homologous recombination
repair and intra S-phase DNA damage checkpoint; member of the RENi (Rad60-Esc2-Nip45) family of SUMO-like domain proteins
1,176485239
CAGL0B04785g SGF29 Probable subunit of SAGA histone acetyltransferase complex 1,193176821
CAGL0I03256g POL32 Third subunit of DNA polymerase delta, involved in chromosomal DNA replication; required for error-prone DNA synthesis
in the presence of DNA damage and processivity; interacts with Hys2p, PCNA (Pol30p), and Pol1p 1,187926948
CAGL0E00737g HMO1 Chromatin associated high mobility group (HMG) family member involved in genome maintenance; rDNA-binding component of the Pol I transcription system; associates with a 5'-3' DNA helicase and Fpr1p, a prolyl isomerase
1,134716772
CAGL0J00517g RRM3 DNA helicase involved in rDNA replication and Ty1 transposition; relieves replication fork pauses at telomeric regions;
structurally and functionally related to Pif1p 1,003359921
CAGL0L02739g SAS5 Subunit of the SAS complex (Sas2p, Sas4p, Sas5p), which acetylates free histones and nucleosomes and regulates
transcriptional silencing; stimulates Sas2p HAT activity 0,91644929
RN
A p
rocessin
g
CAGL0M05181g CUS1 Protein required for assembly of U2 snRNP into the spliceosome, forms a complex with Hsh49p and Hsh155p 2,067222602
CAGL0J09592g CWC2 Member of the NineTeen Complex (NTC) that contains Prp19p and stabilizes U6 snRNA in catalytic forms of the
spliceosome containing U2, U5, and U6 snRNAs; binds directly to U6 snRNA; similar to S, pombe Cwf2 1,912158783
CAGL0J03630g BUD31 Component of the SF3b subcomplex of the U2 snRNP; diploid mutants display a random budding pattern instead of the
wild-type bipolar pattern 1,550942328
CAGL0H04235g DUS1 Dihydrouridine synthase, member of a widespread family of conserved proteins including Smm1p, Dus3p, and Dus4p;
modifies pre-tRNA(Phe) at U17 1,289984046
CAGL0J10010g GCD10 Subunit of tRNA (1-methyladenosine) methyltransferase with Gcd14p, required for the modification of the adenine at
position 58 in tRNAs, especially tRNAi-Met; first identified as a negative regulator of GCN4 expression 1,557794839
CAGL0I02860g CEX1 Cytoplasmic component of the nuclear aminoacylation-dependent tRNA export pathway; interacts with nuclear pore
component Nup116p; copurifies with tRNA export receptors Los1p and Msn5p, as well as eIF-1a and the RAN GTPase Gsp1p
1,26789901
CAGL0K01485g PUS9 Mitochondrial tRNA:pseudouridine synthase, catalyzes the formation of pseudouridine at position 32 in mitochondrial
tRNAs; contains an N-terminal mitochondrial targeting sequence 1,340885247
CAGL0E05676g TYW1 Protein required for the synthesis of wybutosine, a modified guanosine found at the 3'-position adjacent to the anticodon of
phenylalanine tRNA which supports reading frame maintenance by stabilizing codon-anticodon interactions 1,177368463
CAGL0M03751g TRF5 Non-canonical poly(A) polymerase, involved in nuclear RNA degradation as a component of the TRAMP complex;
catalyzes polyadenylation of hypomodified tRNAs, and snoRNA and rRNA precursors; overlapping but non-redundant functions with Pap2p
1,263127003
123
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
RN
A p
rocessin
g
CAGL0C03531g TRM112 Subunit of tRNA methyltransferase (MTase) complexes in combination with Trm9p and Trm11p; subunit of complex with Mtq2p that methylates Sup45p (eRF1) in the ternary complex eRF1-eRF3-GTP; deletion confers resistance to zymocin
1,137861235
CAGL0I05676g PRP2 RNA-dependent ATPase in the DEAH-box family, required for activation of the spliceosome before the first
transesterification step in RNA splicing 1,084153571
CAGL0E03784g OCA5 Cytoplasmic protein required for replication of Brome mosaic virus in S, cerevisiae, which is a model system for studying
replication of positive-strand RNA viruses in their natural hosts 1,108695749
CAGL0K01573g PRP9 Subunit of the SF3a splicing factor complex, required for spliceosome assembly; acts after the formation of the U1 snRNP-
pre-mRNA complex 1,2279619
CAGL0L03846g DBP2 Essential ATP-dependent RNA helicase of the DEAD-box protein family, involved in nonsense-mediated mRNA decay and
rRNA processing 1,026244238
CAGL0D04840g MSS18 Nuclear encoded protein needed for efficient splicing of mitochondrial COX1 aI5beta intron; mss18 mutations block
cleavage of 5' exon - intron junction; phenotype of intronless strain suggests additional functions 1,15613398
CAGL0E05786g LEA1 Component of U2 snRNP; disruption causes reduced U2 snRNP levels; physically interacts with Msl1p; invovled in
telomere maintenance; putative homolog of human U2A' snRNP protein 0,978016975
CAGL0L10120g RAT1 Nuclear 5' to 3' single-stranded RNA exonuclease, involved in RNA metabolism, including rRNA and snRNA processing as
well as poly (A+) dependent and independent mRNA transcription termination 0,928619408
CAGL0J11396g SWT21 Protein involved in mRNA splicing; contains a consensus nuclear export signal (NES) sequence similar to the consensus
sequence recognized by Crm1p; interacts genetically with Prp40p and Tgs1p; contains WD40 repeats 0,915093931
CAGL0I03014g POP3 Subunit of both RNase MRP, which cleaves pre-rRNA, and nuclear RNase P, which cleaves tRNA precursors to generate
mature 5' ends 0,864583805
Tra
nscriptio
n
CAGL0A01408g PGD1 Subunit of the RNA polymerase II mediator complex; associates with core polymerase subunits to form the RNA
polymerase II holoenzyme; essential for basal and activated transcription; direct target of Cyc8p-Tup1p transcriptional corepressor
1,953117811
CAGL0F07381g TAF6 Has domain(s) with predicted protein heterodimerization activity, role in DNA-dependent transcription, initiation, regulation
of sequence-specific DNA binding transcription factor activity and nucleus localization 2,25542292
CAGL0A01325g PGD1 Has domain(s) with predicted RNA polymerase II transcription cofactor activity, role in regulation of transcription from RNA
polymerase II promoter and mediator complex localization 2,089278535
CAGL0E00627g SRB8 Subunit of the RNA polymerase II mediator complex; associates with core polymerase subunits to form the RNA
polymerase II holoenzyme; essential for transcriptional regulation; involved in glucose repression 2,31618766
CAGL0E05478g RPA43 RNA polymerase I subunit A43 1,87267044
CAGL0E00935g TAF10 Subunit (145 kDa) of TFIID and SAGA complexes, involved in RNA polymerase II transcription initiation and in chromatin
modification 1,826211064
CAGL0F07249g TAF6 Subunit (60 kDa) of TFIID and SAGA complexes, involved in transcription initiation of RNA polymerase II and in chromatin
modification, similar to histone H4 1,564448336
CAGL0A02695g TFC6 One of six subunits of RNA polymerase III transcription initiation factor complex (TFIIIC); part of TFIIIC TauB domain that
binds BoxB promoter sites of tRNA and other genes; cooperates with Tfc3p in DNA binding; human homolog is TFIIIC-110 1,423930861
CAGL0J01848g RPA135 RNA polymerase I subunit A135 1,567066001
CAGL0M03487g RPC34 RNA polymerase III subunit C34; interacts with TFIIIB70 and is a key determinant in pol III recruitment by the preinitiation
complex 1,540832401
124
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Tra
nscriptio
n
CAGL0E01551g MED7 Subunit of the RNA polymerase II mediator complex; associates with core polymerase subunits to form the RNA
polymerase II holoenzyme; essential for transcriptional regulation 1,548057671
CAGL0M04477g RRN5 Protein involved in transcription of rDNA by RNA polymerase I; transcription factor, member of UAF (upstream activation
factor) family along with Rrn9p and Rrn10p 1,541296159
CAGL0E05324g MIP1 Catalytic subunit of the mitochondrial DNA polymerase; conserved C-terminal segment is required for the maintenance of
mitochondrial genome; related to human POLG, which has been associated with mitochondrial diseases 1,211859347
CAGL0J03806g WTM1 Transcriptional modulator involved in regulation of meiosis, silencing, and expression of RNR genes; required for nuclear
localization of the ribonucleotide reductase small subunit Rnr2p and Rnr4p; contains WD repeats 1,213816035
CAGL0E01111g SAC3 Nuclear pore-associated protein, forms a complex with Thp1p that is involved in transcription and in mRNA export from the
nucleus 1,046033713
CAGL0G06974g RPC17 RNA polymerase III subunit C17; physically interacts with C31, C11, and TFIIIB70; may be involved in the recruitment of
pol III by the preinitiation complex 1,114568168
CAGL0J00869g RPC25 RNA polymerase III subunit C25, required for transcription initiation; forms a heterodimer with Rpc17p; paralog of Rpb7p 0,968157568
Tra
nscriptio
nal R
egula
tio
n
CAGL0E01331g SWI5 Transcription factor that activates transcription of genes expressed at the M/G1 phase boundary and in G1 phase;
localization to the nucleus occurs during G1 and appears to be regulated by phosphorylation by Cdc28p kinase 1,964607063
CAGL0E00693g NGG1 Transcriptional regulator involved in glucose repression of Gal4p-regulated genes; component of transcriptional adaptor
and histone acetyltransferase complexes, the ADA complex, the SAGA complex, and the SLIK complex 1,625906875
CAGL0G07557g UAF30 Subunit of UAF (upstream activation factor), which is an RNA polymerase I specific transcription stimulatory factor
composed of Uaf30p, Rrn5p, Rrn9p, Rrn10p, histones H3 and H4; deletion decreases cellular growth rate 1,190038675
CAGL0A01628g MIG1 Transcription factor involved in glucose repression; sequence specific DNA binding protein containing two Cys2His2 zinc
finger motifs; regulated by the SNF1 kinase and the GLC7 phosphatase 1,193944361
CAGL0M06193g SWD3 Essential subunit of the COMPASS (Set1C) complex, which methylates histone H3 on lysine 4 and is required in
transcriptional silencing near telomeres; WD40 beta propeller superfamily member and ortholog of mammalian WDR5 1,080795093
CAGL0M06699g SDS3 Component of the Rpd3p/Sin3p deacetylase complex required for its structural integrity and catalytic activity, involved in
transcriptional silencing and required for sporulation; cells defective in SDS3 display pleiotropic phenotypes 1,099892224
CAGL0C05335g RTG1 Transcription factor (bHLH) involved in interorganelle communication between mitochondria, peroxisomes, and nucleus 1,12709131
CAGL0F06259g ARG80 Transcription factor involved in regulation of arginine-responsive genes; acts with Arg81p and Arg82p 1,130515386
CAGL0G08646g POG1 Putative transcriptional activator that promotes recovery from pheromone induced arrest; inhibits both alpha-factor induced G1 arrest and repression of CLN1 and CLN2 via SCB/MCB promoter elements; potential Cdc28p substrate; SBF regulated
1,04938451
CAGL0L12738g SGF11 Integral subunit of SAGA histone acetyltransferase complex, regulates transcription of a subset of SAGA-regulated genes,
required for the Ubp8p association with SAGA and for H2B deubiquitylation 0,962269351
Tra
nsla
tio
n
CAGL0E00715g RSM24 Mitochondrial ribosomal protein of the small subunit 1,6262855
CAGL0E01463g CDC33 Cytoplasmic mRNA cap binding protein and translation initiation factor eIF4E; the eIF4E-cap complex is responsible for
mediating cap-dependent mRNA translation via interactions with translation initiation factor eIF4G (Tif4631p or Tif4632p) 1,281597789
CAGL0E00781g SUP35 Translation termination factor eRF3; altered protein conformation creates the [PSI(+)] prion, a dominant cytoplasmically
inherited protein aggregate that alters translational fidelity and creates a nonsense suppressor phenotype 1,084216704
CAGL0E05698g RKM1 SET-domain lysine-N-methyltransferase, catalyzes the formation of dimethyllysine residues on the large ribsomal subunit
protein L23a (RPL23A and RPL23B) 1,249597409
125
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID
Sc Homologous
Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Translation CAGL0E06314g RSM22 Mitochondrial ribosomal protein of the small subunit; also predicted to be an S-adenosylmethionine-dependent
methyltransferase 1,056784489
Sig
nal P
ath
ways
CAGL0A01177g PLC1 Phospholipase C, hydrolyzes phosphatidylinositol 4,5-biphosphate (PIP2) to generate the signaling molecules inositol
1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG); involved in regulating many cellular processes 1,76396697
CAGL0E01419g MKC7 GPI-anchored aspartyl protease (yapsin) involved in protein processing; shares functions with Yap3p and Kex2p 1,358220132
CAGL0E01089g SSY1 Component of the SPS plasma membrane amino acid sensor system (Ssy1p-Ptr3p-Ssy5p), which senses external amino acid concentration and transmits intracellular signals that result in regulation of expression of amino acid permease genes
1,483344612
CAGL0A02431g YPS7 Putative GPI-anchored aspartic protease, located in the cytoplasm and endoplasmic reticulum 1,391540648
CAGL0J07282g GPB1 Multistep regulator of cAMP-PKA signaling; inhibits PKA downstream of Gpa2p and Cyr1p, thereby increasing cAMP
dependency; inhibits Ras activity through direct interactions with Ira1p/2p; regulated by G-alpha protein Gpa2p; homolog of Gpb2p
1,312620959
Oxidation reduction
CAGL0E05280g GRE2(B) Putative methylglyoxal reductase (NADPH-dependent) 1,408717258
Stress Adaptation
CAGL0G08151g GRX3 Hydroperoxide and superoxide-radical responsive glutathione-dependent oxidoreductase; monothiol glutaredoxin subfamily
member along with Grx4p and Grx5p; protects cells from oxidative damage 1,159009325
CAGL0F05709g ATC1 Nuclear protein, possibly involved in regulation of cation stress responses and/or in the establishment of bipolar budding
pattern 1,045921092
Cofactors CAGL0E05808g THI6 Bifunctional enzyme with thiamine-phosphate pyrophosphorylase and 4-methyl-5-beta-hydroxyethylthiazole kinase
activities, required for thiamine biosynthesis; GFP-fusion protein localizes to the cytoplasm in a punctate pattern 1,503181097
Mitochondria
l
Org
aniz
atio
n
CAGL0A02475g ATP22 Mitochondrial inner membrane protein required for assembly of the F0 sector of mitochondrial F1F0 ATP synthase, which
is a large, evolutionarily conserved enzyme complex required for ATP synthesis 1,709525177
Autophagy CAGL0E00649g PTC6 Mitochondrial protein phosphatase of type 2C with similarity to mammalian PP1Ks; involved in mitophagy; null mutant is
sensitive to rapamycin and has decreased phosphorylation of the Pda1 subunit of pyruvate dehydrogenase 1,51112831
Unkow
n F
unctio
n
CaglfMp03_cytB COB - 3,190166821
CaglfMp05_Cgai1 - - 2,350762186
CAGL0C00781g - - 2,177291566
CAGL0E00605g AHC2 Protein of unknown function, putative transcriptional regulator; proposed to be a Ada Histone acetyltransferase complex
component; GFP tagged protein is localized to the cytoplasm and nucleus 2,12858154
CAGL0A01366g FLO1 (EPA9) - 1,945704406
CAGL0E05214g YPL088W - 1,606187157
126
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID Sc
Homologous Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Unkow
n F
unctio
n
CAGL0E01485g RTC1 Protein of unknown function; may interact with ribosomes, based on co-purification experiments; null mutation suppresses
cdc13-1 temperature sensitivity 1,960286315
CAGL0E05962g FMP40 Putative protein of unknown function; proposed to be involved in responding to environmental stresses; the authentic, non-
tagged protein is detected in highly purified mitochondria in high-throughput studies 1,955775973
CAGL0E00231g - - 1,769047321
CAGL0F03641g YML018C Has domain(s) with predicted membrane localization 1,531545244
CAGL0M13915g YMR310C Putative protein of unknown function; predicted to be involved in ribosome biogenesis; green fluorescent protein (GFP)-
fusion protein localizes to the nucleus; YMR310C is not an essential gene 1,590497519
CAGL0E05522g YOR342C Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and the
nucleus 1,306992342
CAGL0E01573g EMW1 Essential protein of unknown function; fluorescent protein (GFP or YFP)-tagged protein localizes to cytoplasm and nucleus 1,348024031
CAGL0L06072g COM2 Protein of unknown function 1,409342692
CAGL0K00170g - - 1,445253228
CAGL0K01155g YGR079W Putative protein of unknown function; YGR079W is not an essential gene 1,377501362
CAGL0I08437g - - 1,47183407
CAGL0E01507g BSC6 Protein of unknown function containing 8 putative transmembrane seqments; ORF exhibits genomic organization
compatible with a translational readthrough-dependent mode of expression 1,384558603
CAGL0L12320g GEP5 Protein of unknown function, required for mitochondrial genome maintenance; detected in highly purified mitochondria in
high-throughput studies; null mutant has decreased levels of cardiolipin and phosphatidylethanolamine 1,205570638
CAGL0E00517g YCR087C-A Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the nucleolus; YCR087C-
A is not an essential gene 1,320172029
CAGL0J03278g YER077C Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the mitochondrion; null
mutation results in a decrease in plasma membrane electron transport 1,323322734
CAGL0E01221g GIR2 Highly-acidic cytoplasmic RWD domain-containing protein of unknown function; interacts with Rbg1p and Gcn1p;
associates with translating ribosomes; putative intrinsically unstructured protein 1,195448996
CAGL0D04180g UTP25 Nucleolar protein of unknown function; proposed to function as an RNA helicase based on structure prediction and remote
homology searches; essential for viability 1,266328475
CAGL0M05599g TOS1 Covalently-bound cell wall protein of unknown function; identified as a cell cycle regulated SBF target gene; deletion
mutants are highly resistant to treatment with beta-1,3-glucanase; has sequence similarity to YJL171C 1,328872808
CAGL0K02013g - - 1,262650924
CAGL0K11319g YDR249C Putative protein of unknown function 1,179041652
CAGL0L08404g URN1 Putative protein of unknown function containing WW and FF domains; overexpression causes accumulation of cells in G1
phase 1,315746519
127
Table S4 - Gene ID, S. cerevisiae homologous, description and clotrimazole resistance vs susceptibility (log2 change) for each up regulated gene at the fluconazole induction
time of 31 days (continued).
Gene ID Sc
Homologous Description
Clotrimazole Resistance vs Susceptible
(Log2 change)
Unkow
n F
unctio
n
CAGL0I03344g NRP1 Putative RNA binding protein of unknown function; localizes to stress granules induced by glucose deprivation; predicted to
be involved in ribosome biogenesis 1,136497431
CAGL0D04488g RRG8 Putative protein of unknown function, required for mitochondrial genome maintenance; null mutation results in a decrease
in plasma membrane electron transport 1,187117086
CAGL0C02805g GPN2 Protein of unknown function required for establishment of sister chromatid cohesion; contains an ATP/GTP binding site motif; similar to YLR243W and is highly conserved across species and homologous to human gene GPN2/ATPBD1B
1,218349299
Cgla_YGOB_Anc_7,246
- - 1,194727842
CAGL0H06391g SWC3 Protein of unknown function, component of the SWR1 complex, which exchanges histone variant H2AZ (Htz1p) for
chromatin-bound histone H2A; required for formation of nuclear-associated array of smooth endoplasmic reticulum known as karmellae
1,11989733
CAGL0B03861g YJR011C Putative protein of unknown function; GFP-fusion protein expression is induced in response to the DNA-damaging agent
MMS 1,14548996
CAGL0E04532g SFM1 Putative protein of unknown function; YOR021C is not an essential gene; predicted to be involved in rRNA processing and
ribosome biogenesis and in biopolymer catabolism 1,033028679
CAGL0E05456g YOR338W Putative protein of unknown function; YOR338W transcription is regulated by Azf1p and its transcript is a specific target of
the G protein effector Scp160p; identified as being required for sporulation in a high-throughput mutant screen 1,10664132
CAGL0C04785g YJR115W Putative protein of unknown function 1,103881479
CAGL0J06088g YNL162W-A Putative protein of unknown function; identified by homology 1,07232067
CAGL0M05313g YPL077C
Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and nucleus; YBR197C is not an essential gene
1,081741845
CAGL0F07623g MTC2 Protein of unknown function; mtc2 is synthetically sick with cdc13-1 1,004197924
CAGL0I03432g MHF2 Putative protein of unknown function 1,048670973
CAGL0C00671g MSC3 Protein of unknown function, green fluorescent protein (GFP)-fusion protein localizes to the cell periphery; msc3 mutants
are defective in directing meiotic recombination events to homologous chromatids; potential Cdc28p substrate 1,002762699
CAGL0E01067g YDR161W Putative protein of unknown function; non-essential gene; proposed function in rRNA and ribosome biosynthesis based on
transcriptional co-regulation; genetic interactions suggest a role in ER-associated protein degradation (ERAD) 0,997747059
CAGL0E06292g YHR022C Putative protein of unknown function; YHR022C is not an essential gene 0,996740825
CAGL0D00396g - - 1,008721402
CAGL0M05819g - - 0,949668361
CAGL0M04345g USB1 Essential protein of unknown function; fluorescent protein (GFP or YFP)-tagged protein localizes to mitochondria,
cytoplasm and nucleus 0,983486764
CAGL0M10065g - - 0,877986105
CAGL0H01749g - - 0,895828975
128
Table S5 - Gene ID, S. cerevisiae homologous, description and fluconazole and voriconazole resistance vs susceptibility (log2 change) for each down regulated gene at the
fluconazole induction time of 45 days.
Gene ID
Sc Homologous
Description
Fluconazole and
Voriconazole Resistance vs
Susceptible
Cell Wall CAGL0F00297g HOC1
Alpha-1,6-mannosyltransferase involved in cell wall mannan biosynthesis; subunit of a Golgi-localized complex that also contains Anp1p, Mnn9p, Mnn11p, and Mnn10p; identified as a suppressor of a cell lysis sensitive pkc1-371 allele
-0,942777378
CAGL0E01771g YPS1 Putative aspartic protease; predicted GPI-anchor; member of a YPS gene cluster that is required for virulence in mice; gene
is downregulated in azole-resistant strain -1,186179367
Ion Homeosta
sis CAGL0G04631g IZH1
Membrane protein involved in zinc ion homeostasis, member of the four-protein IZH family; transcription is regulated directly by Zap1p, expression induced by zinc deficiency and fatty acids; deletion increases sensitivity to elevated zinc
-0,94151266
Cell Cycle CAGL0K03817g POM152 Nuclear pore membrane glycoprotein; may be involved in duplication of nuclear pores and nuclear pore complexes during
S-phase; -1,009748251
Transport CAGL0G08085g DNF2 Aminophospholipid translocase (flippase) that localizes primarily to the plasma membrane; contributes to endocytosis,
protein transport and cell polarity; type 4 P-type ATPase -0,981474527
Unknown Function
CAGL0J04466g PUN1 Putative protein of unknown function; localizes to bud and cytoplasm; co-localizes with Sur7p in punctate patches in the
plasma membrane; null mutant displays decreased thermotolerance; transcription induced on cell wall damage -1,294931493
Table S6 - Gene ID, S. cerevisiae homologous, description and fluconazole and voriconazole resistance vs susceptibility (log2 change) for each up regulated gene at the
fluconazole induction time of 45 days.
Gene ID
Sc Homologous
Description
Fluconazole and
Voriconazole Resistance vs Susceptible
Carb
on a
nd E
nerg
y
Me
tabolis
m
CaglfMp08_ATP8 ATP8 ATP synthase subunit 8 1,390266135
CaglfMp11_COX2 COX2 cytochrome-c oxidase subunit II 1,339905441
CaglfMp12_COX3 COX3 cytochrome-c oxidase subunit III 1,238468657
CaglfMp09_ATP6 ATP6 ATP synthase subunit 6 1,191958938
CaglfMp04_COX1 COX1 cytochrome-c oxidase subunit I 1,10182479
CaglfMp10_ATP9 ATP9 ATP synthase protein 9 1,139753985
CAGL0J02926g PET117 Protein required for assembly of cytochrome c oxidase 0,785600788
Drug Resistance
CAGL0M01760g PDR5 Multidrug transporter of ATP-binding cassette (ABC) superfamily, involved in resistance to azoles; expression regulated by
Pdr1p; increased abundance in azole resistant strains; expression increased by loss of the mitochondrial genome 1,663594468
CAGL0F02717g PDR15 Plasma membrane ATP binding cassette (ABC) transporter, multidrug transporter and general stress response factor
implicated in cellular detoxification; regulated by Pdr1p, Pdr3p and Pdr8p; promoter contains a PDR responsive element 1,302221581
129
Table S6 - Gene ID, S. cerevisiae homologous, description and fluconazole and voriconazole resistance vs susceptibility (log2 change) for each up regulated gene at the
fluconazole induction time of 45 days.
Gene ID
Sc Homologous
Description
Fluconazole and
Voriconazole Resistance vs Susceptible
Cell
Wall
CAGL0H00110g STA1 Adhesin-like protein with internal repeats; predicted GPI-anchor; likely a C-terminal fragment of a single ORF with
CAGL0H00132 1,465279375
CAGL0G10219g FLO5 Adhesin-like protein with 5 tandem repeats; predicted GPI-anchor; similarity to S. cerevisiae flocculins, cell wall proteins
that mediate adhesion 1,393971377
CAGL0E00231g - Putative adhesin-like protein; contains tandem repeats and a predicted GPI-anchor 1,038372496
CAGL0H10626g FLO1 Predicted cell wall adhesin with a predicted role in adhesion; predicted GPI anchor; contains tandem repeats 0,82179517
Stress Adaptation
CAGL0E04356g SOD2 Mitochondrial superoxide dismutase, protects cells against oxygen toxicity; phosphorylated 0,886409552
CAGL0M11704g AHP1 Thiol-specific peroxiredoxin, reduces hydroperoxides to protect against oxidative damage; function in vivo requires
covalent conjugation to Urm1p 0,827551685
Unknow
n F
unctio
n
CAGL0M12947g YIL077C Mitochondria-localized protein; gene is upregulated in azole-resistant strain 1,815041402
CAGL0F03641g YML018C Has domain(s) with predicted membrane localization 1,571137176
CAGL0M09713g YIM1 Protein of unknown function; null mutant displays sensitivity to DNA damaging agents; the authentic, non-tagged protein is
detected in highly purified mitochondria in high-throughput studies 1,228456873
CAGL0G07183g2 - - 1,032973548
CaglfMp03_cytB COB - 1,04563215
CaglfMp07_Cgai3 AI4 - 1,092513851
CaglfMp05_Cgai1 - - 1,082676891
CAGL0L00157g - - 0,910359446
CAGL0H10054g YBR053C Putative protein of unknown function; induced by cell wall perturbation 0,873787021
CAGL0E03498g - - 0,803713459
CAGL0G07183g1 - - 0,815212097
CAGL0K08734g YIR014W Putative protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the vacuole; expression
directly regulated by the metabolic and meiotic transcriptional regulator Ume6p; YIR014W is a non-essential gene 0,789650414
130
Table S7. Gene ID, S. cerevisiae homologous, description and fold changes (FC) of each gene at each fluconazole induction time correspondent to posaconazole, clotrimazole
and fluconazole and voriconazole resistance.
Gene ID Sc.
homologous Description FC at 21st day FC at 31st day FC at 45th day
CAGL0E06644g FLO1 - 1,870734152 2,352128051 1,074598874
CAGL0A01284g FLO1 (EPA10) Putative adhesin-like protein 0,55427669 2,026494398 1,685480291
CAGL0I10147g FLO1 (PWP1) Protein with 32 tandem repeats; putative adhesin-like protein 0,548874241 2,275144738 1,684678975
CAGL0A01366g FLO1 (EPA9) Putative adhesin 0,523827464 3,852258206 1,469688062
CAGL0I10362g FLO5 (PWP4) Cell wall adhesin; predicted GPI anchor; contains tandem repeats 0,466763134 1,560991743 1,57806765
CAGL0I10200g FLO1 (PWP3) Protein with tandem repeats; putative adhesin-like protein 0,357394407 13,71520113 1,687742885
CAGL0G10219g FLO5 Adhesin-like protein with 5 tandem repeats; predicted GPI-anchor; similarity to S. cerevisiae flocculins, cell wall proteins that
mediate adhesion 0,900596603 13,64721653 2,628011115
CAGL0E06688g FLO10 (EPA3) Epithelial adhesion protein 1,808611243 4,737169939 1,209307909
CAGL0H10626g FLO1 Predicted cell wall adhesin with a predicted role in adhesion; predicted GPI anchor; contains tandem repeats 0,757209073 3,759216014 1,767604085
CAGL0C00968g YOL155C Adhesin-like protein with a predicted role in cell adhesion; predicted GPI-anchor 0,538695347 5,962730149 1,534169369
CAGL0H00110g STA1 Adhesin-like protein with internal repeats; predicted GPI-anchor; likely a C-terminal fragment of a single ORF with
CAGL0H00132 0,926582392 8,301618955 2,761169351
CAGL0E00231g NA Putative adhesin-like protein; contains tandem repeats and a predicted GPI-anchor 0,892064353 3,408288172 2,053909331
CAGL0F01463g TIR2 Putative cell wall mannoprotein of the Srp1p/Tip1p family of serine-alanine-rich proteins; transcription is induced by cold
shock and anaerobiosis 1,152718091 0,5014263 1,755313505
CAGL0M11726g CCW12 Cell wall mannoprotein, mutants are defective in mating and agglutination, expression is down-regulated by alpha-factor 1,486847984 0,274684697 1,279010825
CAGL0E01815g MKC7 (YPS8) Putative aspartic protease; predicted GPI-anchor; member of a YPS gene cluster that is required for virulence in mice; induced
in response to low pH and high temperature 0,39311964 1,059965638 1,824784529
CAGL0E01771g YPS1 Putative aspartic protease; predicted GPI-anchor; member of a YPS gene cluster that is required for virulence in mice; gene is
down-regulated in azole-resistant strain 1,100060489 0,727856524 0,439465139
CAGL0C03575g AGA1 Anchorage subunit of a-agglutinin of a-cells, highly O-glycosylated protein with N-terminal secretion signal and C-terminal
signal for addition of GPI anchor to cell wall, linked to adhesion subunit Aga2p via two disulfide bonds 0,441455298 2,351144773 1,156526304
CAGL0H01639g SPS1 Putative protein serine/threonine kinase expressed at the end of meiosis and localized to the prospore membrane, required
for correct localization of enzymes involved in spore wall synthesis 0,586830792 1,013814013 1,324197409
CAGL0G06072g ECM14 Putative metalloprotease with similarity to the zinc carboxypeptidase family, required for normal cell wall assembly 0,526502768 1,052312998 1,320404097
CAGL0G01738g PIL1 Primary component of eisosomes, which are large immobile cell cortex structures associated with endocytosis; null mutants
show activation of Pkc1p/Ypk1p stress resistance pathways; detected in phosphorylated state in mitochondria 0,300369278 0,730792104 2,388696427
CAGL0C02211g UTR2 Chitin transglycosylase that functions in the transfer of chitin to beta(1-6) and beta(1-3) glucans in the cell wall; similar to and
functionally redundant with Crh1; glycosylphosphatidylinositol (GPI)-anchored protein localized to bud neck 2,138202156 1,24462598 0,762139104
CAGL0A01474g SCW11 Cell wall protein with similarity to glucanases; may play a role in conjugation during mating based on its regulation by Ste12p 1,828102645 1,363570447 0,6788764
CAGL0J09702g ACK1 Protein that functions upstream of Pkc1p in the cell wall integrity pathway; GFP-fusion protein expression is induced in
response to the DNA-damaging agent MMS; non-tagged Ack1p is detected in purified mitochondria 0,195633181 4,184305935 1,160481829
CAGL0F00297g HOC1 Alpha-1,6-mannosyltransferase involved in cell wall mannan biosynthesis; subunit of a Golgi-localized complex that also
contains Anp1p, Mnn9p, Mnn11p, and Mnn10p; identified as a suppressor of a cell lysis sensitive pkc1-371 allele 1,006169616 0,691944165 0,520230404
CAGL0E04334g ERG11 Lanosterol 14-alpha-demethylase, catalyzes the C-14 demethylation of lanosterol to form 4,4''-dimethyl cholesta-8,14,24-
triene-3-beta-ol in the ergosterol biosynthesis pathway; member of the cytochrome P450 family 1,51602832 2,810475851 0,606924125
CAGL0M13981g TGL3 Triacylglycerol lipase of the lipid particle, responsible for all the TAG lipase activity of the lipid particle; contains the consensus sequence motif GXSXG, which is found in lipolytic enzymes; required with Tgl4p for timely bud formation
0,568115374 0,667290931 1,405998028
131
Table S7. Gene ID, S. cerevisiae homologous, description and fold changes (FC) of each gene at each fluconazole induction time correspondent to posaconazole, clotrimazole
and fluconazole and voriconazole resistance (continued).
Gene ID Sc.
homologous Description FC at 21st day FC at 31st day FC at 45th day
CAGL0L03135g SPO14 Phospholipase D, catalyzes the hydrolysis of phosphatidylcholine, producing choline and phosphatidic acid; involved in
Sec14p-independent secretion; required for meiosis and spore formation; differently regulated in secretion and meiosis 0,527983117 1,035317388 1,480335827
CAGL0A01177g PLC1 Phospholipase C, hydrolyzes phosphatidylinositol 4,5-biphosphate (PIP2) to generate the signaling molecules inositol 1,4,5-
triphosphate (IP3) and 1,2-diacylglycerol (DAG); involved in regulating many cellular processes 0,496491875 3,396307227 1,054674274
CAGL0H10340g ROG1 Putative lipase; involved in lipid metabolism; YDL109C is not an essential gene 1,278809582 2,146538222 0,872016822
CAGL0F05071g ECI1 Peroxisomal delta3,delta2-enoyl-CoA isomerase, hexameric protein that converts 3-hexenoyl-CoA to trans-2-hexenoyl-CoA,
essential for the beta-oxidation of unsaturated fatty acids, oleate-induced 0,537706765 1,099130042 1,631950858
CAGL0H09174g PEX1 AAA-peroxin that heterodimerizes with AAA-peroxin Pex6p and participates in the recycling of peroxisomal signal receptor
Pex5p from the peroxisomal membrane to the cystosol; induced by oleic acid and up-regulated during anaerobiosis 0,506384283 2,401961838 1,307620047
CAGL0K06853g PCS60 Peroxisomal AMP-binding protein, localizes to both the peroxisomal peripheral membrane and matrix, expression is highly
inducible by oleic acid, similar to E, coli long chain acyl-CoA synthetase 0,350340826 0,602632236 1,842564826
CAGL0I10450g PEX4 Peroxisomal ubiquitin conjugating enzyme required for peroxisomal matrix protein import and peroxisome biogenesis 0,579964235 1,864271183 1,744072854
CAGL0K10846g PCD1 Peroxisomal nudix pyrophosphatase with specificity for coenzyme A and CoA derivatives, may function to remove potentially
toxic oxidized CoA disulfide from peroxisomes to maintain the capacity for beta-oxidation of fatty acids 0,245528995 2,136083568 1,423240841
CAGL0L02167g FOX2 Multifunctional enzyme of the peroxisomal fatty acid beta-oxidation pathway; has 3-hydroxyacyl-CoA dehydrogenase and
enoyl-CoA hydratase activities 0,565804401 0,864892495 0,813039396
CAGL0C02717g SPO7 Putative regulatory subunit of Nem1p-Spo7p phosphatase holoenzyme, regulates nuclear growth by controlling phospholipid
biosynthesis, required for normal nuclear envelope morphology, premeiotic replication, and sporulation 0,740439983 2,241642932 1,023793069
CAGL0I06050g INO1 Inositol 1-phosphate synthase, involved in synthesis of inositol phosphates and inositol-containing phospholipids;
transcription is coregulated with other phospholipid biosynthetic genes by Ino2p and Ino4p, which bind the UASINO DNA element
0,199149497 0,980644708 2,231103342
CAGL0L11154g NTE1 Serine esterase, homolog of human neuropathy target esterase (NTE); Nte1p-mediated phosphatidylcholine turnover
influences transcription factor Opi1p localization, affecting transcriptional regulation of phospholipid biosynthesis genes 0,489665337 1,030944908 1,161214794
CAGL0H05401g GPI2 Protein involved in the synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI), the first intermediate in the
synthesis of glycosylphosphatidylinositol (GPI) anchors; homologous to the human PIG-C protein 0,488983161 0,669866267 1,457107783
CAGL0J03674g DGA1 Diacylglycerol acyltransferase, catalyzes the terminal step of triacylglycerol (TAG) formation, acylates diacylglycerol using
acyl-CoA as an acyl donor, localized to lipid particles 0,55605394 0,929138238 1,316069534
CAGL0L11440g TCB3 Lipid-binding protein, localized to the bud via specific mRNA transport; non-tagged protein detected in a phosphorylated
state in mitochondria; GFP-fusion protein localizes to the cell periphery; C-termini of Tcb1p, Tcb2p and Tcb3p interact 0,4937996 1,382651279 1,417009946
CAGL0D05918g ATF2 Alcohol acetyltransferase, may play a role in steroid detoxification; forms volatile esters during fermentation, which is
important in brewing 0,49848754 3,546955615 1,081035909
CAGL0M06347g YPC1 Alkaline ceramidase that also has reverse (CoA-independent) ceramide synthase activity, catalyzes both breakdown and
synthesis of phytoceramide; overexpression confers fumonisin B1 resistance 0,405796489 1,000120463 1,701430819
CAGL0H01309g DPL1 Dihydrosphingosine phosphate lyase, regulates intracellular levels of sphingolipid long-chain base phosphates (LCBPs),
degrades phosphorylated long chain bases, prefers C16 dihydrosphingosine-l-phosphate as a substrate 0,394561658 1,347064849 1,772875274
CAGL0E03201g CHO2 Phosphatidylethanolamine methyltransferase (PEMT), catalyzes the first step in the conversion of phosphatidylethanolamine
to phosphatidylcholine during the methylation pathway of phosphatidylcholine biosynthesis 0,327551601 0,497245489 1,806545868
CAGL0K01749g OSH2 Member of an oxysterol-binding protein family with seven members in S, cerevisiae; family members have overlapping,
redundant functions in sterol metabolism and collectively perform a function essential for viability 0,264256373 0,975453963 1,838935384
132
Table S7. Gene ID, S. cerevisiae homologous, description and fold changes (FC) of each gene at each fluconazole induction time correspondent to posaconazole, clotrimazole
and fluconazole and voriconazole resistance (continued).
Gene ID Sc.
homologous Description FC at 21st day FC at 31st day FC at 45th day
CAGL0I04620g CST26 Protein required for incorporation of stearic acid into phosphatidylinositol; affects chromosome stability when
overexpressed 0,584647632 0,48776133 1,185525994
CAGL0J10868g HTD2 Mitochondrial 3-hydroxyacyl-thioester dehydratase involved in fatty acid biosynthesis, required for respiratory growth and
for normal mitochondrial morphology 1,142434294 2,201509086 0,963847181
CAGL0F07535g YJU3 Serine hydrolase with sequence similarity to monoglyceride lipase (MGL), localizes to lipid particles 0,434976111 2,295762543 1,231749857
CAGL0E02189g SHR5 Subunit of a palmitoyltransferase, composed of Shr5p and Erf2p, that adds a palmitoyl lipid moiety to heterolipidated
substrates such as Ras1p and Ras2p through a thioester linkage; palmitoylation is required for Ras2p membrane localization 0,79497511 1,91406189 1,381289856
CAGL0M01760g
PDR5 Multidrug transporter of ATP-binding cassette (ABC) superfamily, involved in resistance to azoles; expression regulated by
Pdr1p; increased abundance in azole resistant strains; expression increased by loss of the mitochondrial genome 1,743461565 1,288997951 3,168048601
CAGL0F02717g PDR15 Plasma membrane ATP binding cassette (ABC) transporter, multidrug transporter and general stress response factor
implicated in cellular detoxification; regulated by Pdr1p, Pdr3p and Pdr8p; promoter contains a PDR responsive element 0,517443746 0,866466838 2,466083383
CAGL0M07293g
PDR12 Plasma membrane ATP-binding cassette (ABC) transporter, weak-acid-inducible multidrug transporter required for weak
organic acid resistance; induced by sorbate and benzoate and regulated by War1p; mutants exhibit sorbate hypersensitivity 0,460446292 0,328164817 0,982655789
CAGL0E03674g TPO1 Polyamine transporter that recognizes spermine, putrescine, and spermidine; catalyzes uptake of polyamines at alkaline pH
and excretion at acidic pH; phosphorylation enhances activity and sorting to the plasma membrane 0,489347375 0,626747554 1,000775658
CAGL0G05093g YDR061W Protein with similarity to ATP-binding cassette (ABC) transporter family members; lacks predicted membrane-spanning
regions; transcriptionally activated by Yrm1p along with genes involved in multidrug resistance 0,371550616 2,043490094 1,73413457
CAGL0K10208g PPH3 Catalytic subunit of an evolutionarily conserved protein phosphatase complex containing Psy2p and the regulatory subunit
Psy4p; required for cisplatin resistance; involved in activation of Gln3p 1,817240189 1,337045579 0,81768846